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ABSTRACT 
Dairy calf weaning is associated with increases in ketone levels that exceed 
measured rates of utilization in adults and present a potential energy loss that may be 
mitigated by ionophores. Therefore, effects of weaning and ionophore supplementation 
on nutrient metabolism and growth in dairy calves pre- and post-weaning were examined 
in two experiments. The first experiment consisted of 24 Jersey bull calves blocked in 
groups of two according to birth date and weight and randomly assigned to receive either 
a commercial pelleted starter (CON), or the same diet containing lasalocid (TRT; 83 
mg/kg DM) to examine effects of weaning transition on weight (BW), gain (ADG), and · 
blood concentrations of glucose, acetoacetate (ACAC), (3-hydroxybutyrate (BHBA), 
non-esterified fatty acids (NEF A), volatile fatty acids (VF A), lactate, pyruvate, insulin, 
and glucagon· over 16  wk. The second experiment assessed the effects of weaning and 
lasalocid supplemented starter (listed above) on BW, ADG, net portal-drained viscera, 
hepatic, and total splanchnic fluxes of the same metabolites listed above for Experiment 
1 ,  but were measured on d 35, 56, 84, and 1 1 2 in nineteen Jersey bull calves that were 
equipped with catheters in portal, hepatic, and mesenteric veins and artery at wk 3 - 4. In 
Experiments 1 and 2 all calves were fed milk replacer from d 3 - 34. On d 35, �alves 
began receiving either CON or TRT calf starter ad libitum plus their milk replacer ration 
until weaning on d 49. From d 49-1 1 2  calves received only CON or TRT ad libitum. 
Post-weaning intake, ADG, and feed:gain did not differ between CON and TRT in either 
Experiment 1 and 2. Total VF A and ketones significantly increased and NEF A and 
glucose significantly decreased following introduction of solid feed in both experiments. 
Both experiments demonstrated significant effects of ionophore supplementation on 
VI 
ACAC, BHBA, and VF A during the early post-weaning period. In both experiments 
significant changes in metabolic profile of transition calves were demonstrated peri­
weaning and ionophore appears to moder�te alimentary output at a post-weaning period 
where ketone concentrations have potential to exceed whole animal capacity for 
utilization. 
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PART I 
INTRODUCTION 
1 
2 
The existence and categorical success of mature ruminant animals is largely 
dependent on the end-products of microbial fermentation of complex carbohydrates and 
post-ruminal digestion of microbial protein. However, prior to weaning the animal is 
dependent on a liquid diet of milk and an essentially monogastric digestive system with 
which to process ingesta. The first two months of a young ruminants life require several 
major adaptations. First, the animal must adjust to extra-uterine life and establish a 
functional digestive system capable of obtaining required nutrients from a feedstuff 
instead of maternal blood supply. The second adaptation is weaning to a solid feed. This 
transformation of a preruminant to a functional ruminant is one of the greatest 
modifications of digestive physiology that the animal will ever experience. It is not 
surprising that this period is one of the more perilous in the ruminant animals life. 
Economic loss due to weaning related stress can be substantial for all species of 
production animals. Dairy calf mortality in the first three months of life can range 
between 7 - 14% of all live births (James et al., 1 984; Hartman et al., 1 974; Oxender et 
al., 1 973 ; Speicher and Hepp, 1 973). In addition to mortality, production losses can be 
due to a post-weaning lag in growth rate, increased susceptibility to disease, delayed 
genetic progress, reduced replacements for voluntary culling, and increased purchase of 
replacement calves (James et al., 1 984). Furthermore, rapid rates of daily gain (0.6 - 0.7 
kg/d, depending on breed size) are required to allow dairy calves to reach sufficient 
weight (- 340 kg) for breeding at 14-1 5 months of age. 
The average cost of raising a replacement heifer has been reported to be $1 000 to 
$1 300 per animal (Cady and Smith, 1 996). One management strategy currently in 
practice to reduce costs of replacement heifers is to wean the calf as early as possible. 
3 
This is an attempt to minimize mortality losses and reduce feed and labor costs associated 
with milk feeding. Through daily encouragement of early dry feed intake to stimulate 
rumina} development calves can be weaned as early as 3 - 4 weeks of age without 
negatively affecting subsequent rates of gain (Anderson et al., 1987a; Quigley et al., 
1 991a; Winter, 1 985). 
Encouraging the calf to make the required metabolic, nutritional, and behavioral 
changes to become a functional ruminant and expecting rapid rates of gain immediately 
thereafter represents an extreme challenge to both the animal and the producer. Given 
that feed costs per unit of height or weight increase are lowest during the first 6 months 
of life (Davis and Drackley, 1998) and the dairy industry's increasing emphasis on 
accelerated growth schemes, a clear understanding of the metabolic and physiologic 
challenges the calf faces during this dietary transition is critical to efficient nutritional 
management of replacement heifers. 
Currently, optimal management of the transition from neonatal mono-gastric 
digestion to ruminant fermentative digestion is still largely undefined due to a dearth of 
information concerning the underlying mechanisms controlling use and assimilation of 
nutrients in visceral and peripheral tissues. This includes the period where the animals 
declining dependence on milk-derived nutrients and the increasing dependence on 
fermentative end products do not equally offset each other. This may also require the 
. adaptation of peripheral tissue nutrient utilization systems to a change in source and type · 
of nutrients supplied. The necessity for nutrient production and utilization to act in 
concert is exemplified by the rapid transient nature that rumina} volatile fatty acids 
4 
(VF A) and circulating ketone concentrations increase in conjunction with weaning dry 
feed intake (Quigley et al., 1991a). 
Considerable advancements were made during the 1960's in understanding 
enzyme activity changes relative to weaning and changes in energy metabolite 
concentrations in blood of young ruminants. However, there are few, if any, reports 
regarding changes in net nutrient flux across splanchnic tissues during the transition at 
) 
weaning. Circulating concentrations of a metabolite are a function of the rate of 
appearance and (or) disappearance of that metabolite (Heitmann, 1989). Because the 
available data consists primarily of replicated single site blood samples, they only 
represent the metabolite of interest at a specific location and time and thus, limit the 
scope of interpretation. Because of increasing emphasis on early weaning and potential 
for the rate of post-weaning growth to influence production as an adult, more in depth 
studies that address the physiological changes occurring in digestive tissues surrounding 
weaning should be undertaken. While all species of young ruminants generally undergo 
these adaptations, the dairy calf is unique in the accelerated rate at which it is expected to 
digestively mature. Thus, it is the physiological predicament of the dairy replacement calf 
and the homeorhesis of weaning that is the focus of the following discussion and 
experiments. 
PART II 
LITERATURE REVIEW 
5 
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DEVELOPMENT OF THE FOREGUT 
Development Versus Diet 
Critical to performance of a calf during and after weaning is the ability to progress 
from obtaining energy via post-ruminal digestion of milk/milk replacer to obtaining 
energy from the end products of rumen microbial fermentation of carbohydrates. 
Following parturition, the onset of ruminal development is primarily dependent on the 
diet. However, post-weaning diets cannot adequately provide the nutrients required to 
support maintenance and growth if rumen development is inadequate. At birth the rumen 
has a volume of less than one liter and comprises only one third of the neonate's total 
stomach capacity, while the rumen of a mature animal comprises approximately two 
thirds of the total stomach capacity and a volume of about 150 liters (Church, 1975). The 
absorptive tissue lining the luminal surface of the neonatal rumen is smooth, contains 
minimal papillation, and does not possess the ability produce ketones, which is a 
hallmark characteristic of a functionally mature rumen (Baldwin and Jesse, 1992; 
Giesecke et al., 1979). 
The adult rumen epithelium is very similar in cell type to skin. A keratinized 
stratified squamous epithelium, it consists of four cell strata: the stratum corneum, 
stratum granulosum, stratum spinosum, and stratum basale (Steven and Marshall, 1970). 
Like skin, rumen epithelial cells are keratinocytes that provide a protective barrier, but 
differ from skin as the rumen lining is also an absorptive epithelium. Cells making up the 
stratum bas ale are thought to be responsible for the majority. of metabolic activity 
attributed to mature form of this tissue, as demonstrated by their extensive rate of 
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ketogenesis relative to cells isolated from the other layers (Baldwin and Jesse, 1 991 ; 
1992). The number of metabolically active cells per gram of rumen epithelium decreases 
with age (Lavker et al., 1969). This results from the increasing proportion of 
metabolically inactive cells that comprise the granulosa/ and corneal cell strata 
increasing with age relative to the number of metabolically active cells in basal in 
spinous strata (Lane et al., 2000). The newborn epithelium is non-keratinized and 
contains a high concentration of glycogen (Henrikson, 1970; Wardrop, 1961). However, 
seven days after birth the epithelium begins to resemble the keratinizing epithelium of an 
adult and retains only traces of glycogen, which are completely lost by day 35 
(Henrikson, 1970). The complete disappearance of cellular glycogen is concomitant with 
the appearance of a prominent intercellular glycocalyx and basal infoldings which are 
indicative of a developing transport function in the tissue (Henrikson, 1970). 
Functional development of rumen epithelium, particularly papillary growth 
appears to coincide with the initiation of dry feed intake (Warner et al., 1956; Tamate et 
al. ,  1962). However, the development in physical size of the organ is not pari passu with 
papillary growth (Brownlee, 1956). Blaxter et al. (1 952) noted that calves fed milk and 
hay had a marked increase in the capacity of the nimen, reticulum, and omasum without 
an increase in the empty weight of the respective organs. Tamate et al. (1 962) introduced 
indigestible sponges into the rumen of milk fed calves and observed an increase in overall 
rumen capacity and musculature, but not papillary development. Thus, there is a 
requirement for bulk, but growth, development and differentiation of the rumen mucosa 
appear to be dependent on resulting chemical stimuli and end products of rumen 
fermentation. Specifically, production and subsequent absorption of volatile fatty acids 
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(VFA) have been associated with the onset of rumination as early as seven days 
following birth (Tamate et al., 1962). Two weeks after parturition the oxidation of both 
butyrate and glucose to carbon dioxide by the rumen epithelial cells has been shown to 
occur at similar rates in vitro (Baldwin and Jesse, 1 992). However, as noted above, the 
capacity of rumen cells to produce ketones from butyrate is very low prior to weaning 
and increases rapidly post-weaning (Baldwin and Jesse, 1 992; Giesecke et al., 1 979). The 
post-weaning increase in ketogenic potential coinci.des with a decline in glucose 
oxidation and an increased preference for butyrate as an oxidative substrate (Baldwin and 
Jesse, 1 992; Bush, 1 988). 
Establishment of rumina} fermentation and successive production of VF A 
stimulates neonatal rumen development. Many changes in the ruminal environment are 
necessary for increases in surface area and metabolic activity of the rumen to coincide 
with dry feed intake. Increased bacterial numbers, rumina} synthesis and concentration of 
VF A, and decreased ruminal pH have all been related to feed consumption (Anderson et 
al ., 1 987a; Anderson et al. ,  1 987b). Two to three weeks following weaning, forestomach 
development and concentrations of ruminal metabolites typically reach levels associated 
with those found in mature ruminants (Wardrop, 1 961 ; Fahey and Berger, 1 993). 
Through ruminal infusion of VF A, an increased absorptive capacity and metabolic 
activity of the epithelium including the production of ketones, primarily from butyrate 
· has been observed (Hird and Weidemann, 1 964; Sutton et al., 1 963a; Sutton et al.; 1 963b; 
Walker and Simmonds, 1 962). Other studies have shown that infusion of VF A into the 
rumen of calves promoted increases in papillary size and greater blood flow to epithelial 
tissue {Tamate et al., 1 962; Sander et al., 1 959; Flatt et al., 1 959). Conversely, the degree 
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of subepithelial vesiculation in the rumen, a necessary component of metabolite 
absorption from the rumen to the portal blood, has not been shown to be a result of age of 
the calf or dietary management (Lotz et al. ,  1 997). 
These increases in absorption and metabolic activity result from the large 
increases in papillae numbers and size, which expand the luminal surface area of the 
rumen available for VFA absorption (Warner et al., 1956; Tamate et al. ,  1 962). Butyrate 
is thought to be the primary luminal stimulator of rumen epithelial development in vivo 
(Sakata and Tamate, 1 976, 1 978) and also has, through dietary treatments, been 
implicated in influencing the size, thickness of the corneal layer, and metabolism of the 
rumen mucosa in adult ruminants (Harmon et al. 1 991  ). The rapid increase in ruminal 
VF A peri-weaning results in significant increases in cell mitotic indices of sheep in vivo 
(Sakata and Tamate, 1 978) with butyrate being the most efficacious. In contrast, cultured 
rumen epithelial cells treated with butyrate demonstrate decreased cell DNA synthesis 
(Neogrady et al. 1 989) and decreased cell proliferation (Baldwin, 1 999). This disparity in 
actions of butyrate in vivo and in vitro is unclear and is still an area of research that is 
being actively investigated. In light of the conflicting reports, it is unlikely that butyrate is 
solely responsible for stimulation of development, but may require the complement of 
some other product of rumen fermentation for complete development to occur (Lane and 
Jesse, 1 997). 
Glucose and Propionate Metabolism 
Prior to weaning, the calf is dependent on dietary carbohydrates for its supply of 
glucose (Lyford and Huber, 1 993). Following weaning, all glucose must be derived from 
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non-carbohydrate compounds via hepatic gluconeogenesis, or post-ruminal glucose 
absorption. From three to eight weeks of age rumen development must be sufficiently 
advanced to provide adequate VF A to satisfy energy requirements of the young animal. 
By about eight weeks of age capacity for glucose uptake and oxidation by rumen 
epithelium becomes limited (Baldwin and Jesse, 1992; Bush, 1988; Giesecke et al., 
1979). 
It has been estimated that as much as 60 to 80% of an adult ruminant's daily 
energy requirement is derived from VFA absorbed from the rumen (0rskov, 1980). As 
the young animal becomes increasingly reliant on VF A as a primary energy source, 
propionate stands out as the only glucogenic VF A. Propionate undergoes varying degrees 
of metabolism to lactate and pyruvate by the rumen epithelium during absorption and 
numerous laboratories have suggested that the amount of propionate converted to lactate 
by the rumen epithelium is between 30 - 50% (Pennington and Sutherland, 1956; Leng et 
al., 1967; Stevens, 1970; Bergman and Wolff, 1971). However, subsequent investigations 
concluded that an average of 2 to 3% propionate was converted to lactate by rumen 
epithelium and was of little quantitative significance to the animal (Weekes and Webster 
1975; Weekes 1972; Weigand et al., 1972). This disparity in propionate metabolism is 
likely the result of species (sheep have a higher propionyi-CoA synthetase activity than 
cattle and may be partially the cause of the increased epithelial metabolism) and 
experimental diet differences. The purpose of epithelial metabolism of propionate to 
lactate relative to the conversion of butyrate to acetoacetate (ACAC) and Jl­
hydroxybutyrate (BHBA) may serve to satisfy mitochondrial and cytosolic redox states 
of the cell (Baldwin and Jesse, 1996; Weekes and Webster, 1975). 
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Regardless of the extent of propionate conversion by the rumen epithelium, there 
is little propionate found in arterial blood because of effective hepatic removal of it from 
the portal vein (Bergman et al., 1966). In a normally fed animal the liver removes up to 
80-1 OOo/o of the propionate from the portal blood (Bergman and Wolff, 197 1 ). In addition 
to the extensive utilization of propionate for gluconeogenesis, amino acids have shown 
increased potential as gluconeogenic substrates as the demand for glucose increases 
(Wolff et al., 1972; Overton et al. ,  1999). Nocek et al. ( 1980) reported higher propionyl-
CoA synthetase (E. C. 6.2. 1. 17) activity in the rumen epithelium of calves fed ground hay 
compared to those fed chopped hay at eight weeks of age. Also, the amount of propionate 
converted to lactate by the rumen epithelium is affected by concentrations of butyrate, 
which has been shown in vitro to inhibit the metabolism of propionate, as a result of the 
inhibition of the activating enzyme propionyl-CoA synthetase (Ash and Baird, 1973). 
Thus, the metabolic fate of propionate in ruminal and hepatic tissue is directly related not 
only the to animals stage of development, but also to diet type. 
Butyrate and Ketone Metabolism 
In addition to supporting increased absorption of VF A, the papillae appear to be 
the major site of metabolism and are one of the few mammalian ketogenic organs 
(Leighton et al., 1 983). In fed and non-pregnant ruminants, the rumen epithelium has 
been shown to be the most active ketogenic organ (Heitmann et al., 1987; Huntington and 
Reynolds, 1 987). Typically in the adult ruminant, as much as 90% of the ruminally 
absorbed butyrate is metabolized by the rumen epithelium (Bergman, 1975; Bergman, 
1 990) and approximately 75% to 80% of the absorbed butyrate is converted to BHBA 
) 
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and ACAC by the rumen prior to release into portal circulation (Heitmann, et al., 1 987; 
Ramsey and Davis, 1965 ; Stevens, 1970). It has been demonstrated that mature rumen 
papillae contain enzymes necessary for ketone production, including fl-hydroxy, fl­
methylglutaryl-CoA (HMG-CoA) synthase (E.C. 4. 1 .3 .5), HMG-CoA lyase (E.C. 
4. 1 .3 .4), acetoacetyl-CoA thiolase (E.C. 2.3 . 1 .9), and BHBA dehydrogenase (E.C. 
1 . 1 . 1 .30; Baird et al. , 1 970; Bush and Milligan, 1 97 1  ; Koundak:jian and Snoswell, 1 970). 
In contrast, the undeveloped papillae of a preruminant lacks sufficient activity of key 
enzymes demonstrated by the inability to produce notable amount of ketones from 
butyrate prior to 6 weeks of age (Baldwin and Jesse, 1 992; Giesecke et al., 1979). 
Through the developmental processes papillae making up the maturing rumen mucosa 
achieve high activities of these enzymes. Recent findings by Lane et al. (2000) using 
isolated rumen epithelial cells from lambs consuming milk replacer demonstrated that 
consumption of solid feed and resultant VF A production were not required to stimulate 
development of rumen epithelial ketogenic potential. This strongly supports findings of 
Giesecke et al. (1 979) and Bush (1 988) who used rumen epithelial slices taken from 
preweanling lambs and calves (respectively) to demonstrate that rumen ketogenesis is 
largely increased with age, particularly between 4 and 1 0 weeks, even when stimulation 
by rumen fermentation products is prevented. These three in vitro studies indicate that 
consumption of solid feed and production of VF A are not required to stimulate 
development of epithelial ketogenesis. This suggests an ontogenic respo�se rather than a 
diet induced event and that certain aspects of rumen metabolic development may occur 
independently from morphological development. 
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P-Hydroxybutyrate is the matn circulating ketone body released into portal 
circulation in fed ruminants (Katz and Bergman, 1969a; Heitmann et al. ,  1 987) and 
ACAC produced by rumen epitheliwn is quantitatively removed from circulation by 
conversion to BHBA by the liver (Heitmann et al., 1 986). This is the result of rumen 
epithelial BHBA dehydrogenase being located in the mitochondria (Leighton et al., 
1 983), but the hepatic isozyme of BHBA dehydrogenase resides primarily in the cytosol 
(Watson and Lindsay, 1972; Koundakjian and Snoswell, 1 970). However, during fasting, 
changes in the circulating insulin-to-glucagon ratio, and release of non-esterified fatty 
acids (NEF A) from adipose will result in hepatic metabolism of NEF A to ketone bodies 
(Robinson and Williamson, 1980) causing a shift from alimentary to hepatic ketogenesis. 
Peripheral utilization of the ketones ACAC and BHBA may be for oxidation or 
lipogenesis and because the presence of ketones serves to conserve other body fuels (in 
particular glucose, alanine, and glycerol) they are associated with metabolic regulation 
(Robinson and Williamson, 1 980). The portal-drained viscera (PDV) and hepatic tissues 
contribute to nutrient partitioning by regulating the structure and quantity of absorbed 
nutrients available (a cost of service function) to the peripheral tissues and by regulating 
the amounts of insulin and glucagon released to peripheral tissues (Reynolds and Maltby, 
1994). Ketones produced by the rumen epitheliwn and liver can be used as an energy 
source by most tissues. The initial step in the oxidation of BHBA is dehydrogenation to 
ACAC by 13-hydroxybutyrate dehydrogenase (E. C.  1 . 1 . 1  .30). Acetoacetate must then be 
converted to acetoacetyl-CoA by succinyl-CoA transferase (E.C. 2.8.3 .5), cleaved by 
acetoacetyl-CoA thiolase (E.C. 2.3 . 1 .9) to yield two acetyl-CoA moieties, which are 
\ 
subsequently oxidized in the TCA cycle (RobinSon and Williamson, 1 980). Alternatively, 
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ketones may be used for lipid synthesis through acetyl-CoA and malonyl-CoA formation 
(Kronfeld, 1970). 
A prerequisite for the neo-ruminant to utilize ketones is the presence of the 
necessary enzymes in peripheral tissues in sufficient concentrations to accommodate a 
sudden increase in circulating ketone concentrations. Vamam et al . (1 978a) evaluated 
succinyl-CoA transferase (E.C. 2.8.3.5) activities in renal, cardiac, and cerebral tissue 
from fed and fasted sheep. Following a four-day fast, succinyl-CoA transferase activity in 
all three tissues was significantly lower than the respective activity measured in fed 
sheep. Because succinyl-CoA transferase is required for metabolism of acetoacetate, a 
lack of activity or significant decrease will reduce the capacity of the tissue to oxidize 
ketones. In a review of lipid and carbohydrate metabolism during ruminant post-natal 
development, Leat ( 1 970) points out that as the calf makes the transition from milk to a 
solid feed diet between 3 to 8 weeks of age the metabolic predominance of absorbed 
glucose is decreasing, but plasma VF A levels can be insufficient because ruminal 
development has not progressed sufficiently to provide enough VF A to satisfy energy 
requirements. This incomplete development may also be the case for ketone utilization 
components in peripheral tissues. This places the animal in a precarious balance between 
fed and fasted states and a mild stress is enough to deplete liver glycogen and increase 
circulating concentrations ofNEF A. 
In vivo measures of circulating metabolites have demonstrated that a strong 
positive relationship exists between increasing calf starter dry matter intake (DMI) and 
blood BHBA and ACAC concentrations (Quigley et al., 1 991a; Quigley et al ., 1992; 
Quigley, 1996). In the early 1990's a series of studies monitored blood metabolite 
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concentrations in young calves. These studies evaluated the effects of grain feeding and 
weaning age (4 or 8 weeks) on concentrations of blood metabolites (Quigley et al. ,  
199 1  a; Quigley et al. ,  1991 b), the relationship of time of feeding and sampling on 
concentrations of rumina} and blood metabolites (Quigley and Bernard, 1992), and the · 
inclusion of lasalocid on rumina} fermentation and blood metabolites in young calves 
(Quigley et al., 1992). Each experiment reported that concentrations of blood ketones 
were positively correlated with increased grain intake in young calves. Normal levels of 
NEF A and glucose measured in the above studies by Quigley and co-workers suggests 
that the elevated ketones were not the result of hepatic ketogenesis. Unexpectedly, 
average postweaning increases of total ketone concentrations greater than 1 mmole/L 
and, occasionally greater than 2 mmole/L were observed (Quigley et al., 1991 a). 
Generally, in adults, blood ketone concentrations of 1 mmole/L are indicative of 
subclinical ketosis (Bergman, 1 984) and concentrations above 2 mmole/L result in 
clinical symptoms. However, it was noted by Quigley et al. ( 1991a) that no negative 
effects or symptoms were observed that could be related to the observed hyperketonemia. 
It was reported by Bergman ( 197 1 )  for ACAC and also by Leng (1 965) for BHBA that 
rate of ketone turnover and oxidation to carbon dioxide by peripheral tissues is 
proportional to the circulating concentrations up to approximately � mmole/L. Beyond 
this concentration, slight increases in ketone production resulted in considerable increases 
in blood concentration. This phenomenon is a potential explanation for the rapid increase 
in circulating ketone concentrations found in the weanling calf. 
Unfortunately, the majority of data concerning the peri-weanling calf including 
the Quigley studies discussed above were obtained via peripheral, single site sampling 
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(e.g., jugular venipuncture) of metabolites that are solely (e.g. , propionate), or partially 
(e.g., amino acids) dependent on dietary intake, rumen fermentation, or absorption and 
are confounded by PDV and hepatic metabolism. In addition, the liver extracts amino 
acids from the portal blood of fed sheep at rates similar to their addition by the PDV 
(Heitmann and Bergman, 1 980). Currently, the only publications concerning net nutrient 
flux in preruminant calves have been published by Ortigues et al. (1 994, 1995, 1 996). 
However, they were using veal calves, thus only concerned with events pre-weaning and 
not the effect of weaning. Consequently, changes in interorgan metabolism that may 
represent nutritional or physiological stress may be occurring peri-weaning that are not 
reflected by single site sampling in the current literature and is an area of research that 
should be pursued in greater detail. 
HEPATIC ADAPTATIONS TO FOREGUT DEVELOPMENT 
Development Versus Adaptation 
The concentration of any circulating metabolite is a �ction of relative rates of 
production and utilization. Production may be endogenous (biosynthesis) or exogenous 
(dietary). Hepatic output is a function of the type and quantity of nutrients delivered 
mainly ( -90 %; Reynolds et al., 1 995) via the portal vein. Because all portal derived 
exogenous nutrients must pass through it, the liver has a central role in determining the 
amount and variety of nutrients available to peripheral tissues. In developing animals, the 
peri-weaning digestive adaptation from a preruminant to functional ruminant causes a 
significant change . in the portal blood profile. Consequently, this change in dietary 
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nutrient pattern and supply causes substantial alterations in hepatic function and output. 
Most research directed at elucidating hepatic mechanisms involved with this period of 
transition have attempted to determine whether the preruminant liver is always equipped 
to accommodate the digestive adaptations of the foregut or whether the liver undergoes a 
maturation process of its own in response to ruminal development. 
Hepatic Enzymatics 
The most notable of changes in principle metabolic processes during ruminal 
development is the shift from a glycolytic to glucogenic liver. Table 2. 1 is a 
representative compilation of enzymes and changes in activities relative to weaning. As 
microbial fermentation increases, less carbohydrate is available for post-ruminal 
digestion and the dietary supply of glucose diminishes. Like the rumen epithelium, these 
changes in glucose metabolism were reviewed in detail by Leat (1 970). There is a basic 
reduction in enzyme capacity for hepatic glucose oxidation via glycolytic and hexose 
monophosphate pathways (Bartley et al., 1966) caused by decreased activities of hepatic 
glucose-6-phosphate dehydrogenase (E.C. 1 . 1 . 1 .49), 6-phosphogluconate dehydrogenase 
(E.C. 1 . 1 . 1 .44) and fructose 1 ,6-bisphosphate aldolase (E.C. 4. 1 .2. 1 3), glyceraldehyde 3-
phosphate dehydrogenase (E.C. 1 .2. 1 . 1 2; Goetsch, 1966; Leat, 1970). Hepatic tissue must 
now support a larger portion of the animals glucose requirements. Concurrent with 
decreased importance of glycolytic pathways is the rapid increase in activity of hepatic 
gluconeogenic enzymes (Table 2 . 1 )  with ruminal development, with glucose 6- · 
phosphatase (E.C. 3 . 1 .3 .9) activity shown to double during this period (Bartley et al., 
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Table 2.1 .  Changes in hepatic enzyme activity with the shift in metabolic priorities 
associated with rumina} develoEment. 
Activity1 
Enzyme Species Pre- Ruminant Source ruminant 
Pentose Phosphate Pathway 
Glucose-6-phosphate dehydrogenase Bovine + Goetsch, 1 966 
6-Phosphogluconate dehydrogenase Bovine + Howarth et al., 1968 
Glycolysis 
Hexokinase Ovine + Leat, 1970 
Fructose- I ,6-bisphosphate aldolase Bovine + Howarth et al., 1968 
Glyceraldehyde 3-phosphate Bovine + Howarth et al., 1968 dehydrogenase 
Pyruvate kinase Ovine NC NC Edwards et al ., 1975 
Tricarboxylic Acid Cycle 
Citrate Synthase Ovine NC NC Edwards et al., 1975 
Malate dehydrogenase Ovine NC NC Edwards et al., 1975 
Gluconeogenesis 
Glucose-6-phosphatase Bovine + Bartley et al., 1 966 
Ovine + Ballard and Oliver, 1 965 
Fructose-I ,6-bisphosphatase Ovine + Ballard and Oliver, 1 965 
Pyruvate carboxylase Ovine + Warnes et al., 1977 
Lactate dehydrogenase Ovine + Edwards et al., 1 975 
Glycogen Metabolism 
Glycogen synthase Ovine + Ballard and Oliver, 1 965 
Glycogen phosphorylase Ovine + Ballard and Oliver, 1 965 
Bovine + Bartley et al., 1966 
Ketone Metabolism 
�-hydroxybutyrate dehydrogenase Ovine + Vamam et al., 1 978b 
Acetyl-CoA acetyltransferase Ovine + Vamam et al., 1 978b 
Acetyl-CoA synthetase Ovine NC NC Leat, 1 970 
1Changes in enzyme activity relative to before or after weaning: (+) = increased 
enzyme activity, (-) = reduced enzyme activity, (NC) = no change in enzyme 
activity. 
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1 966). At this point in the animal's post-weaning development, propionate can be taken 
up from the portal blood by hepatic tissues and activated to propionyl-CoA, carboxylated 
to methylmalonyl-CoA, and enter the tri-carboxylic acid {TCA) cycle as succinyl-CoA 
(Bergman, 1 990). The three carbons originally from propionate can now be converted 
through the gluconeogenic pathway to be released in the hepatic vein as glucose or 
remain in the liver stored as glycogen. 
Concomitant with changes in enzyme activity associated with decreased glucose 
oxidation is the fact that basal rates of hepatic gluconeogenesis from propionate are 
similar in newborn, weaned, and adult sheep (Ballard and Oliver, 1965) and in cattle 
(Young et al., 1 965; Donkin and Armentano, 1995). Hepatic glucose production is 
thought to be the primary means of lactate clearance in the preruminant (Edwards et al., 
1975). The capacity for hepatic metabolism of L-lactate or pyruvate to glucose is two to 
three-fold greater in preweanling than adult sheep (Ballard and Oliver, 1 965; Savan et al., 
1 986). More recently, using hepatocyte monolayers taken from preruminating and 
ruminating calves, Donkin and Armentano ( 1 995) demonstrated that gluconeogenesis 
.from lactate was approximately 1 0-fold greater in preruminating than ruminating calves. 
Ortigues et al . (1 996) determined the maximum contribution of lactate to hepatic glucose 
production was 20% in preruminant calves fitted with chronic indwelling catheters in · 
portal, hepatic, and mesenteric vein and artery. Van der Walt et al. ( 1983) also attributed 
20% of hepatic uptake of lactate being released as glucose in adult sheep. This apparent 
contradiction by lack of difference using preruminant and ruminant in vivo models is 
probably attributable to a species difference, because cattle and sheep show different 
rates of propionate conversion to lactate by rumen mucosa (reviewed by Bergman, 1990). 
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While preruminants can convert either lactate or propionate to glucose, the inhibition of 
gluconeogenesis from lactate in ruminants is probably a result of increased availability of 
propionate (Donkin and Armentano, 1 994). Thus, the shift in hepatic gluconeogenic 
metabolism may be a response to development of the functional rumen generating a more 
continuous supply of glucogenic substrate in the form of propionate in contrast to 
preruminant prandial patterns of nutrient delivery. 
Insulin and Glucagon 
Differences in preruminant and ruminant portal nutrient delivery to the liver are 
also evident in hormonal regulation of liver function. As rumina} development progresses 
there is a decreased sensitivity of hepatic gluconeogenesis in response to acute 
aberrations in insulin and glucagon concentrations. In hepatocytes isolated from 
preruminants, glucagon effectively increases hepatic gluconeogenesis from propionate 
and lactate, but had no effect on mature ruminant hepatocytes (Donkin and Armentano, 
1 995). Donkin and Armentano ( 1 995) also demonstrated decreased gluconeogenesis and 
increased net de novo glycogenesis from propionate in the presence of insulin only in 
preruminant hepatocytes. Activities of enzymes (Table 2. 1 )  glycogen synthetase (E. C. 
-
2.4. 1 . 1 1 )  and phosphorylase (E.C. 2.4. 1 . 1 )  associated glycogen formation and 
degradation were elevated, but appeared to decrease to adult levels by 2-3 months 
(Ballard and Oliver, 1 965). Hepatic glycogen reserves of the preruminant typically equal 
or exceed adult levels (Ballard and Oliver, 1 965). However, a short 1 6  hour fast results in 
consumption of almost all liver glycogen, while similar fasts had little effect on hepatic 
glycogen in adults (Boda et al. ,  1 962). Much more sensitive to insulin, the young 
t... 
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preruminant is similar to non-ruminants (Leat, 1970), but concurrent with rumina! 
development is decreased sensitivity to glucagon and a complete loss of insulin 
sensitivity (Donkin and Armentano, 1 995). This is probably also a result of the liver 
becoming a steady producer of glucose and cessation of post-prandial spikes in 
circulating concentrations of glucose. 
Hepatic Ketogenesis 
Unlike the adult where the foregut is the primary producer of ketones, the 
preruminant foregut produces negligible amounts of ketones due to the absence of 
microbial fermentation, the liver being the primary site of ketogenesis. The immature 
fetal lamb liver is incapable of acetoacetate synthesis, but hepatic tissue of term fetus and 
the 1 5  week old lamb are capable of both synthesis of acetoacetate and conversion to �­
hydroxybutyrate (Varnam et al., 1970). Following birth, the preruminant liver has the 
ability to synthesize acetoacetate from acetyl-CoA (V arnam et al., 1 978b) and from 
butyrate (Hird and Weidemann, 1 964 ). In developing sheep, hepatic activities (Table 2. 1 )  
of �-hydroxybutyrate dehydrogenase (1 . 1 . 1 .30) and acetyl-CoA transferase (E. C .  2.3 . 1 .9) 
increased with increasing J3-hydroxybutyrate concentrations, but were not as high as 
activities measured in fed adults when the rumina! epithelium was the primary ketone 
producer (Varnam et al., 1978a). This is a likely indication of the adult hepatic 
conversion of portal-derived acetoacetate to �-hydroxybutyrate by cytosolic �­
hydroxybutyrate dehydrogenase (Koundakjian and Snoswell, 1 970) that results in a net 
hepatic output of �-hydroxybutyrate and uptake of acetoacetate (Heitmann et al., 1987). 
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In the event of fasting, the unfed preruminant is capable of hepatic ketogenesis from the 
time of birth, but does not assume the role of secondary ketone producer until ruminal 
development is complete. 
While the change in diet that occurs peri-weaning causes a morphological and 
metabolic transformation in the foregut, changes in hepatic physiology appear to be 
. secondary and more of an adjustment to a change in portal supplied nutrients brought on 
by a prolific ruminal fermentation. 
LASALOCID SUPPLEMENTATION 
Basic Chemical and Biologic Properties 
Lasalocid (Figure 2. 1 )  belongs to a class of compounds identified as carboxylic 
polyether ionophore antibiotics (commonly referred to as ionophores) and was isolated 
from Streptomyces lasaliensis (Westley et al., 1974). Ionophores as a group have a 
carbon backbone and oxygen atoms located throughout the molecule. The backbone can 
assume conformations that allow the oxygen molecules to congregate in the center of a 
HO 
Me 
OH 
Me 
Figure 2.1 . Chemical structure of lasalocid, acyclic form 
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ring or cavity. Through hydrogen bonding between the ether, hydroxyl, and carboxylic 
oxygen and the cation, the ionophore can effectively trap a cation (McGuffey et al . ,  
2001 ). It is this conformation and binding that gives most ionophores the biological 
ability to alter movements of cations such as sodium, potassium, and calcium across cell 
membranes (Chalupa, 1980). Ionophores have both polar and nonpolar regions that 
enhance cation entrapment and interaction with cell membranes (McGuffey et al., 2001 ). 
When bound with a cation the ionophore-cation complex is able to form a stable 
zwitterion that is lipophilic and can readily solubilize in the phospholipid bilayer making 
up cell membranes (Pressman, 1976). Because ionophores have this ability to attach to 
membranes of bacteria and protozoa (Chow et al ., 1994), they facilitate the movement of 
cations across the membrane or concentration gradient. 
Cation gradients and relative affinities drive the resultant primary and secondary 
cation-proton exchanges. These exchanges occur rapidly and possibly at rates exceeding 
1000 events per second (Pressman, 1976). These actions culminate in disruption of 
normal physiological concentration gradients (Russell and Strobel, 1989). Ultimately, the 
bacteria (typically gram-positive) are forced to utilize energy consuming transport 
systems such as proton and sodium A TPase pumps to dissipate the accumulating 
intracellular W and Na+. This generates an energetic p�eoccupation with active transport 
that reduces energy reserves and diminishes the means for cell division. For ruminal 
microbes this typically leaves the affected organism unable to sustain a rate of cell 
division necessary to adequately maintain metabolic significance (Russell and Strobel, 
1989). 
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Lasalocid has affinities for both monovalent and divalent cations and when 
immersed in a membrane, exchanges them for one or two protons, respectively 
(Pressman, 1 976). Specifically, lasalocid has affinities for monovalent cations, Na + and 
K+ with a greater affinity for K+ (Painter and Pressman, 1 985; McGuffey et al., 2001 ). 
Lasalocid also has the ability to form dimer complexes (Westley, 1 978) that creates a 
larger chelation cavity and causes a significant affinity for divalent cations (e.g., Ca2} 
and K+ over Na+. 
As mentioned above, lasalocid and ionophores in general have a predominant 
effect on gram-positive bacteria. The resistance of the majority of gram-negative bacteria 
to ionophorous perturbations is thought to be a consequence of the outer membrane that 
is impermeable to large molecules (Russell and Strobel, 1989). The cell envelope of 
gram-negative bacteria consists of a multilayered complex of two distinct membranes 
that are divided by a rigid peptidoglycan layer (Bergen and Bates, 1 984). This broad 
selection of bacteria by the ruminal presence of an ionophore modulates the resident 
populations and is the predominant cause of all effects associated with supplementation. 
Effects of Lasalocid Supplementation 
Supplementing animal feed with ionophores results in a large number of 
biological responses, a number of which are advantageous to production efficiency. 
Ionophores have been fed to reduce the occurrence of bloat and coccidiosis and to 
improve feed efficiency and growth rate (Goodrich et al., 1 984). Spears ( 1 990) 
demonstrated that lasalocid-supplemented cattle had 2.0% increase in apparent 
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digestibility that was significant over controls. Lasalocid has been reported to have 
similar effects on ADG and feed:gain as monensin (Bergen and Bates, 1 984). 
. The most widely recognized response associated with the supplementation of 
ionophores is the modification of rumina} microbial populations and subsequent shift in 
VF A production ratios. Due to the microbial selectivity of the ionophore, shifts in rumen 
fermentation patterns occur (Nagaraja et al. ,  1 987) causing a decrease in gram-positive 
bacteria that are commonly producers of acetate, butyrate, H2, and ammonia. This 
response, in tum, allows increased production of the gluconeogenic precursor propionate 
(Schelling, 1 984). Chalupa (1 977) determined the efficiencies of fermenting hexoses to 
acetate, propionate, and butyrate, and demonstrated that production of propionate was 
more energy efficient than production of either butyrate or acetate. Increased ruminal 
propionate production increases energy efficiency for retention by decreasing 
fermentative energy lost as eructated methane. Ionophores do not inhibit methanogenesis 
per se, but divert metabolic H2 and formate away from methane production to propionate 
production (Bergen and Bates, 1 984). Moreover, propionate appears to be more 
efficiently used by tissues than acetate (0rskov et al., 1 979) and may either be oxidized 
or used for gluconeogenesis depending on the prevailing metabolic demand. 
Because it is possible to manipulate the proportions of VF A produced in ruminal 
fluid, it should be possible to manipulate the proportions of energy substrates released in 
the portal blood from the rumen epithelium. Using monensin-supplemented steers 
consuming a high concentrate diet, Harmon and A very ( 1987) reported a decreaSe in net 
portal flux of butyrate and no significant increase in propionate release into the portal 
vein. Murdock and Wallenius (1 980) suggested that increasing proportions of rumina} 
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butyrate might Increase the rate of ruminal development, as butyrate is especially 
mitogenic to ruminal epithelium (Tamate et al., 1 962; Sander et al ., 1 959). However, 
feeding high grain rations to increase concentrations of rumina} butyrate may serve to 
further increase production of blood ketones from ruminally produced butyrate and 
contribute to elevation of ketone concentrations at weaning. 
Krehbiel et al. (1 992) demonstrated that increased ruminal butyrate resulted in an 
increased portal-drained visceral flux of butyrate, which was associated with an increased 
portal-drained visceral flux of ACAC, but not BHBA. In contrast, monensin reduced 
blood ketone concentrations in lactating dairy cows (Sauer et al., 1989), which appears to 
result from a shift towards higher rumina} production of propionate (Bull et al., 1 979). 
Research examining lasalocid demonstrated decreased ruminal butyrate and blood f3-
hydroxybutyrate in weaned calves (Quigley et al., 1 992) and appeared to decrease 
alimentary ketogenesis in mature ewes (Heitmann et al., 1 994} and wethers (Housewright 
et al., 1994). 
Ionophores are implicated in myriad of effects that contribute to a greater overall 
ruminant efficiency. As such, supplementing weanling calf diets with ionophores may be 
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an effective method to decrease circulating levels of ketones or increase circulating levels 
of glucose-sparing propionate. This change in ruminally derived nutrients may minimize 
any potential exacerbation of the post-weaning lag in growth reported by James et al. 
(1 984). 
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PART III 
EFFECTS OF WEANING AND AN IONOPHORE ON SELECTED 
BLOOD METABOLITES AND GROWTH IN DAIRY CALVES 
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ABSTRACT 
Dairy calf weaning is associated with elevated ketone levels in excess of 
measured rates of utilization in adults and excess concentrations excreted in urine present 
a potential energy loss. Lasalocid is frequently supplemented as an anticoccidial in calf 
starters, but in adults is also known to alter molar ratios of rumina! VF A. Jersey bull 
calves (n = 24) were blocked in groups of two according to birth date and weight and 
randomly assigned to receive either a commercial pelleted starter (CON), or the same 
diet containing lasalocid (TRT; 83 mg/kg DM) to examine effects of weaning transition 
on weight (BW), dry matter intake (DMI), gain (ADG), and blood glucose, (l-
hydroxybutyrate (BHBA), non-esterified fatty acids (NEFA), volatile fatty acids (VFA), 
insulin, and glucagon (GLN) concentrations over 16  wk. From d 3 - 34 all calves were 
fed milk replacer twice daily, d 35 - 48 received replacer and CON or TRT, and d 49 -
1 12 received ad libitum CON or TRT. Body weights and metabolite concentrations from 
jugular samples were measured and recorded weekly. Postweaning intake (2.35 vs. 2.34 
kgld; ± 0.07), ADG (0.78 vs. 0.75 kgld; ± 0.03), and feed : gain (3 . 10  vs. 3 . 19; ± 0. 1 1 ) 
did not differ between CON and TRT. Glucose and NEFA concentrations did not differ 
between CON and TRT, but declined with age. Insulin and GLN concentrations did not 
differ between CON and TRT, but GLN increased with weaning. Total VFA significantly 
' 
increased following introduction of solid feed at d 35, but there was a one-wk lag period 
with TRT. Acetate and butyrate concentrations were greater in CON than TRT during wk 
7 (P < 0.05). Propionate concentrations and acetate : propionate ratios did not differ 
between CON and TRT. Blood BHBA concentrations were greater in CON than TRT (P 
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< 0.05) during wk 8 and 9 (1 .0, 1 . 1  vs. 0.7, 0.8 mmol/L; ± 0. 1 ). Consumption of starter 
with lasalocid delayed peak acetate and butyrate and lowered peak BHBA concentrations, 
but did not appear to significantly influence post-weaning growth or efficiency. 
INTRODUCTION 
Rumen development In the young calf originates from dry feed intake, 
establishment of ruminal fermentation, and resultant volatile fatty acid (VF A) production 
(Tamate et al., 1962; Sutton et al ., 1 963a). Butyrate is the most mitogenic of the three 
major rumina} VFA (Sakata and Tamate, 1976; 1 978) and once absorbed, butyrate is 
extensively metabolized by the rumen epithelium to acetoacetate (ACAC) and �­
hydroxybutyrate (BHBA) prior to release into portal circulation (Bergman, 1 990). At 
weaning there is a large increase in ACAC and BHBA production by the rumen 
epithelium (Baldwin and Jesse, 1992). Quigley et al. ( 199 1a) reported post..;weaning 
ketone concentrations that exceeded levels typically used as an indication of subclinical 
ketosis (Bergman, 1984 ). Utilization of ketones by peripheral tissues is first order 
kinetics, i.e., a concentration dependent process. Once blood ketone concentrations reach 
2.0 mM, however, the system appears to achieve a maximum velocity (V max; Bergman, 
1971 ; Leng, 1965) and a small increase in production beyond this level generates large 
increases in circulating concentrations. The elevated ketone levels measured in the post­
weaning calf approximate this concentration limit and could be a potential loss of energy 
at a developmental stage when energy is at a premium. 
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Supplementing animal feed with ionophores results in varied biological responses, 
many of which are advantageous to production efficiency (Bergen and Bates, 1 984; 
Spears, 1 990). Increases in production efficiency of cattle results from modification of 
rumen fermentation and selection against protozoa that cause coccidiosis (McGuffey et 
al., 2001 ). The most widely recognized response associated with the supplementation of 
ionophores is the modification of rumina} VF A production. In studies using mature 
ruminants, supplementation generally results in greater ruminal propionate production at 
the expense of acetate and butyrate productions (Russell and Strobel, 1 989). 
Quigley et al. ( 1 992) investigated the effects of lasalocid on pre- and post­
weaning calves and found that lasalocid administered directly into the rumen via cannula 
significantly reduced circulating concentrations of ACAC and BHBA during the 
postweaning period. This is not a common route for ingestion of feed and is not a method 
available to producers, who must incorporate additives into feeds. Also, the experimental 
period ended when the calves reached 1 2  weeks of age, which coincided with the 
experiment's highest measured concentrations of BHBA. Thus, the age at which 
circulating concentrations decrease to adult levels was not apparent. The objectives of 
this experiment, therefore, were to examine the effects of weaning on selected 
metabolites in dairy calves from birth to 1 6  wks of age and to determine the post-weaning 
effect of lasalocid supplementation through a commercially available calf starter on blood 
metabolites, growth, intake and efficiency. 
3 1  
MATERIALS AND METHODS 
Animals and Management 
Calves and housing. All procedures were conducted under protocols approved by 
the University of Tennessee Animal Care and Use. Committee (protocol # 1 004). Twenty-
four Jersey bull calves were obtained from the University of Tennessee Dairy Experiment 
Station (Lewisburg, TN) where they were maintained for the duration ?f the experiment. 
Calves received adequate colostrum intake and were castrated before 3 d of age. Calves 
were housed in individual calf hutches with individual pens providing outdoor access for 
the duration of the experiment. 
Diets and feeding. Calves had ad libitum access to fresh water and trace-
mineralized salt (Champions Choice; Cargill Inc., Minneapolis, MN) for the duration of 
the study. Starting at 3 d of age, all calves received 227 g commercial milk replacer 
brought to an approximate volume of 2 L with H20 ( 1 2% solids; w/v; Instant Nursing 
Formula NT Medicated, Land O'Lakes Animal Milk Products Co., Fort Dodge, lA) twice 
daily at 0800 and 1 630 hours from nipple bottles. At 2 1  d of age the milk replacer 
concentration was increased to 284 g per 2 L H20 ( 15% solids; w/v). At 5 weeks of age 
(d 35) a commercially prepared high fiber calf starter (Calf Primer-I and Calf Primer-1-B; 
Tennessee Farmers Cooperative, Lavemge, TN) was offered for ad libitum consumption. 
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At this time, the calves were still receiving milk replacer twice daily, but was reduced to 
227 g/2 L. Starting at week six (d 42), only the AM replacer ration was offered and at 
week seven ( d 49) the calves were weaned. Calves often acquired scours at least once 
during their time on the study. Calves with scours were treated with a commercial oral 
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electrolyte solution (Revitilyte, Vets Plus, Inc., Knapp, WI) between the AM and PM 
feedings ( 1200). 
Calf starter diets were commercially prepared and pelleted without (CON) or with 
lasalocid (TRT) supplement (83 mglkg DM). Calves were sequentially assigned by birth 
weight and birth date to either CON (n = 12) or TRT (n = 12) starter in blocks of two. 
Starter was fed in a single ration at 0800. When a calf consumed an entire previous days 
ration, the ration was increased by I 05% of previous days consumption. Feed rations and 
refusals were recorded daily. 
Measurements 
Blood sampling. Weekly blood samples were taken from the jugular vein for 1 6  
weeks at 0800 and 0900. This was always within one hour post-prandial to the AM 
ration. Two 1 0-mL samples were collected in 16  x 75 Vacutainer tubes (Becton, 
Dickinson and Co., Franklin Lakes, NJ) containing K3EDTA ( 15% solution, 0. 1 17  mL). 
The samples were then packaged in an insulated shipping container with cold packs and 
shipped overnight to our laboratory in Knoxville for next day metabolite analysis. 
Body weights and feed samples. Prior to feeding, calves were weighed weekly for 
the entirety of the study. Additional body weight measures were also recorded at birth, 
weaning, and termination. All diets in this study were commercially prepared and were 
obtained from the same lot number. Feeds (milk replacer and calf starters) were sampled 
monthly and composited for later proximate analysis. 
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Chemical Analyses 
Blood samples. Whole blood samples were analyzed for concentrations of 
glucose, L-( +)-lactate, pyruvate, ACAC, and BHBA. Spectrophotometric analyses for 
glucose, ACAC, and BHBA were performed the same day samples were received. 
Deproteinized lactate and pyruvate samples were centrifuged (1 600 X g at 4 °C) and 
supernatants were harvested and frozen (-20°C) for analysis within two weeks. Plasma 
was harvested from the remaining blood sample following centrifugation at 1 600 x g at 
4°C then frozen (-20°C) and stored for later analysis of NEFA, VFA, glucagon, and 
insulin. Analyses for BHBA and ACAC (Appendices 4 and 5) were done using 
enzymatic assays of Williamson and Mellanby ( 197 4) and Mellanby and Williamson 
(1 974), respectively. L-(+)-lactate and pyruvate (Appendices 7 and 8) were determined 
using procedures from the Sigma kits for lactate and pyruvate (#726-UV and #826-UV, 
Sigma Chemical Co., St. Louis, MO). Analysis of NEF A (Appendix 9) utilized the 
WAKO NEFA-C kit (WAKO Chemical USA, Dallas, TX). Blood glucose (Appendix 6) 
was determined using the Sigma glucose kit (#5 1 0; Sigma Chemical Co., St. Louis, MO). 
Plasma glucagon and insulin were determined using ·the double antibody 
radioimmunoassay and the Coat-A-Count® insulin kits and protocols from Diagnostics 
Products Corporation (Los Angeles, CA). For hormone analyses, intra-assay errors 
greater than 1 0% were not accepted and samples were rerun. Plasma VFA (Appendix 1 1 ) 
were analyzed by the procedure described by Reynolds et al. (1 986) and modified by 
Quigley et al. ( 1991 b) for capillary column, and Benson et al., (2002) with a Hewlett 
Packard gas chromatograph (5890A), auto-sampler (7637 A), integrator (3393A), and a 
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J& W Scientific 530 J.lm HP-FF AP capillary column (Agilent Technologies Inc., Palo 
Alto, CA). 
Feed samples. Composite dietary samples of CON and TRT starter were ground 
through a 1-mm screen in a Wiley Mill (Author H. Thomas Co., Philadelphia, P A) and 
analyzed (Table 3 . 1 )  with composite milk replacer sample for DM, N (model FP-2000 
nitrogen analyzer, LECO, St. Joseph, Ml), gross energy (model 1 24 1  adiabatic 
calorimeter, Parr Instruments, Moline, IL) ether extract (AOAC, 1 999), NDF, ADF 
(ANKOM Technology, 2003a; 2003b; ANKOM 200 series fiber analyzer, ANKOM 
Technology Corp. Macedon, NY), and minerals (Unicam Solaar 969, atomic absorption 
spectrometer, Cambridge, UK). 
Statistical Analyses 
Data for weekly BW and blood variables were analyzed statistically as a 
randomized complete block design for the effect of age (week) and dietary treatment 
(starter with or without lasalocid) using the mixed models procedures of SAS (version 
8.2; SAS Inst., Inc., Cary, NC). As the experimental units, calves (n = 24) did not start 
the project simultaneously, thus calves were blocked on birth date and birth weight in 
groups of two. The statistical model used was: 
where: 
Table 3.1 . Measured chemical composition of feeds1 
Componenr Milk Replacer Control Treatmenf 
DM, % 93 .3 1 89.89 90.7 1 
Crude Protein, % 23 .00 1 9.8 1  1 9.38 
Ether extract, % 17.5 1 3 . 1 7  2.92 
NDF, % 0. 17  34.45 33 .97 
ADF, % 0.03 1 9.03 19 . 1 3  
Ash, % 1 1 .93 8.36 8 .44 
Calcium, g/kg 7. 17  1 1 .58 1 0.55 
Phosphorus, g/kg 9.8 1  8.27 7 .99 
Magnesium, g/kg 1 .58 3 .53 3 .58  
Potassium, g/kg 27.66 1 3 .8 1  1 3 . 1 9  
Gross Energy, Meal/kg 4.91 4.37 4.33 
1Milk replacer was Instant Nursing Formula (Land O'Lakes, Fort Dodge, IA) and calf 
starters were Calf Primer I =  control and Calf Primer 1-B = treatment (Tennessee 
Farmers Cooperative, Lavergne, 1N). 
2Composition on a dry matter basis. 
3Treatment calf starter formulated to contained lasalocid supplement at 83 mglkg DM. 
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Yijk = dependent variables, 
J..l = overall mean, 
�i = effect of block i, 
Dj = effect of diet j, 
�·Dij = effect of diet by block (error term for diet), 
wk = effect of week k (age), 
W*Djk = effect of week by diet interaction, 
�*W*Dijk = error term for week and week by diet (residual). 
Because the age of a calf across the 1 6  sampling weeks is a treatment whose order was 
fixed by definition, a repeated measures model over time was included as a treatment 
design, with diet as between-subject and week as within-subject factors. Since the dietary 
treatment did not commence until wk 5, the sampling period of wk 1 - 4 was analyzed 
separately to ensure that any observed effects were the result of treatment effects and not 
pre-existing conditions. There were no differences detected in blood variables measured 
prior to initiation of dietary treatment at wk 5, so results presented include analysis across 
all 1 6  weeks. 
Similar to factors described above, data for birth ( d 0), weaning ( d 49), and 
termination (1 12 d) weights; pre-weaning, post-weaning, and overall ADG; post-weaning 
feed efficiency, and DMI were analyzed as a randomized complete block design for 
effect of dietary treatment. Class variables were diet and block, but there was no week 
effect or repeated measures treatment design included in the analysis of these data. 
Consequently, the error term for analysis of these variables was block x diet. 
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Death of one calf between gth and 9th sampling periods would have created an 
incomplete block and therefore this block was removed from the study. Also, two 
separate instances where samples were damaged during shipping resulted in additional 
missing observations and results presented are least square means. Thus, blood variables, 
weekly BW, and post-weaning measures of ADG, feed efficiency, and termination 
weights were analyzed using 22 calves. Measures of birth weight, weaning weight, and 
ADG from birth to weaning were analyzed using all 24 calves. 
Due to heterogeneous variance causing abnormal distribution, blood variables 
propionate, butyrate, and insulin were rank transformed using rank procedure of SAS to 
improve normality. This resulted in data for these variables being ranked by block and 
ANOV A performed on ranks for least square mean separation. Least square mean 
separation was done using least significant difference features in SAS. Probabilities of P 
< 0.05 are discussed as significant throughout unless otherwise noted. 
RESULTS 
Overall, calves remained healthy throughout the study. Calves typically scoured at 
some time during the pre-weaning portion of the study and the average duration was 3.5 d 
(range 1 -5 d). Two calves developed pink-eye within their second week in the experiment 
and were treated accordingly (Gentocin spray and LA-200). On� calf died of unknown 
causes at 8 wk of age. No other health problems were noted following weaning and due 
to nearly identical weaning weights it is unlikely that any negative health effects from the 
pre-weaning period compromised the post-weaning treatment comparisons. 
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Analysis of chemical composition of milk replacer and calf starter supplemented 
with (treatment; TRT) or without (control; CON) lasalocid is in Table 3 . 1 . All 
components for all feeds matched the ranges specified by the manufacturer. There were 
no apparent differences between analyses of CON and TRT calf starters. 
Body Weights, Dry Matter Intake, and Efficiency of Gain 
All calves had similar birth and weaning BW (Table 3 .2) and wk 1 to 4 BW 
(Figure 3 . 1  ). This verifies that no pre-existing differences between calves influenced the 
measurements taken after dietary treatment was initiated at wk 5 .  Average daily gain 
calculated from birth to weaning does include the two-wk adaptation period where calves 
were receiving milk replacer and CON or TRT calf starter, but did not differ by dietary 
assignment. Final ( 1 6-wk) BW, ADG from weaning to 1 6-wk, ADG from birth to 1 6-wk, 
post-weaning DMI and feed:gain were not significantly different between CON and TRT 
calf starters (Table 3 .2). Weekly body weight measurements progressed with similar 
trends between CON and TRT calves (Figure 3. 1 ). There was a significant wk effect (P < 
0.0 1 )  and a tendency (P = 0. 1 0) for diet effect from wk 5 to 1 6. Prior to initiation of 
dietary treatment B W measures overlapped. Initiation of dry feed caused an apparent 
change in the slope between wk 5 and 7 and the lines diverged slightly and TRT 
remained slightly lower and progressed parallel with CON to wk- 16. Body weight 
measures for CON became significantly greater than TRT (P < 0.05) during wk 14  and 
1 5  (Figure 3. 1 ). 
Table 3.2 . Means for body weight, dry matter intake, gain, and efficiency of gain 
for calves fed calf starter with or without lasalocid pre- and post-weaning 
Variable1 Control Treatment SE P <2 
Body weight, kg 
Birth (d 0) 25 .06 25 .89 0.84 0.3 1 
Wean (d 49) 35.30 34.77 1 .27 0.67 
Final (d 1 12) 83.90 8 1 .47 2.7 1 0.39 
ADG, kg/d 
Birth to final ( d 0-1 12) 0.53 0.50 0.02 0. 1 3  
Birth to wean ( d 0-49) 0.2 1 0. 1 8  0.02 0.22 
Wean to final (d 49- 1 12) 0.78 0.75 0.03 0.47 
DMI, kg/d3 2.35 2.34 0.07 0.92 
Feed:Gain3 3. 1 0  3 . 1 9  0. 1 1 0.44 
1Final BW, ADG birth to final, ADG wean to final, DMI, and feed:gain 
measurements are n = 1 1  per dietary treatment. All other observations are n = 12. 
2 Probability of greater F for the effect of dietary treatment on variable; not 
significant at P > 0. 1 0. 
3Calculated from post-weaning period data, thus represents period from wean to 
finish. 
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Figure 3.1 . Effects of calf starter supplemented with (O) or without lasalocid (•) on 
weekly body weights. Arrows indicate initiation of starter ration at wk 5 and cessation 
of milk replacer ration at wk 7. Weeks 1 to 4 are means ± SE for 22 calves. From wk 5 
to 16  effect of diet was significant (P = 0. 1 0) and all values are means (n = 1 1  per 
treatment) ± SE. 
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Blood Metabolites 
Glucose and non-esterified fatty acids. Concentrations of blood glucose were not 
significantly affected by treatment, but wk effect was significant (Figure 3 .2). Analysis of 
variance for diet and diet x week interaction were not significant. There was no post­
weaning effect of supplementation on glucose observations. Concentrations for both 
treatments decreased significantly with age reaching a nadir at wk 7 and 8 (2.5 and 2. 7 
mmol/L, respectively), which coincided with weaning. Concentrations began to increase 
and by wk 1 5  and 16  (3 .6 mmol/L) were similar to levels observed at wk 1 (3 .7 mmol/L). 
Concentrations of plasma NEF A were not significantly affected by post-weaning 
ionophore supplementation (Figure 3.3). Both diet and week effects were significant (P < 
0.0 1 ), but diet x week interaction was not significant. While there was no significance 
detected between CON and TRT at individual wk, there was a large drop between wk 5 
and 8 (274.7 and 1 58.8 J.UilOIIL, respectively). Like glucose this nadir coincided with the 
cessation of the milk replacer rations. Concentrations of NEFA pre-weaning (wk 1 -7) 
were significantly greater than those taken post-weaning (wk 8- 16; P < 0.05). 
Ketones. Concentrations of ACAC were highly variable and although week effect 
was significant there was no trend observed (Figure 3.4). There were no observed 
differences between diets or pre- and post-weaning. The concentration of ACAC was 
static and the expected increase in concentrations beginning at wk 5 to 7 in association 
with starter intake was not distinguishable. 
Circulating concentrations of BHBA were more dynamic than ACAC across the 
1 6-wk experimental period (Figure 3.5). The effect of week was significant, but neither 
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Figure 3.2.  Effects of calf starter supplemented with ( o) or without lasalocid (•) on 
weekly glucose concentrations. Arrows indicate initiation of starter ration at wk 5 and 
cessation of milk replacer ration at wk 7. Weeks 1 to 4 are means ± SE for 22 calves. 
From wk 5 to 1 6  all values are means (n = 1 1  per treatment) ± SE. 
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Figure 3.3 .  Effects of calf starter supplemented with (O) or without lasalocid (•) on 
weekly non-esterified fatty acid (NEF A) concentrations. Arrows indicate initiation of 
starter ration at wk 5 and cessation of milk replacer ration at wk 7. Weeks 1 to 4 are 
means ± SE for 22 calves. From wk 5 to 1 6  effect of diet was significant (P < 0.05) 
and all values are means (n = 1 1  per treatment) ± SE. 
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Figure 3.4. Effects of calf starter supplemented with (O) or without lasalocid (1•) on 
weekly acetoacetate (ACAC) concentrations. Arrows indicate initiation of starter 
ration at wk 5 and cessation of milk replacer ration at wk 7. Weeks 1 to 4 are means ± 
SE for 22 calves. From wk 5 to 1 6  all values are means (n = 1 1  per treatment) ± SE. 
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Figure 3.5. Effects of calf starter supplemented with ( o) or without lasalocid (r•) on 
weekly P-hydroxybutyrate (BHBA) concentrations. Arrows indicate initiation of 
starter ration at wk 5 and cessation of milk replacer ration at wk 7. Weeks 1 to 4 are 
means ± SE for 22 calves. From wk 5 to 1 6  all values are means (n = 1 1  per treatment) 
± SE. 
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diet or diet x week interaction effects were significant. When all calves were receiving 
milk replacer, BHBA concentrations were constant (0. 1 mM for wk 1 -4) and did not 
differ. During the adaptation period during wk 5 and wk 6 there was an evident increase 
in both CON and TRT. By wk 8, concentrations of ·BHBA in calves receiving the CON 
starter had increased 5-fold (0.99 mmol/L) from the 5-wk concentrations (0. 1 8  mmol/L) 
and reached a zenith at wk 9 ( 1 . 1 2  mmol/L). Calves receiving the TRT starter had lower 
(P < 0.05) BHBA concentrations than CON during wk 8 and 9 (0.73 and 0. 80 mmol/L 
respectively) and appeared to asymptote at wk 10  (0.93 mmol/L). Concentrations from 
wk 1 0  to wk 1 6  ranged between 0.8 and 1 .0 mmol/L and did not differ between wk or 
diet. 
Volatile fatty acids. Plasma concentrations of acetate measured across 1 6  wk are 
presented in Figure 3 .6. Both effects of diet and week were significant for acetate, but 
diet x week interaction was not. Prior to wk 5 concentrations of acetate were stable 
staying at or below 0.2 mmol/L for all calves. After dry feed intake was initiated (wk 5), 
an increase similar to BHBA was observed. At weaning ·(wk 7) acetate concentrations of 
calves receiving CON starter (0.54 mmol/L) .were greater than calves receiving TRT 
(0.35 mmol/L; P < 0. 1 0). Concentrations of acetate (Figure 3 .6) continued to increase 
after weaning in a similar manner, but CON was not significantly greater than TRT until 
wk 1 3  (P < 0.05). Like BHBA (Figure 3.5), the post-weaning increase in acetate 
concentrations for TRT group appeared to be delayed and have a lower maximum 
concentration relative to CON. The highest acetate concentrations were measured at wk 
1 0  (0.80 mmol/L) and 1 3  (0.93 mmol/L) for TRT and CON, respectively. 
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Figure 3.6. Effects of calf starter supplemented with ( o) or without lasalocid (•) on 
weekly acetate concentrations. Arrows indicate initiation of starter ration at wk 5 and 
cessation of milk replacer ration at wk 7. Weeks 1 to 4 are means ± SE for 22 calves. 
From wk 5 to 1_6 effect of diet was significant (P < 0.05) and all values are means (n = 
1 1  per treatment) ± SE. 
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Plasma concentrations of propionate did not differ between calf starter treatments 
(Figure 3 .7). There was a significant week effect, but diet and diet x week were not 
significant. Concentrations increased considerably at weaning ( wk 7) and both CON and 
·TRT groups reached a zenith at wk 9 ( 1 1 0.5 and 98.3 J.UllOIIL, respectively). After wk 9, 
concentrations began to decline in similar manner for both groups and reached 
concentrations at wk 1 6  (37.6 J.liilOIIL) that were similar to those measured at wk 5 (37.59 
J.liilO 1/L ). 
Plasma butyrate concentrations prior to wk 6 remained at or below 4 J.liilOl/L 
(Figure 3.8). Like acetate and propionate there was a significant effect of week, but not 
for diet or diet x week. During the adaptation period, between wk 5 and wk 7, there was a 
five-fold increase in butyrate for CON (1 .6 to 1 1 .2 J.liilOl!L), but only a two-fold increase 
in TRT (2.6 to 6.0 J.liilOIIL). Butyrate concentrations at wk 7 were greater in CON than 
\ 
TRT (P = 0.09). Week 7 butyrate concentrations in TRT were decreased from those 
measured at wk 6 and may be responsible for the observed difference. Maximum plasma 
butyrate for the CON group was measured at wk 9 ( 1 7.3 J.liilOIIL), while TRT 
concentrations peaked at wk 1 0  ( 1 4.0 J.liilOIIL ). Similar to plasma propionate, butyrate 
concentrations began a decline after each acme and continued in parallel to wk 1 6. 
Lactate and pyruvate. Concentrations of blood lactate and pyruvate had a 
significant week effect, but diet effects and diet x week interactions were not significant 
for either metabolite (Figures 3.9 and 3 . 1  0, respectively). The effect of weaning 
generated no visible response in either metabolite. Lactate and pyruvate concentrations 
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Figure 3. 7. Effects of calf starter supplemented with ( o) or without lasalocid (fll) on 
weekly propionate concentrations. Arrows indicate initiation of starter ration at wk 5 
and cessation of milk replacer ration at wk 7. Weeks 1 to 4 are means ± SE for 22 
calves. From wk 5 to 1 6  all values are means (n = 1 1  per treatment) ± SE. 
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Figure 3.8. Effects of calf starter supplemented with ( o) or without lasalocid ( •) on 
weekly butyrate concentrations. Arrows indicate initiation of starter ration at wk 5 and 
cessation of milk replacer ration at wk 7. Weeks 1 to 4 are means ± SE for 22 calves. 
From wk 5 to 1 6  all values are means (n = 1 1  per treatment) ± SE. 
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Figure 3.9. Effects of calf starter supplemented with (O) or without lasalocid (�•) on 
weekly lactate concentrations. Arrows indicate initiation of starter ration at wk 5 and 
cessation of milk replacer ration at wk 7. Weeks 1 to 4 are means ± SE for 22 calves. 
From wk 5 to 1 6  all values are means (n = 1 1  per treatment) ± SE. 
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Figure 3.10. Effects of calf starter supplemented with (O) or without lasalocid (!•) on 
weekly pyruvate concentrations. Arrows indicate initiation of starter ration at wk 5 and 
cessation of milk replacer ration at wk 7. Weeks I to 4 are means ± SE for 22 calves. 
From wk 5 to 16  all values are means (n = 1 1  per treatment) ± SE. 
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were highest during wk 12 ( 1 .87 and 0.25 mmol/L, respectively) and lactate 
concentrations were generally six to eight-fold greater than pyruvate across the 1 6  wk 
period. Lactate concentrations appeared to remain elevated from wk 1 2  to wk 1 6, a period 
when propionate concentrations were declining. 
Insulin and glucagon. Plasma concentrations of insulin were variable across all 
1 6  wk of the experiment (Figure 3 . 1 1 ). The CON group had dynamic changes in pre­
weaning concentrations when there was no dietary treatment. The TRT group had an 
obvious decline from wk 1 (22.8 pmol/L) to a nadir at wk 7 ( 1 .4 pmol/L). The 
concentrations of TRT insulin increased after wk 7 and reached a maximum at wk 1 6  
(37.0 pmol/L). 
Measured plasma concentrations of glucagon were less variable than insulin and 
exhibited a response to the dietary regime change at weaning (Figure 3 . 1 2). There was a 
significant week effect, but diet and diet x week were not significant. Concentrations 
measured in both CON and TRT had similar changes across the 1 6  wk period. Glucagon 
was at the lowest concentration at wk 5 ( 1 3.6 pmol/L) and then sharply increased to a 
maximum concentration for wk 8, 9, and 1 0  (25 .6, 26.3, and 24.5 pmol/L, respectively). 
Prior to wk 5,  the ratio of insulin and glucagon was approximately one to one, but 
glucagon became the greater circulating peripheral hormone post-weaning and the ratio 
was below one. 
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Figure 3.1 1 .  Effects of calf starter supplemented with (O) or without lasalocid (•) on 
weekly insulin concentrations. Arrows indicate initiation of starter ration at wk 5 and 
cessation of milk replacer ration at wk 7. Weeks 1 to 4 are means ± SE for 22 calves. 
From wk 5 to 16  all values are means (n = 1 1  per treatment) ± SE. 
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Figure 3.12. Effects of calf starter supplemented with (O) or without lasalocid (•) on 
weekly glucagon concentrations. Arrows indicate initiation of starter ration at wk 5 
and cessation of milk replacer ration at wk 7. Weeks 1 to 4 are means ± SE for 22 
calves. From wk 5 to 1 6  all values are means (n = 1 1  per treatment) ± SE. 
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DISCUSSION 
Diets and Calf Performance 
Chemical analysis of milk replacer used in this experiment {Table 3 . 1 )  met or 
exceeded recommended levels (NRC, 2001)  for percent crude protein, and fat, but was 
slightly below recommended levels for calcium { 1 .00o/o ) . Other published chemical 
analysis of milk replacers reported values for Ca and P similar to the replacer used in this 
study (Quigley and Bernard, 1 992; Quigley, 1 996). Analysis of the current replacer 
corresponded with ranges listed in the guaranteed analysis by the manufacturer. Milk 
replacer quality was not a concern, as protein content consisted of various forms of milk 
protein (whey) and measured crude fiber was below 0.2o/o (Davis and Drackley, 1 998). 
Chemical analysis of both calf starters {Table 3. 1 )  met or exceeded recommended 
levels (NRC, 2001)  and both starters were similar in components that corresponded with 
the ranges listed in the guaranteed analysis of the manufacturer. Gross energy values for 
both starters were comparable to the 4.49 Meal/kg reported by the .NRC (2001 ). The NDF 
and ADF values for starter were substantially greater than the recommended 1 2.8o/o and . 
1 1 .6%, respectively (NRC, 2001 ), but still fell within the acceptable range (ADF 6-20% 
and NDF 1 5-25%; Davis and Drackley, 1 998). The starters used in this experiment were 
complete feeds containing high-fiber byproducts designed to stimulate ruminal 
development and to be fed as the sole feed. 
Previous performance studies summarized by Chalupa ( 1 980) demonstrated that 
lasalocid and monensin produced a small reduction of intake, an increase in ADO, and 
improved feed efficiency (intake/gain) compared to controls. These observations, 
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however, were made primarily from feedlot cattle. Using Holstein calves, Anderson et al. 
( 1 988) reported that calves fed lasalocid from 4-d of age to 1 2-wk of age had a greater 
feed intake and weight gain after 5-wk of age: Conversely, Eicher-Pruiett et al. ( 1 992) 
reported an increase in daily gain with lasalocid supplementation to be greatest during the 
first six weeks. Quigley et al. ( 1 992) and Steen et al. ( 1 992) observed no effects of 
lasalocid administration on BW, ADG, or feed efficiency in Holstein bull calves and 
Holstein heifers, · respectively. This agrees with the results presented in Table 3.2, 
generated from twice the number of calves. Birth weights and weaning weights (Table 
3 .2) were similar to other studies (25 and 34 kg) using Jersey calves (Quigley, 1 996; 
Stanley et al., 2002). 
The above inconsistencies in reported effects of lasalocid supplementation on gain 
and intake is likely a result of differences in supplementation dosage, supplementation 
vehicle, and experimental timelines. All three studies (Anderson et al., 1 988, Eicher­
Pruiett et al., 1 992; Quigley et al., 1 992) supplemented in liquid and solid diets, but 
Quigley et al. ( 1 992) also supplemented via rumen cannula. Weaning occurred at 3 wk of 
age (n = 22), when total dry feed reach 1 .3% of birth weight (n = 40), and at 8 wk of age 
(n = 12), respectively. Dosage of lasalocid could be another effect causing the findings to 
differ. Eicher-Pruiett et al. ( 1 992) concluded that ionophore concentrations greater than 
1 .0 mg/kg of BW were the most effective and should be delivered in all three feeds (milk 
replacer, pre-starter, and starter). Quigley et al. ( 1 992) only included lasalocid in mill.c 
replacer and calf starter and used 1 .0 mglkg of BW (not greater than 1 .0 mglkg as 
suggested by Eicher-Pruiett and co-workers; did not use a pre-starter). In the current 
study, lasalocid was supplemented only in the calf starter and the dosage was dependent 
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on intake of the animal (75 mg/kg as-fed or 83 mg/kg of DM). Concentrations 
supplemented in this study, were close to the amount supplemented by Anderson et al. 
( 1988) in pre-starter (88 mg/kg as fed) and starter (44 mg/kg as fed). However, Anderson 
et al. (1 988) reported that there were periods where calves were consuming two feed 
types, bot� supplemented with ionophore likely generating a larger combined daily 
dosage. Eicher-Pruiett et al . (1 992) also reported that lasalocid supplemented only in pre­
starter and starter combined and starter alone did not perform as well as controls or calves 
receiving lasalocid 'in all three diet types and related it to palatability. This observation 
agrees with results of the current study, where TRT calves were always slightly lower 
than CON in weekly BW measures (Figure 3 . 1 ), although not always significantly and 
DMI was the same. 
Blood Metabolites 
Preruminant blood glucose concentrations (5 .3 mmol/L; lambs; Leat, 1 970) are 
higher than those of mature ruminants (2. 7 mmol/L; sheep; Bergman, 1971  ), but decrease 
to adult values circa 3 months of age. This fall appears to be independent of ruminal 
development or diet changes and is probably caused by alimentary hypoglycemia 
associated with absence of milk and loss of glucose from erythrocytes. Pre-weaning 
blood glucose concentrations in the present study were low by these standards. While the 
lowest concentrations approximated 2.5 mmol/L, the pre-weaning concentrations ranged 
from 3.3 - 3.8 and did not equate with other reports. 
Greenwood et al. (2002) reported glucose concentrations between 5 .0 and 7.0 
mmol/L for two-wk old lambs. Quigley et al. ( 199 1a) reported glucose concentrations 
59 
between 6.3 and 5 .8 mmoi/L for calves one and two weeks old and a nadir of 4.2 mmol/L 
at 9 weeks. Stanley et al. (2002) reported blood glucose concentrations of 4a and 4.4 
mmoi/L at 1 and 2 wk of age for Jersey calves and 5 . 1  and 4.8 mmol/L for Holstein 
calves. At 1 6  wk of age, reported concentrations of glucose in Holstein calves were 
between 4.5 and 5 .0 mmoi/L (Quigley and Bernard, 1 992; Quigley et al., 199 1 a). Quigley 
and Bernard ( 1 992) sampled calves zero hours after feeding, similar to the peri-prandial 
sampling of the current study, and glucose concentrations were slightly lower than other 
post-prandial measures in the experiment. These values for zero-hr glucose were 
presented graphically and exhibit a similar shaped curve, to that of the present study 
(Figure 3 .2) with a dip in concentrations around weaning and a gradual increase to wk 1 6. 
Lower than normal glucose concentrations in the current study appear to be constant 
across all 1 6  wk and can probably be attributed to the time of sampling in relation to 
feeding and the 24-hr shipment period that transpired prior to analysis. This decrease in 
glucose concentrations appeared constant for all measures and suggests that detection of 
significant differences related to the effects of age and diet should be unaffected. 
Consequently, the fact that no dietary effect was observed on blood glucose is 
presumably not a Type II error. 
Propionate is a potent glucogenic compound and is the only VF A that is a glucose 
precursor (Bergman, 1 97 1 ; 1 990). Thus, as a calf undergoes rumina} maturation, 
dwindling concentrations of dietary glucose are replaced by glucogenic compounds like 
propionate. Propionate concentrations presented in Figure 3.7 resemble an inverted 
version of the glucose concentrations in Figure 3.2. Glucose concentrations had reached 
the low point of the 1 6-wk study at wk 7 and at this time p�opionate concentrations were 
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increasing and peaked shortly thereafter. There were no treatment differences detected in 
circulating propionate concentrations in this study or by Quigley et al. (1 992). Anderson 
et al. ( 1 988) reported small, but significant increases in ruminal propionate with lasalocid 
supplementation. This however, was the ruminal concentration. The rumen epithelium 
metabolizes propionate into lactate, pyruvate, carbon dioxide, and amino acids prior to 
release into portal circulation (Bergman, 1 990). The liver then removes most propionate 
not extracted by the rumin�l epithelium of ruminating sheep or calves (Bergman and 
Wolff, 1 97 1 ;  Weigand et al ., 1972) and preruminant calves (Donkin and Armentano, 
1 995) leaving little to enter peripheral circulation. This probably contributed to the low 
concentrations (< 0. 12  mmol/L) measured throughout this study and in other reports 
(Quigley et al ., 1992; and Quigley and Bernard, 1 992). The sudden increase in plasma 
propionate concentration in Figure 3 .  7 coincides exactly with weaning and is comparable 
to other reports in calves (Quigley et al., 1 991b). 
As propionate is absorbed from the rumen a varying percentage is converted to 
lactate and pyruvate (Weigand et al., 1 972; Weekes and Webster, 1 975). In the 
preruminant lamb or calf, the ability to metabolize lactate to pyruvate is significantly 
greater than that in post-weanling lambs and calves and adult sheep (Ballard and Oliver, 
1 965; Savan et al., 1 986; Donkin and Armentano, 1 995). Circulating concentrations of 
lactate (Figure 3.9) or pyruvate (Figure 3 . 10) do not appear to be affected by developing 
rumen function (Bartley et al., 1 966; Quigley and Bernard, 1 992) or ionophore. 
Concentrations of lactate at 3 - 4 wk of age in this study ( 1 .3 mmol/L) agree with 
concentrations in the vena cava (1 .0 - 1 .3 mmol/L) measured in calves ofthe same age by 
Ortigues et al. (1996). Lactate concentrations across 1 6- wk of age in calves differed 
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slightly from results presented by Quigley and Bernard (1 992). They reported a gradual 
decline (wk 1 = 2.7 to wk 1 6  = 1 .3 mmoVL) in lactate concentrations as calves aged, but 
Figure 3.9 shows a lower initial concentration than Quigley and Bernard and then a slight 
increase post-weaning. The apparent increase of lactate and pyruvate after wk 10  
appeared to coincide with a decline in  propionate concentrations occurring during the 
same time period. A possible explanation would be the substantially reduced rate of 
hepatic gluconeogenesis from lactate in the ruminant calf (Donkin and Armentano, 1 995) 
due to decreased lactate dehydrogenase and pyruvate carboxylase activity (Table 2. 1 ). 
Circulating concentrations of NEF A are negatively correlated with intake of solid 
feed by the preruminant calf (Quigley, 1 996). 1bis is presumably in response to the shift 
in nutrient composition from high fat and low carbohydrate to a diet low in fat and high 
in carbohydrate. Similar to glucose concentrations, NEF A declined with age. Measured 
plasma NEFA concentrations in this experiment (Figure 3 .3) agree with other reports of 
pre- (Stanley et al., 2002; Ortigues et al., 1 996; Quigley and Bernard, 1 992) and post­
weaning concentrations (Quigley and Bernard, 1 992; Leat, 1 970). In contrast to the 
current study, Quigley et al. (1 992) reported significantly lower post-weaning 
concentrations of NEF A in calves ·receiving lasalocid in milk replacer and rume� cannula 
that control calves (0.088, 0. 1 0 1 ,  and 0. 1 33 mmol/L, respectively). These values and the 
reported pre-weaning values were consistently lower than pre- and post-weaning values 
reported in this and other experiments. 
Acetate derived from rumen fermentation is largely unused by hepatic 
parenchyma, making acetate the largest source of dietary energy available to 
extrasplanchnic tissues (Armentano, 1 992; Bergman, 1 990). Thus, peripheral measures of 
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circulating acetate relate more closely to intake than propionate or butyrate. Acetate 
constituted over 90% of VF A measured during the study and the patterns exhibited in 
Figure 3 .6 are similar to those reported by Quigley et al. ( 1991b). The significantly 
greater acetate concentrations at wk 7 and wk 1 3  in CON calves suggest that lasalocid 
may have had an effect by mitigating the rate that VF A concentrations increased in TRT 
calves. This is an observation that could have easily been lost for butyrate or propionate 
due to their extensive metabolism and removal by rumen epithelium and liver. 
Butyrate concentrations in Figure 3 .8, however, did show a delayed response 
similar to acetate with CON calves having greater concentrations than TRT when weaned 
at 7 wk of age. Due to extensive rumen epithelial metabolism of butyrate to ketones, 
changes in plasma butyrate following weaning more closely resembled those described 
for propionate. Butyrate concentrations reported by Quigley et al. ( 1991  b) were greater 
than those presented in Figure 3.8 and did not decline post-weaning. However, using data 
from the same study, but published separately, Quigley et al. ( 1 99 1a) reported BHBA 
concentrations in late-weaned calves (which were on a comparable time line as this 
study) approximately 200 IJ.Ill.Ol!L lower than those presented in Figure 3.5 .  Butyrate has 
been estimated to be the source of 80 - 95% of �-hydroxybutyrate released by the rumen 
(Leng and West, 1 969). 
�-Hydroxybutyrate is the reduced form of acetoacetate and is the main circulating 
ketone (Bergman, 1 97 1  ). Measured concentrations of BHBA in this study correspond to 
that published for preruminants (Varnam et al. ,  1 978b; Quigley et al., 1 99 1a) and were 
below 0.2 mmol/L prior to initiation of dry feed intake. After wk 5 there was an abrupt 
increase in BHBA concentrations for both diet groups. Ruminant concentrations of 
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BHBA at 8 and 9 wk of age were significantly higher in CON than TRT (Figure 3 .5) and 
agreed with the significantly greater concentration of BHBA reported by Quigley et al. 
( 1992) in control calves compared to those receiving lasalocid. The effect lasalocid had 
on BHBA concentrations over the 16-wk period resembled the same patterns described 
for butyrate and acetate, with the ionophore mitigating the sharp increase in metabolites 
resulting from the onset of rumen fermentation. Quigley et al. ( 1 992) also reported lower 
post-weaning rumina} butyrate concentrations in calves receiving lasalocid supplement 
over controls. This may explain the observed effect in the reduced circulating BHBA 
concentrations in ionophore supplemented . calves. Conversely, Krehbiel et al. (1 992) 
demonstrated that an increasing rumina} butyrate concentration was associated with an 
increase in portal-drained viscera flux of ACAC, but not BHBA. This is likely due to the 
mitochondrial location of BHBA dehydrogenase in rumen epithelium and it' s saturation 
at high levels of butyrate (Leighton et al ., 1983). 
Pre-weaning ACAC concentrations (Figure 3.4) were similar to those described 
by Quigley et al. ( 1 99 1a), but slightly lower than those reported in lambs by Vamam et 
al. ( 1 978b) and in calves by Quigley et al. ( 1992). There was a lack of response to 
weaning and the increase in alimentary ketogenesis of ACAC was not apparent at wk 7. 
Acetoacetate concentrations actually appeared to stay the same in contrast to the reported 
postweaning increase to 0.025 to 0.05 mmol/L (Quigley et al, 1 992; Quigley et al., 
1 991  a; V arnam et al., 1978b ). Like the glucose concentrations, the absence of an 
expected increase in ACAC concentrations post-weaning may have been a result of the 
24-hr shipping period prior . to analysis. Although the samples where kept cold during 
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shipping, enough time transpired for spontaneous decarboxylation to acetone to occur in 
quantities sufficient to affect sample quality for this metabolite (Bergman, 1 97 1  ). 
Ruminants generally seem more insulin resistant compared to non-ruminants 
"' 
(Brockman, 1 986; Weekes, 1 991)  and the role of glucagon is less clear in ruminants. The 
action of glucagon is opposite that of insulin and stimulates gluconeogenesis. The ratio of 
insulin to glucagon may be more important in stimulating gluconeogenesis than the 
individual concentrations of insulin and glucagon. The adult ruminant liver is glucogenic 
instead of glycogenic and is less sensitive to acute changes in insulin concentration 
(Fahey and Berger, 1 993). Hepatocytes from ruminating calves were less sensitive to 
glucagon and lost all sensitivity to insulin during the transition from preruminant to 
ruminant (Donkin and Armentano, 1 995). 
Insulin measurements in the present study were variable and difficult to interpret 
(Figure 3 . 1 1 )  but, glucagon concentrations increased at weaning (Figure 3 . 1 2). Stanley et 
al. (2002) reported post-weaning glucagon concentrations in 8 wk old Jersey calves of 
24.96 pmol/L that agree with findings of this experiment. This increase of glucagon to a 
maximum at 8 - 1 0  wk of age, coincides with the nadir of glucose, the decrease in NEF A 
(indicating no hepatic oxidation of lipid reserves), and the peak in propionate and 
butyrate concentrations. This reflects the calves' overall shift towards a dependency on 
gluconeogenesis as it develops into a functioning ruminant. 
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CONCLUSIONS 
Measurements of blood metabolites in young calves demonstrated changes 
characteristic of rumen development and metabolism. Declines in glucose and non­
esterified fatty acids along with rapid increases in blood volatile fatty acids and ketones 
with dry feed intake occurred as expected. Feeding calf starter supplemented with the 
ionophore lasalocid at levels used to prevent coccidiosis in calves during pre-weaning 
adaptation period and post-weaning delayed maximum acetate and butyrate 
concentrations and concomitantly lowered peak �-hydroxybutyrate concentrations. 
Consumption of starter containing lasalocid had no detectable improvement on the 
performance characteristics of average daily gain or feed efficiency and seemed to result 
in slightly lower weekly body weights. Thus, feeding a calf starter supplemented with 
lasalocid for coccidiosis does not appear to have any advantageous effects on post­
weaning growth or efficiency, but may have a effect on metabolic transition at weaning. 
This may facilitate the adaptation from a preruminant to a ruminant metabolism by 
reducing the potential for energy loss through sudden influx of volatile fatty acids and 
concomitant ketones. 
66 
PART IV 
NET NUTRIENT FLUX DURING PRE- AND POST-WEANING 
GROWTH IN DAIRY CALVES 
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ABSTRACT 
Dairy calf weaning is associated with increases in ketone levels that exceed 
measured rates of utilization in adults and present a potential energy loss that may be 
mitigated by ionophore. To assess effects of weaning and ionophore on net portal-drained 
viscera (PDV), hepatic (HEP), and total splanchnic tissue {TSP) fluxes in dairy calves, 
glucose, acetoacetate (ACAC), BHBA, NEF A, VF A, lactate, pyruvate and insulin (INS), 
and glucagon (GLN) concentrations and PDV, HEP, and TSP fluxes were determined on 
d 35, 56, 84, and 1 1 2 in Jersey bull calves weaned at d 49. From d 3 - 34 all calves (n = 
19) were fed· .454 gld milk replacer. After sampling on d 35,  calves were randomly 
assigned to a commercial pelleted starter without (CON) or with lasalocid (TRT; 83 
mg/kg DM) ad libitum plus replacer until d 48. From d 49-1 1 2  calves received only CON 
or TRT ad libitum. Calves were equipped with catheters in artery (A), portal (P), and 
mesenteric veins (V) at wk 3 to 4. Calf number varied by treatment and sample day due 
to catheter patency (calves = 3 to 5) and limited interpretations on HEP and TSP net 
fluxes. Blood flow was measured by continual infusion of para-aminohippurate into V 
(1 .5% at 0.764 rnUmin) and 6 serial samples taken at 30-min intervals simultaneously 
from A and P. Portal blood flow increased (P < 0.05) with age, but did not differ between 
CON and TRT. Glucose was released pre-weaning and extracted post-we�ng by PDV, 
but not affected by ionophore. Conversely, pre-weaning uptake of NEFA changed to 
post-weaning release, but this change was delayed to d 84 in TRT. Flux of ACAC and 
BHBA in CON and TRT went from pre-weaning uptake to post-weaning PDV release 
that peaked at d 84, but peak release of ACAC was lower and BHBA tended to be lower 
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in TRT (P = 0.07, 0 . 1 5). Portal release of VFA increased with age, but was similar to 
ketones with both butyrate and propionate PDV release lower at d 84 in TRT (P < 0 . 1 ). 
Importantly, glucagon was greater in CON than TRT at d 84 (P < 0 .05). Significant 
changes in metabolic profile and net PDV flux of transition calves were demonstrated 
and ionophore appears to moderate alimentary output at a post-weaning period (d 84) 
where ketone concentrations have potential to exceed whole animal capacity for 
\ 
utilization. 
INTRODUCTION 
A defining characteristic of adult rumen epithelial tissue is the production of 
ketones and in the fed animal it is the primary ketogenic tissue (Heitmann et al., 1 987). 
The ketogenic capacity of rumen epithelium is minimal from birth until weaning 
(Baldwin and Jesse, 1 992), as such the liver is the primary source of ketone production. 
At weaning the rumen undergoes profound morphological and metabolic changes. 
Although the mechanisms are not entirely understood, a strong relationship exists 
/ 
between dry matter intake and ketogenic potential of the rumina! epithelium (Baldwin 
and Jesse, 1 992; Quigley et al., 1 99 1 a). The oxidation of butyrate to carbon dioxide and 
ketones by the rumen epithelium of adults is concentration dependent, but seems to be 
saturable when very high (5 .0 mM) concentrations are encountered in vitro (Baldwin and 
McLeod, 2000). Peripheral tissue uptake and utilization of acetoacetate (ACAC) and �-
hydroxybutyrate (BHBA) measured in vivo are concentration dependent until 
concentrations greater than 2.0 mM are reached (Bergman, 1 97 1 ;  Leng, 1 965). 
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Homeorhesis at weaning is not well understood and the potential for a metabolic lag from 
imbalance of opposing mechanisms of production and utilization could exist. 
The ruminant liver is the mediator between suppl� of portal nutrients and that 
which is available to peripheral tissues. In adults, hepatic ketogenesis is constant and the 
liver is refractory to acute insulin and glucagon inputs (Donkin et al., 1997). The 
preruminant liver is glycolytic, and gluconeogenesis is highly regulated (Leat, 1970). The 
hepatic capacity for gluconeogenesis from propionate appears to be similar in 
preruminant and ruminant calves (Donkin and Armentano, 1995) and should not be a 
constraint on early weaning. Ortigues et al. ( 1996), using multi catheterized preruminant 
calves, demonstrated a 20% maximum contribution of lactate to hepatic gluconeogenesis. 
This is attenuated in the ruminant calf (Donkin and Armentano, 1995). Also, hepatic and 
hindquarter metabolism of glucose was constant and did not appear to be subject to any 
circadian rhythm ( Ortigues et al., 1996). 
Many of the available reports concerning shifts in calf metabolism at weaning are 
single-site, venous samples. The portal release of metabolites may substantially increase, 
but a proportionate hepatic extraction could result in only slight changes in the overall 
circulating concentrations (Heitmann and Fernandez, 1 986). Thus, many of the actual 
changes occurring in relation to ruminal development would be less evident or concealed 
in measures taken from a single venous sample. There is an absence of information 
regarding interorgan metabolic dynamics of splanchnic tissues in calves around the time 
of weaning. Therefore, the obJective of this study was to determine the effects of weaning 
and post-weaning supplementation of lasalocid on the net portal-drained viscera (PDV), 
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hepatic, and total splanchnic flux of energy and alternate nutrients and insulin and 
glucagon. 
MATERIALS AND METHODS 
Animals and Management 
Calves and housing. All procedures were conducted under protocols that were 
approved by the University of Tennessee Animal Care and Use Committee (protocol # 
1 004). Nineteen Jersey bull calves were obtained from the University of Tennessee 
Knoxville and Dairy Experiment Stations (Lewisburg, TN). Calves were left on-site until 
three days post-partum for adequate intake of colostrum and castration and were then 
transported to the Joseph E. Johnson Animal Research and Teaching Unit (JARTU) at 
the Knoxville Experiment Station. Calves were housed in individual pens ( 4 x 8 ft.) on 
rubber mat flooring for duration of the experiment. Pens were cleaned twice daily (am 
and pm) and prior to cleaning calves were moved to clean pens on the opposite side of 
the room. This permitted daily exercise for the animal and prevented exposure to the 
cleaning process. The temperature of the room was set at 2 1 .0°C (± 3.0°C) and artificial 
lighting was provided from 0600 to 1 800 h. "' 
Diets and feeding. Calves had ad libitum access to fresh water and trace­
mineralized salt (Champions Choice; Cargill Inc., Minneapolis, MN) for the duration of 
the study. Starting at 3 d of age, all calves received 227 g commercial milk replacer 
brought to an approximate volume of 2 L with H20 ( 1 2% solids; w/v; Instant Nursing 
Formula NT Medicated, Land O'Lakes Animal Milk Products Co., Fort Dodge, lA) twice 
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daily at 0800 and 1630 hours from nipple bottles. At 21 d of age the milk replacer ration 
was increased to 284 g per 2 L H20 ( 1 5% solids; w/v). Milk replacer ration was withheld 
the morning of surgery and the calf was offered PM ration upon successful recovery. The 
first of four flux studies was conducted at 5 weeks of age (d 35) and upon completion a 
commercially prepared high fiber calf starter (CO-OP Calf Primer-1 and Calf Primer-1-B, 
Tennessee Farmers Cooperative, Lavergne, TN) was offered for ad libitum consumption. 
At this time, the calf was still receiving milk replacer twice daily, but ration was reduced 
to 227 g/2 L. Starting at week six ( d 42}, only the AM replacer ration was offered and at 
week seven (d 49) the calves were weaned. Calves often acquired scours at least once 
during their time on the study. Calves with scours were treated with an commercial oral 
electrolyte solution (Revitilyte, Vets Plus, Inc., Knapp, WI) that was fed between the AM 
and PM milk replacer feedings ( 1200). No surgeries or flux studies were performed on 
calves with scours, but were rescheduled when animals recovered. 
Calf starter diets were commercially prepared and pelleted without (CON) or with 
lasalocid (TRT) supplement (83 mg/kg DM). Calves were sequentially assigned to either 
CON (n = 12} or TRT (n = 7) starter at birth. Starter was fed in a single ration at 0800. 
When a calf consumed an entire previous days ration, the ration was increased by I 05% 
of previous days consumption. Feed rations and refusals were recorded daily. 
Surgery 
Pre-operative procedures and anesthesia. A pre-surgical subcutaneous dose of 
Penicillin Procaine-G (U.S. VET, Hanford Pharmaceuticals, Syracuse, NY) was 
administered 4 hr before surgery. Because the calves were receiving only milk replacer at 
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the time of the surgery, only the AM ration the day of surgery was withheld. Calves were 
fasted at least 1 6  hours prior to surgery to prevent emesis and other gastrointestinal 
disturbances. Water and trace mineralized salt blocks were removed during this period. 
Prior to surgery calves were initially anesthetized with halothane-oxygen mixture ( 5% 
halothane at 2.0 L/min 02) using a facemask. Immediately after loss of mandible tension 
and swallowing reflex, calves were intubated with an endotracheal tube (9.5 mm i.d. ; 
Mallinckrodt Inc., St. Louis, MO) _through which surgical level anesthesia was introduced 
and maintained (at 2% halothane at 2.0 L/min 02). Lack of pedal reflex, eye dilation and 
position, and finally, lack of response to scalpel were used as determinants of surgical 
level of anesthesia. 
Surgical procedures. Between weeks 3 and 4 post-partum calves were surgically 
equipped with chronic, indwelling-catheters equipped with silastic cuffs (See Appendix 1 
for complete description of catheters) in the mesenteric, portal, and hepatic veins and 
mesenteric artery using techniques first developed by E. N. Bergman (Katz and Bergman, 
1 969b) and modified by Zanzalari et al., 1 989. 
Calves were placed in left lateral recumbency and the area from the sixth lumbar 
vertebra to the 12th thoracic vertebra and from the lumbar vertebra shelf to the linea alba 
was clipped, shaved, scrubbed with iodine, and rinsed with alcohol. A 30-cm celiotomy 
3-cm caudal and paracostal to the 1 3th rib was made beginning 3 em below the 2nd lumbar 
vertebra. The skin and subcutaneous, external oblique, transverse abdominaL and internal 
oblique muscles were dissected individually. Prior to catheter implantation the remnant of 
the umbilical vein was ligated. Major branches of portal and hepatic veins were located 
by palpation on the caudal surface of the left lateral lobe and accessed via puncture 
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incision through the parenchyma and into the veins. Catheters were introduced into both 
the portal and hepatic veins. Portal catheter location was confirmed by palpation of the 
porta-hepatis at the epiploic foramen (foramen of Winslow). Hepatic catheter location 
was confirmed by noting the movement of an intentionally placed air bubble within the 
catheter in response to respiration and heart rate. Upon removal of air bubble the 
catheters were secured by triple ligation directly to the hepatic parenchyma just caudal to 
each cuff with #3 .0 cardiovascular non-degradable silk (Ethicon, Inc. Somerville, NJ). 
The omentum was pulled cranially, exposing a segment of the small intestine and 
accessible branches of the common mesenteric vein and artery were identified (See 
Appendix 2 for description of artery catheter). The artery and vein were elevated and 
cleaned of fascia. During this procedure a topical application of lidocaine was used to 
prevent shriveling of the vein. Both vessels were ligated caudal to the intended site of 
insertion with #0 non-degradable silk and a temporary stasis was applied 3 em cranial to 
the ligation by gently elevating the vessel with #0 silk. While elevated, a small incision 
was made in both vessels between the stasis and ligation. Catheters were introduced 
through the incision and past the stasis until the silastic cuffs were inside the vessels. The 
vessels were triple ligated at positions cranial, medial, and just caudal to the cuffs with 
#0 non-degradable silk. 
Hepatic, portal, and mesenteric catheters were exteriorized in the dorsolumbar 
region via a sterile skin needle and inserted into a denim pouch that was attached between 
the 1st and 3rd lumbar vertebrae with tag cement. Catheters were flushed and filled with 
sodium heparin (1  000 USP units/mL; Elkins-Sinn, Cherry Hill, NJ). Individual muscle 
layers were closed using a continuous Ford interlocking suture of #1 .0 chromic gut 
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(Ethicon, Somerville, NJ) and skin was closed with an interrupted horizontal everted 
mattress suture of #0 silk. 
Post-operative care. Following surgery and removal of the endotracheal tube, the 
calf was placed on its sternum in a padded recovery room and closely supervised until it 
was able to stand without assistance. A second dose of penicillin was administered 
following surgery and at 1 2-hour intervals for 4 days thereafter. Calves were also treated 
with flunixin meglumine (Banamine; Schering-Plough Animal Health Corp., Union, NJ), 
a potent analgesic, following surgery and the following day to minimize discomfort. All 
external suture lines were treated daily with liberal application of an antimicrobial paste. 
Body temperature was recorded for all animals, twice daily post-surgery until they 
completed the experiment. 
Measurements 
Blood sampling. Net flux studies of metabolites across portal-drained viscera, 
liver, total splanchnic tissues and hindquarters were conducted at 5, 8, 12, and 1 6  weeks 
post-partum (2 weeks pre-weaning and 1 ,  5, and 9 weeks post-weaning). Care was taken 
to keep the animals calm during sampling and took place in the normal pen and 
accustomed environment of the calf. The animal had normal access to feed and water 
relative to the particular sample period during sampling. On experiment days the calf was 
weighed and sampling began one hour post-prandial. Prior to sampling, a 23 mL pulse­
dose (one half of one hours infused amount) of para-aminohippuric acid (PAH) was 
infused into the mesenteric vein catheter. Following the pulse-dose, P AH was infused for 
one hr (1 .5% w/v, at 0.764 mL/min). The infusion of PAH was done with a KD Scientific 
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infusion pump (model 200; New Hope, P A) and a 50-mL glass syringe (Becton 
Dickinson, Franklin Lakes, NJ). Following the one-hour equilibration period, six serial 
1 5-mL blood samples were taken simultaneously from the mesenteric artery and portal 
and hepatic veins at 30-minute intervals. Infusion of P AH was continuous until blood 
sampling was completed. Samples were collected in 20-mL syringes that contained 400 
J.lL of Na2EDT A ( 6% ). Because the normal anticoagulant used to maintain catheter 
patency is known to activate lipoprotein lipase and generate inaccurate measure of 
NEF A, catheters contents were replaced with only physiological saline between samples. 
Whole blood samples were kept on ice until analyzed, and samples for ketones, lactate, 
pyruvate, glucose, and P AH were deproteinized (see chemical analyses below) on site 
prior to transport to the laboratory. 
Body weights and feed samples. Prior to feeding, calves were weighed weekly for 
the entirety of the study. Body weight measures were also recorded at birth, weaning, 
termination, and each blood sample day. All diets in this study were commercially 
prepared and were obtained in a single shipment with the same lot number. Feeds (milk 
replacer and calf starters) were sampled monthly and composited for proximate analysis. 
Chemical Analyses 
Blood samples. Analysis for arterial packed-cell volume was done as samples 
were collected using a micro-hematocrit centrifuge and microcapillary reader 
(International Equipment Co., Needham Heights, MA). Whole blood samples were 
analyzed for concentrations of P AH, glucose, L-( +)-lactate, pyruvate, ACAC, and 
BHBA. Spectrophotometric analyses for P AH, glucose, ACAC, and BHBA were 
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performed same day as sampling. Deproteinized lactate and pyruvate samples were 
centrifuged ( 1600 x g at 4°C) and supernatants were collected and frozen (-20°C) for 
analysis within two weeks. Plasma was harvested from the remaining blood sample 
following centrifugation at 1600 x g at 4 °C then frozen ( -20°C) and stored for later 
analysis ofNEF A, VF A, glucagon, and insulin. 
Para-aminohippuric acid (Appendix 1 0) was measured as described in' Kaufman 
and Bergman (197 1 ). Analyses for BHBA and ACAC (Appendices 4 and 5) were done 
using enzymatic assays of Williamson and Mellanby (1 974) and Mellanby and 
Williamson (1 974). L-(+)-lactate and pyruvate (Appendices 7 and 8) were determined 
using procedures modified from the Sigma kits for lactate and pyruvate (#726-UV and 
#826-UV, Sigma Chemical Co., St. Louis, MO). Analysis ofNEFA (Appendix 9) utilized 
the W AKO NEF A-C kit (W AKO Chemical USA, Dallas, TX). Blood glucose (Appendix 
6) was determined using the Sigma glucose kit (#5 1 0; Sigma Chemical Co., St. Louis, 
MO). Plasma glucagon and insulin were determined using the double antibody 
radioimmunoassay and the Coat-A-Count® insulin kits and protocols from Diagnostics 
Products Corporation (Los Angeles, CA). For , the hormones, intra-assay errors greater 
than 1 0% were not accepted and samples were rerun. Plasma VF A analysis (Appendix 
1 1 ) used the procedure described by Reynolds et al. ( 1 986) and modified by Quigley et 
al. ( 1991b) for capillary column, and Benson et al ., (2002) with a Hewlett Packard gas. 
chromatograph (5890A), auto-sampler (7637A), integrator (3393A), and a J&W 
Scientific 530 Jlm HP-FFAP capillary column (Agilent Technologies Inc., Palo Alto, 
CA). 
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Feed samples. Composite dietary samples of CON and TRT starter were ground 
through a 1-mm screen in a Wiley Mill (Author H. Thomas Co., Philadelphia, PA) and 
analyzed (Table 4. 1 )  with composite milk replacer sample for DM, N (model FP-2000 
nitrogen analyzer, LECO, St. Joseph, Ml), GE (model 1241 adiabatic calorimeter, Parr 
Instruments, Moline, IL) ether extract (AOAC, 1 999), NDF and ADF (ANKOM 
Technology, 2003a; 2003b; ANKOM 200 series fiber analyzer, ANKOM Technology 
Corp. Macedon, NY), and minerals (Unicam Solaar 969, atomic absorption spectrometer, 
Cambridge, UK). 
Calculations 
Equations used to determine blood flow, net flux rates, and extraction ratios have 
been published in full by Heitmann and Fernandez (1 986) and Heitmann (1 989) and are 
detailed in Appendix 2. Blood flows were determined using the indicator dilution method 
via P AH infusion. Blood flow in portal and hepatic veins were measured directly and 
hepatic artery flow was determined by taking the difference in portal and hepatic 
measurements. Plasma flow was calculated by multiplying the whole blood flows by the 
measured plasma percent. Net fluxes across the PDV, liver, and total splanchnic tissues 
were calculated as a product of the venous-arterial concentration difference multiplied by 
the respective blood or plasma flow. Total splanchnic flux is simply the sum of the PDV 
and hepatic fluxes, but was calculated separately. Values reported are net fluxes and 
represent a combination of metabolite uptake and release. These values are not 
unidirectional flux rates and cannot differentiate absorption, interconversion and release 
'"\ 
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Table 4. 1 .  Measured chemical composition of feedsa 
Componentb Milk Replacer Control Treatmentc 
DM, % 93 .77 91 .01  90.98 
Crude Protein, % 22.69 1 9.85 19.09 
Ether extract, % 19.55 2.87 2 .89 
NDF, % 0.39 33. 1 8  34.45 
ADF, % 0.14  17.7 1 1 8.67 
Ash, % 12 .46 7.75 7.75 
Calcium, glkg 7.04 8 .82 8.54 
Phosphorus, glkg 9.95 7.93 7.5 1 
Magnesium, glkg 1 .62 3 .66 3 .64 
Potassium, g/kg 28.2 1 12 .89 12 .80 
Gross Energy, Meal/kg 4.96 4.34 4.33 
aMilk replacer was Instant Nursing Formula (Land O'Lakes, Fort Dodge, lA) and calf 
starters were Calf Primer I =  control and Calf Primer 1-B = treatment (Tennessee 
Fanners Cooperative, Lavergne, TN). 
bComposition on a dry matter basis. 
crreatment calf starter formulated to contained lasalocid supplement at 83 mg/kg DM. 
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of a metabolite from de novo production and release of a metabolite. A positive net flux 
indicates net release or production of a metabolite and a negative net flux indicates net 
uptake or tissue utilization of a metabolite by the specific tissue (Heitmann, 1 989). 
Statistical Analyses 
This experiment was originally designed as a randomized complete block that 
blocked calves in groups of two by birth date and weight and incorporated age at 
sampling as a repeated measures treatment design. Difficulties associated with catheter 
implantation, maintenance of catheter patency, and calf mortality limited the ability to 
obtain samples from arterial, portal and hepatic catheters at each of the four sampling 
periods for both control and treatment calves within a block. This resulted in a 
considerable number of incomplete blocks or variety of different combinations of 
/ 
catheters sampled between calves within a block. Also, sparse data across the four 
sampling ages resulted in non-convergence of the maximum likelihood solution for 
covariance parameter ·estimates when week was used as a repeated measure. Thus, block 
effect was dropped from the model and age at sampling (week) was used as a fixed factor 
instead of a repeated measure. Data for total splanchnic and hepatic flux was analyzed as · 
described below, but number of experimental units for these determinations is likely too 
low to safely make any conclusions without committing Type II error. 
All statistical analyses were conducted using mixed model procedures of SAS 
(version 8.2; SAS lnst., Inc., Cary, NC). Data for blood variables, rates of metabolism 
(net flux), and weekly body weights were analyzed as a completely randomized design. 
Data obtained from each sampling site were analyzed separately. Analyses of variance 
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for measured variables were performed with effects of diet (starter with or without 
lasalocid), age (week), and diet x age in the model. The statistical model used was: 
where: 
Yijk = 1.1 + Di + Wj + D*Wij + R(D*W)ijk 
Y ijk = dependent variable, 
J.l = overall mean, 
Di = effect of diet i, 
Wj = effect of week j (age at sampling), 
D*Wij = effect of diet by week interaction, 
R(D*W)ijk = effect of calf (replicate) k nested within diet by week (residual error). 
Individual means presented are averages of the six serial blood samples (number 
of observations) taken and averaged across all replicates (n = # of calves) for each 
metabolite for each week. Because of the unbalanced number of observations, all data are 
presented as least square means ± SE. Significant treatment interactions were separated 
using least significant difference features in SAS. Effects were considered significant at P 
� 0.05 and are discussed as having a tendency to be significant at P � 0. 1 0. 
Similar to factors described above, data for birth (d 0), d 35,  weaning (d 49), d 56, 
d 84, . and term (1 12  d) weights; pre-weaning, post-weaning, and overall ADG; post­
weaning feed:gain efficiency, and DMI were analyzed as a completely randomized 
design for effect of dietary treatment. Class variable was diet, but there was no week 
8 1  
effect included in the analysis of these data. Consequently, the error term for analysis of 
these variables was calf nested within dietary treatment. 
RESULTS 
Due to problems with calf mortality and catheter patency, calf numbers vary 
between measured and calculated values. Included in the study are only data from calves 
that were healthy and consuming a consistent daily ration. Data presented in the results 
and corresponding discussion will pertain primarily to portal-drained viscera (PDV) data. 
Data for net flux of metabolites across hepatic (HEP) and total splanchnic (TSP) tissue 
beds will be presented, but discussed in less detail due the low number of experimental 
units limiting statistical interpretation of the data. When a negative net flux, or uptake of 
a metabolite occurred, the extraction ratio for that metabolite was calculated, but due the 
sparcity of the data set these calculations could not be analyzed and are not included. 
Analysis of chemical composition of milk replacer and calf starter supplemented 
with (treatment; TRT) or without (control; CON) lasalocid is in Table 4. 1 .  All 
components for all feeds matched the ranges specified by the manufacturer and did not 
vary between calf starters. The same feeds were used in this experiment that were used in 
the previous experiment and agreed with results presented for diets in Chapter 3.  
Body Weights, Dry Matter Intake, and Efficiency of Gain 
All calves had similar birth, weaning, day 35 BW (Table 4.2) and wk 1 -5 BW 
(Figure 4. 1 ). This suggests that no pre-existing differences between calves influenced the 
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Table 4.2 . Effects of age and calf starter with (treatment) or without (control) 
lasalocid on body weights, dry matter intake, gain, and efficiency of gain for calves 
fed pre- and post-weaning. 
Variable1 Control2 SEM Treatment3 SEM p <:'  
Body weight, kg 
Birth (d 0) 26.88 1 .06 26.38 1 .44 NS 
Day 35 32.20 0.83 3 1 .55 1 .08 NS 
Wean (d 49) 36.55 0.97 36.34 1 .27 NS 
Day 56 40. 10  1 .29 39.07 1 .69 NS 
Day 84 6 1 . 1 9  2. 1 9  58.24 2.87 NS 
Final (d 1 1 2) 8 1 .48 3 .43 78.85 4.49 NS 
ADG, kg/d 
Birth to final ( d 0- 1 1 2) 0.48 0.03 0.47 0.04 NS 
-
Birth to wean ( d 0-49) 0. 1 9  0.02 0.20 0.03 NS 
Wean to final (d 49- 1 12) 0.71 0.04 0.67 0.06 NS 
DMI, kg/d5 2.07 0. 14  1 .83 0. 19  NS 
Feed:Gain5 2.94 0. 1 1 2.74 0. 1 5  NS 
1 Measures for variables birth and d 3 5 weights occurred prior to initiation of control 
and treatment starter diets on d 35 and represent pre-weaning period of milk replacer 
diet. 2Control means and SE calculated using n = 1 1  for birth weight, ADG (birth to final), 
and ADG (birth to wean) and n = 12  for all remaining variables. 
3Treatment means and SE calculated using n = 6 for birth weight, ADG (birth to 
final), and ADG (birth to wean) and n = 7 for all remaining variables. . 4Probability of greater F for the effect of dietary treatment on variable; not significant 
�NS) at P >  0. 1 0. 
Calculated from post-weaning period data only, thus represents period from wean to 
finish. 
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Figure 4.1 . Effects of calf starter supplemented with (O; n = 7) or without lasalocid (• ; 
n = 12) on weekly body weights. Arrows indicate initiation of starter ration at wk 5 and 
cessation of milk replacer ration at wk 7. All values are means ± SE and from wk 5 to 1 6  
effect of diet was significant (P < 0.05). 
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measurements taken after the dietary treatment was initiated at wk 5 post-sampling. 
Average daily gain calculated from birth to weaning does include the two-wk adaptation 
period where calves were receiving milk replacer and CON or TRT calf starter, but did 
not differ by dietary assignment. Day 56, 84, and final ( 1 6-wk) BW; ADG from weaning 
to 1 6-wk and from birth to 1 6-wk; and post-weaning DMI and feed:gain were not 
significantly different between CON and TRT calf starters (Table 4.2). Weekly body 
weight measurements progressed with similar trends between CON and TRT (Figure 
4. 1). There were significant wk (P < 0.0 1)  and diet (P < 0.05) effects for weekly weights. 
Prior to weaning BW measures overlapped. Weaning caused an apparent change in the 
slope after wk 7 and the lines diverged slightly and TRT remained slightly lower and 
progressed parallel with CON to wk-1 6. However, body weight measures did not 
significantly differ between CON and TRT (P < 0.05) at any point during the experiment 
(Figure 4. 1 ). 
Blood Flow and Packed-Cell Volume 
Means and standard errors for portal and hepatic veins and hepatic artery are 
summarized in Table 4.3 . Plasma percent values for flow rates and packed-cell volumes 
) can be found in Appendix 3 (Table A3. 1  ). Arterial packed-cell volume differed between 
CON and TRT prior to initiation of dietary treatment, but not after weaning. There is no 
,. 
apparent physiological or experimental explanation for this difference. Post-weaning 
packed-cell volume il)creased across Periods 2, 3, and 4. 
Blood flow through the portal vein increased with age (P < 0.0 1)  and almost 
doubled between sampling Periods 1 and 2 and continued to increase through Period 4. 
Table 4.3. Means and standard errors for blood flow (L/h) in pre-weaning and post-weaning dairy calves receiving calf starter 
with lasalocid 
�treatment� or without �control�. 
Period and age (d) 
Blood flow and 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) dietary assignment 
Portal vein, Llh2 
Control 1 45.5d ± 1 9 .9 223 .3c ± 22.2 377.4ab ± 22.2 4 1 6.83 ± 25 .7 
Treatment 1 1 7.3d ± 22.2 236.3c ± 1 9.9 342.6b ± 22.2 422.98 ± 25.7 
Hepatic vein, Llh3 
Control 229.8cd ± 37.3 265 .7cd ± 37.3 336.3bc ± 52.7 
Treatment 1 77.3d ± 37.3 393 .2b ± 37.3 499.98 ± 37.3 
Hepatic artery, L/h4 
Control 76.2ab ± 56.5 58 .2b ± 56.5 
Treatment 72.4b ± 39.9 2 1 3 .9a ± 39.9 1 06.2 ± 39.9 
a,b
,c,dMeans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 1Probability of a greater F statistic. 
Effect1 
Diet Age D x A  (D) (A) 
0.49 < 0.0 1 0 .62 
0.02 < 0.0 1 0.02 
0. 1 3  0.22 0. 1 1 
2Control starter: Period 1 (n = 5), Periods 2 and 3 (n = 4), and Period 4 (n = 3). Treatment starter: Periods 1 and 3 (n = 4), Period 2 (n = 
5), and Period 4 (n = 3). 3Control starter: Periods 1 and 2 (n = 2) and Period 3 (n = 1 ) . Treatment starter: Periods 1 through 3 (n = 2). 4Control starter: Periods 1 and 2 (n = 1 ). Treatment starter: Periods 1 through 3 (n = 2). 
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There was no effect of ionophore supplementation on portal vein ·blood flow. Like the 
portal vein, blood flow through the hepatic vein in TRT calves was significantly affected 
by age (P < 0.0 1 )  and demonstrated a marked increase in flow (Lihr) between Periods 1 
and 2 .  Rates of blood flow presented in Table 4.4 were adjusted by body weight (Lihr per 
kg). Only the pre- and post-weaning (Period 1 and Period 2, respectively) portal blood 
flow remained different (P < 0.05). The post-weaning blood flow rates no longer were 
significantly different and suggests that at weaning there is an increase in blood flow to 
gut tissues that stabilizes post-weaning, perhaps due to rapid growth in the rumen and 
other splanchnic tissues. 
Arterial Concentrations 
Concentrations of blood and plasma metabolites and ho�ones measured from . 
hepatic and portal veins are presented in Appendix 3 (Tables A3.2 - A3.4 and A3.5 -
A3.7, respectively). All arterial concentrations of blood and plasma metabolites and 
hormones were significantly affected by age (Tables 4.5, 4.6, and 4.7; respectively). 
There were no significant differences between CON and TRT arterial concentrations 
during the pre-weaning measurements of Period 1 when all calves were receiving milk 
replacer. With the exception of glucose, NEF A, and insulin, the arterial concentrations of 
ketones, lactate, VFA, and glucagon all increased from Period 1 to Period 2 (P < 0.05). 
Arterial concentrations for glucose and NEF A (and for TR T calves insulin) decreased 
from Period 1 to Period 2 (P < 0.05). Glucose (Table 4.5) was lowest 1 -wk post-weaning 
(Period 2) for CON and TRT and concentrations for both CON and TRT increased (P < 
0.05) to those measured in Periods 3 and 4. Arterial concentrations of NEF A (Table 4.6) 
Table 4.4. Means and standard errors for blood flow adjusted for body weight (L/h per kg) in pre-weaning and post-weaning 
dai� calves receivini calf starter with lasalocid �treatment� or without �control). 
Period and age (d) Effece 
--
Blood flow and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 12) Diet Age D x A  assignment (D) (A) 
Portal vein, Llh per k� 0.4 1 < 0.0 1 0.68 
Control 4.3bc ± 0.3 5 .2ab ± 0.3 5 .88 ± 0.4 5 .2ab ± 0.4 
Treatment 3 .7c ± 0.3 5 .48 ± 0.3 5.58 ± 0.3 5 .oab ± 0.4 
Hepatic vein, Llh per kg3 0.05 0.27 0.07 
Control 7. l ab ± 0.9 6.3b ± 0.9 5 .4b ± 1 .3 
Treatment 6.2b ± 0.9 9.78 ± 0 .9 7.9ab ± 0.9 
Hepatic artery, Llh per kg4 0. 1 2  0.5 0. 1 5  
Control 2.4ab ± 1 .5 1 .4b ± 1 .5 
Treatment 2.6ab ± 1 . 1  5 .38 ± 1 . 1  1 .6 ± 1 . 1  
a,b,c,dMeans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. · 
2Control starter: Period 1 (n = 5), Periods 2 and 3 (n = 4), and Period 4 (n = 3 ) . Treatment starter: Periods 1 and 3 (n = 4), Period 2 (n = 
5), and Period 4 (n = 3). 
3Control starter: Periods 1 and 2 (n = 2) and Period 3 (n = 1 ). Treatment starter: Periods 1 through 3 (n = 2). 
4Control starter: Periods 1 and 2 (n = 1 ). Treatment starter: Period 1 through 3 (n = 2). 
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Table 4.5. Means and standard errors for arterial concentration of metabolites (mmol/L) in pre-weaning and post-weaning 
da� calves receivini calf starter with lasalocid �treatmentl or without � controll. 
Period and age (d) Effect1 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A assignmenr (D) (A) 
Glucose 0.80 < 0.00 1 0.4 1 
Control 4. 1 o· ± o.o1 ·2.82c ± 0.08 3 .3 1 b ± 0.07 3 .48b ± 0. 1 0  
Treatment 4. 1 8. ± 0. 1 0  2.7 1c ± 0.08 3 .4 1  b ± 0.09 3 .34b ± 0. 1 1 
Acetoacetate 0.002 < 0.001 0. 1 2  
Control 0.0 1 9c ± 0.002 0.0523 ± 0.002 0.040b ± 0.002 0.032cd ± 0.003 
Treatment 0.0 14  c ± 0.003 0.038bc ± 0.002 0.038bcd ± 0.003 0.029d ± 0.003 
J3-hydroxybutyrate 0. 1 9  <0.00 1 0.66 
Control 0.084c ± 0.082 1 .45 1 ab ± 0.088 1 .5238 ± 0.082 1 .236b ± 0. 1 08 
Treatment 0.089c ± 0.097 1 .238b 
J 
± 0.088 1 .436ab ± 0.097 1 . 1 78b ± 0. 1 25 
Lactate 0.2 1 < 0.00 1 0.00 1 
Control o.sscc� ± o.o8 1 . 19a ± 0.08 0.9 1 b ± 0.08 0.79bc ± 0. 1 0  
Treatment 0.4-rt ± 0. 10  0.77bc ± 0.08 1 . 1 7. ± 0.09 0 .71  bed ± 0. 1 2  
Pyruvate < 0.001 < 0.00 1 0.03 
Control 0. 1 7b ± 0.01  0.238 ± 0.0 1 0.233 ± 0.0 1 0.233 ± 0.02 
Treatment 0. 1 5b ± 0.02 0. 1 5b ± 0.0 1 0. 1 7b ± 0.02 0.233 ± 0.02 
a,b,c,d,�eans within row and dietary between treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. 
2Control starter: Periods 1 and 3 (n = 7), Period 2 (n = 6), and Period 4 (n = 4). Treatment starter: Period 1 glucose and lactate (n = 4), 
acetoacetate, J3-hydroxybutyrate, and pyruvate (n = 5); Period 2 (n = 6), Period 3 (n = 5), and Period 4 (n = 3). 
Table 4.6. Means and standard errors for arterial plasma concentration of metabolites (mmol/L) in pre-weaning and post-
weanin� dai� calves receivini calf starter with lasalocid �treatmentl or without (controll. 
Period and age (d) Effect1 
Variable and dietary 1 (3 5) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenf (D) (A) 
NEFA 0.25 < 0.00 1 0.47 
Control 0.866' ± 0.036 0. 1 3 1  b ± 0.039 0.23 1 b ± 0.036 0. 1 1 8b ± 0.047 
Treatment 0.8838 ± 0.042 0.2 1 6b ± 0.039 0.20 1 b ± 0.042 0. 1 86b ± 0.055 
Acetate 0.34 < 0.00 1 0.05 
Control 0. 1 99e ± 0.063 1 .8498 ± 0.075 1 .226d ± 0.068 1 .46 1 be ± 0.084 
Treatment 0. 1 99e ± 0.075 1 .570b ± 0.068 1 .332cd ± 0.075 1 .428bcd ± 0.097 
Propionate < 0.00 1 < 0.00 1 <0.00 1 
Control 0.008d ± 0.0 1 1 0.2598 ± 0.0 1 2  0. 1 54b ± 0.0 1 1 0.079c ± 0.0 1 4  
Treatment 0.006d ± 0.0 13  0. 1 53b ± 0.0 1 2  0. 1 08c ± 0.0 1 3  0.083c ± 0.0 1 6  
Butyrate 0.03 < 0.00 1 0.3 5 
Control 0.002e ± 0.004 0.075' ± 0.005 0.052b ± 0.004 0.035cd ± 0.006 
Treatment 0.003e ± 0.005 0.058b ± 0.005 0.045bc ± 0.005 0.026d ± 0.007 
a,b,c,d,�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Periods 1 and 3 (n = 7), Period 2 for acetate (n = 5) and NEF A, propionate, and butyrate (n = 6); and Period 4 (n = 4). 
Treatment starter: Periods 1 and 3 (n = 5), Period 2 (n = 6), and Period 4 (n = 3). 
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Table 4.7. Means and standard errors for arterial plasma concentration of hormones (pmol/L) in pre-weaning and post-
weanin� dai!! calves receivin� calf starter· with lasalocid �treatment) or without (control�. 
Period and age (d) 
Variable and dietary 
assignmenr I (35) 2 (56) 3 (84) 4 ( 1 12) 
Insulin 
Control 20. 12c ± 4.6 I 1 8 .77 c ± 4.98 46.03a ± 4.72 38 .73ab ± 6.23 
Treatment 29. I I bc  ± 5 .55 3 . 8 I d ± 4 .98 49.478 ± 5 .55 I 7 .66cd ± 7.04 
Glucagon 
Control I 4.38e ± 1 .49 24.66b ± I .60 20.5 1bcd ± I .SO I 6.5 1 de ± 1 .96 
Treatment 1 8 .50cde ± 1 .96 30.9 I 8  ± 1 .60 2 1 .39bc ± 1 .76 I 5 .60de ± 2.27 
Effect1 
Diet Age 
(D) (A) 
0. 1 3  < O.OO I 
0.04 < O.OO I 
\0 0 
D x A  
0.02 
0. 19  
a.b,c,d.�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Periods 1 and 3 (n = 7), Periods 2 (n = 6), and Period 4 (n = 4). Treatment starter: Period I glucagon (n = 4) and insulin (n 
= 5); Period 2 (n = 6), Period 3 (n = 5), and Period 4 (n = 3). 
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did not differ between CON and TRT and significantly decreased from over 800 J.UilOl/L 
(Period 1)  to concentrations below 250 J..lmol/L in Period 2 where they stayed for the 
remainder of the experiment. 
Arterial concentrations of lactate (Table 4.5) were affected by weaning in both 
CON and TRT and increased from Period 1 to Period 2 (P < 0.05). The diet x age 
interaction was also significant for lactate concentrations and concentrations measured in 
CON calves were greater in Period 2 than TRT (P < 0.05). Period 3 lactate concentrations 
were the inverse with greater lactate concentration from TRT calves than CON (P < 
0.05). Pyruvate concentrations (Table 4.5) increased after Period 1 in CON and did not 
differ thereafter, but concentrations in TRT calves did not significantly increase until 
Period 4 where they matched concentrations in CON calves. 
Arterial concentrations of ACAC and BHBA {Table 4.5) were below 0.02 and 
0.09 mmol/L during Period 1 .  There was a significant diet effect for ACAC (P < 0.05) 
and there tended to be one for BHBA (P = 0. 19). Period 2 concentrations of ACAC were 
greater (P < 0.05) in CON than TRT calves and BHBA was numerically, but not 
statistically greater. In CON calves, ACAC and BHBA concentrations peaked at Period 2 
and 3 (0.05 and 1 .5 mmol/L, respectively) and declined each sampling period thereafter. 
In TRT calves, maximum ACAC concentrations were observed during Periods 2 and 3 
and BHBA concentrations did not significantly differ post-weaning. 
Acetate, propionate, and butyrate arterial concentrations {Table 4.6) were all 
greater in CON than TRT calves 1 wk post-weaning at Period 2 (P < 0.05)� Unlike 
acetate and butyrate concentrations which did not differ between CON and TRT at 
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Periods 3 and 4, propionate concentrations were still significantly greater in CON at 
Period 3 but were similar to TRT with CON at Period 4. 
Insulin arterial concentrations (Table 4.7) in CON did not change until an increase 
at Period 3,  but TRT calves insulin concentration decreased at Period 2 and was lower 
than CON (P < 0.05). Conversely, glucagon concentrations at Period 2 were significantly 
greater in TRT than CON. Insulin and glucagon concentrations at Periods 3 and 4 were 
generally not different by period or diet. 
Venous-arterial Concentration Differences 
Portal -arterial concentration differences are · presented in Tables 4.8, 4.9, and 
4. 1 0  for blood and plasma metabolites and hormones respectively. Due to low sample 
numbers, tables containing hepatic-arterial and hepatic-portal concentration differences 
are located in Appendix 3 in Tables A3.8 - A3 . 1 0  and A3 . 1 1  - A3. 1 3, respectively. 
Student's t-tests were used to determine if the portal-arterial (P A) concentration 
differences differed from zero which would be an indication of significant net flux. 
Glucose P A differences were significant from zero at Period 1 ,  but not different in 
Periods 2 - 4. Non-esterified fatty acid PA difference (Table 4.9) was not significant 
from zero at any of the four sample periods. Conversely, lactate, acetate, insulin, and 
glucagon P A differences were significantly different from zero in all four sampling 
periods. Portal-arterial differences for ketones, propionate, and butyrate were all 
significantly different from zero at Periods 2 - 4, but not for Period 1 .  Pyruvate was the 
only metabolite that had significance in one dietary treatment and not the other. Pyruvate 
Table 4.8. Means and standard errors for portal venous-arterial concentration differences of metabolites (mmol/L) in pre-
weanin� and eost-weanin� dai� calves receivin� calf starter with lasalocid �treatment) or without �controQ. 
Period and age (d) Effece 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenf (D) (A) 
Glucose 0. 14  < 0.00 1 0.99 
Control 0.2 1 38 ± 0.025 -0.022b ± 0.029 -0.033b ± 0.028 -0.029b ± 0.032 
Treatment o. 1 8s• ± 0.028 -0.059b ± 0.025 -0.066b ± 0.026 -0.052b ± 0.033 
Acetoacetate 0.37 < 0.00 1 0.03 
Control -0.002c ± 0.002 0.026cd ± 0.002 0.038a ± 0.002 0.035ab ± 0.002 
Treatment -0.002c ± 0.002 0.025d ± 0.002 0.030bc ± 0.002 0.038a ± 0.002 
J3-hydroxybutyrate 0.40 < 0.00 1 0.78 
Control -0.008c ± 0.0 12  0.077 b ± 0.0 1 4  0.2048 ± 0.0 14  0. 1 808 ± 0.0 1 6  
Treatment -0.0 13c ± 0.0 1 2  0.083b ± 0.0 1 2  o. 1 8s• ± 0.0 1 2  0. 1 65a ± 0.0 1 6  
Lactate ' 0.20 0.0 1 3  0.5 1 
Control 0.090abc ± 0.02 0.068bc ± 0.023 0.092abc ± 0.023 0. 1 19ab ± 0.026 
Treatment 0. 1 1 7ab ± 0.02 0.050c ± 0.020 0. 1 388 ± 0.02 0. 1 448 ± 0.026 
Pyruvate < 0.00 1 < 0.00 1 0.8 1 
Control 0.0 10ab ± 0.007 -0.035cd ± 0.008 -0.045cd ± 0.008 -0.058d ± 0.009 
Treatment 0.0248 ± 0.007 -0.007b ± 0.007 -0.028c ± 0.007 -0.036cd ± 0.009 
a,b,c,d,�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. 
2Control starter: Period 1 (n = 5), Periods 2 and 3 (n = 4), and Period 4 (n = 3). Treatment starter: Period 1 (n = 5) except glucose (n = 4); 
Periods 2 and 3 (n = 5}, and Period 4 (n = 3). 
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Table 4.9. Means and standard errors for portal venous-arterial plasma concentration differences of metabolites (mmol/L) in 
£re-weanini and ;eost-weanini dai� calves receivini calf starter with lasalocid �treatment) or without ( controll. 
Period and age (d) Effect1 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 12) Diet Age D x A  assignmenr (D) (A) 
NEFA 0.99 0. 1 5  0.79 
Control -0.007 ± 0.0 13  0.0 10  ± 0.0 14 0.008 ± 0.0 1 4  0.0 1 8  ± 0.0 1 6  
Treatment -0.0 1 0  ± 0.0 1 3  -0.005 ± 0 .0 1 3  0.0 1 7  ± 0.0 1 3  0.027 ± 0.0 1 6  
Acetate 0. 1 7  < 0.00 1 0.45 
Control 0.086e ± 0.03 1 0.527 c ± 0 .034 0.620abc ± 0.034 0.7 1 98 ± 0.040 
Treatment o.o8se ± 0.03 1 0.433d ± 0.03 1 0.6 1 6bc ± 0.03 1 0.683ab ± 0.04 1 
Propionate < 0.00 1 < 0.00 1 < 0.00 1 
-
Control 0.028c ± 0.0 1 8  0.6168 ± 0.020 0.6078 ± 0.020 0.508b ± 0.024 
Treatment 0.024c ± 0.0 1 8  0.46 1 b ± 0 .0 1 8  0.484b ± 0.0 1 8  0.5868 ± 0.024 
Butyrate < 0.00 1 < 0.00 1 0.06 
Control 0.0 1 6c ± 0.007 0. 1248 ± 0.008 0. 1 23& ± 0.008 0. 1 04ab ± 0.009 
Treatment 0.0 1 8c ± 0.007 0.096b ± 0.007 0.088b ± 0.007 0.088b ± 0.009 
a.b.c.a�eans within row and dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Period 1 (n = 5}, Periods 2 and 3 (n = 4}, and Period 4 (n = 3). Treatment starter: Periods 1 through 3 (n = 5) and Period 4 
(n = 3). 
Table 4.10. Means and standard errors for portal venous-arterial plasma concentration differences of hormones (pmol/L) in 
pre-weaning and post-weaning dairy calves receiving calf starter with lasalocid (treatment) or without (control). 
Period and age (d) Effect1 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenr (D) (A) 
Insulin 
Control 1 0.24bc ± 2.36 8.5 1 cd ± 2.64 1 7.36a ± 2 .70 1 6.77ab ± 3 .05 
Treatment 5 .64cd ± 2.40 3 . 1 2d ± 2.36 1 8 .0a ± 2.36 1 7.84ab ± 3 .05 
Glucagon 
Control 1 .576d ± 0.500 1 .622cd ± 0.559 4.482a ± 0.559 3 .594ab ± 0.646 
Treatment 2. 127bcd ± 0.559 1 .278d ± 0.500 1 .95 1 cd ± 0.500 3 .2 1 7abc ± 0.646 
a,b,c,d.�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability.of a greater F statistic. 
0.27 < 0.00 1 0.48 
0.09 < 0.00 1 0.03 
2Control starter: Period 1 (n = 5), Periods 2 and 3 (n = 4}, a�d Perio.g 4 (n = 3). Treatment starter: Period 1 (n = 5) except glucagon (n = 4); 
Periods 2 and 3 (n = 5}, and Period 4 (n = 3). 
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P A was not significantly different than zero for Period 1 CON calves and Period 2 TRT 
calves. All remaining periods had P A that were significantly different than zero. 
Portal-Drained Visceral Metabolism 
All net portal-drained visceral (PDV) flux of blood and plasma metabolites had a 
significant age effect (Tables 4. 1 1 , 4. 1 2; respectively). There was a net PDV release of 
glucose during Period 1 only and subsequent measures did not differ with age or calf 
starter. Lactate and acetate also had net PDV release, but unlike glucose, net release of 
lactate and acetate continued to increase across sampling periods with CON calves 
having a greater numerical net release of acetate than TR T. Calves receiving the lasalocid 
had higher net PDV release of lactate at Period 3 than CON calves (P < 0.05). During 
Periods 3 and 4, TRT calves had a net PDV uptake of pyruvate (Table 4. 1 1 ) that was 
50% lower than in CON calves (P < 0.05). Net PDV flux of propionate and butyrate 
(Table 4. 12) and ACAC and BHBA (Table 4. 1 1 )  during Period 3 was greater in CON 
than TRT (P < 0.05), but by Period 4 net release VFA and ketones no longer differed 
between diets. 
The net release of insulin and glucagon (Table 4. 1 3) did not differ between 
Periods 1 and 2 ,  but an increase in PDV release measured in Periods 3 and 4 was greater 
than Periods 1 and 2 (P < 0.05). For insulin flux, there was only a significant age effect 
(P < 0.001 ), but for glucagon effects for diet, age and diet x age interaction were 
significant. Net PDV release of glucagon was significantly lower in TRT than CON 
calves during Period 3 ,  but like the metabolites above no differences were detected at 
Period 4. 
Table 4.1 1 .  Means and standard errors for net portal-drained visceral flux of blood metabolites (mmol/h) in pre-weaning and 
e2st-weanin� dai!! calves receivin� calf starter with lasalocid �treatment� or without (control�. 
Period and age (d) Effece 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenf (D) (A) 
Glucose 0.39 < 0.00 1 0.8 1 
Control 3 1 .85a ± 5.3 1 -8.97b ± 5 .93 -1 4.30b ± 5 .93 -9. 14b ± 6.85 
Treatment 34.8 1  a ± 6.85 - 1 6.45b ± 5 .3 1 -2 1 .28b ± 5 .93 -1 2.70b ± 6.85 
Acetoacetate 0. 14  < 0.00 1 0. 1 5  
Control -0. 1 9d ± 1 .04 6. 1 5c ± 1 . 16 1 5 .56a ± 1 . 1 6 1 5 .76a ± 1 .34 
Treatment -0. 13d ± 1 . 16 5 .92c ± 1 .04 1 1 .04b ± 1 . 1 6  1 5 .44a ± 1 .34 
J3-hydroxybutyrate 0.03 < 0.00 1 0.33 
Control - l . l Od ± 6.38 24.83c ± 7. 1 3  87.04a ± 7. 1 3  77. 8 1  ab ± 8.23 
Treatment - 1 . 19d ± 7. 13 20.73c ± 6.38 64. 1 3b ± 7. 13  60.6 1 b ± 8.23 
Lactate 0.08 < 0.00 1 0. 1 1  
Control 12. 1 9b ± 5 .44 2 1 .99b ± 6.08 27.96b ± 6.2 1 46.74a ± 7.02 
Treatment 1 5 . 1 6b ± 6.08 1 5 . 1 9b ± 5 .44 48.62a ± 6 .08 60.93a ± 7.02 
Pyruvate < 0.00 1 < 0.00 1 0.36 
Control 1 .24a ± 2.36 - 1 0.20b ± 2.59 -1 8 .66c ± 2.59 -27.28d ± 2.99 
Treatment 3 . 8 1a ± 2.59 - 1 .82a ± 2.32 -9.37b ± 2.59 -1 5 .68bc ± 2.99 
a,b,c,d,�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. 
2Control starter: Period I (n = 5), Periods 2 and 3 (n = 4), and Period 4 (n = 3). Treatment starter: Periods 1 and 3 (n = 4) except Period 1 
glucose (n = 3); Period 2 (n = 5), and Period 4 (n = 3). 
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Table 4.12. Means and standard errors for net portal-drained visceral flux of plasma metabolites (mmol/h) in pre-weaning and 
eost-weanin� dai� calves receivin� calf starter with lasalocid (treatment) or without (control). 
Period and age (d) Effect1 
Variable and dietary I (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenf (D) (A) 
NEFA 0.36 0.007 0.32 
Control 0.50bc ± 1 .52 3 .78ab ± 1 .67 2.46abc ± 1 .67 5 .928 ± 1 .93 
Treatment -0.5 1 be ± 1 .67 -0.89c ± 1 .50 3 .47abc ± 1 .67 6. 1 58 ± 1 .93 
Acetate 0.02 < 0.00 1 0.64 
Control 8.56e ± 14. 13  97.95d ± 1 5 .79 1 8 1 .06bc ± 1 5 .79 235.558 ± 1 8 .24 
Treatment 6.26e ± 1 5 .79 7 1 .40d ± 1 4. 1 3  146.02c ± 1 5 .79 195 .63ab ± 1 8 .76 
Propionate 0. 1 3  < 0.00 1 0.07 
Control 2.93d ± 1 1 .84 108 .26bc ± 13 .24 169.698 ± 1 3 .24 164.5 1 8  ± 1 5 .29 
Treatment 1 .60d ± 13 .24 79.72c ± 1 1 . 84 120.4 1 b ± 13 .24 1 85 .38a ± 1 5 .29 
Butyrate 0.004 < 0 .00 1 0 . 1 6  
Control 1 .5 1  d ± 2.67 20.23(; ± 2.94 36.558 ± 2.94 32. 1 7ab ± 3 .39 
Treatment 1 .23d ± 2.94 16.82c ± 2.63 24. 1 8bc ± 2.94 23 .49bc ± 3 .39 
a.b,c,cl,�eans within row and dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. . 
2Control starter: Period I (n = 5), Periods 2 and 3 (n = 4), and Period 4 (n = 3). Treatment starter: Periods I and 3 (n = 4), Period 2 (n = 5), 
and Period 4 (n = 3). 
Table 4.13. Means and standard errors for net portal-drained visceral flux of plasma hormones (nmol/h) in pre-weaning and 
post-weaning dairy caly����ceiving calf starter with ���ocid (treatment) or without (control). 
Period and age (d) Effect1 
Variable and dietary 
assignmenf 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) 
Diet 
(D) 
Age 
(A) D x A  
Insulin 
Control 1 .2Sb ± 0.54 1 .54b ± 0.60 4.643 ± 0.62 4.5 1 3  ± 0.72 
Treatment 0.60b ± 0.62 0.53b ± 0.54 4.0 1 3  ± 0.62 5 .233 ± 0.70 
Glucagon 
Control 0. 1 7c ± 0. 1 1  0.22bc ± 0. 1 2  1 . 1 28 ± 0. 1 2 1 . 1 28 ± 0. 1 4  
Treatment 0. 1 8bc ± 0. 12  0. 1 7bc ± 0. 1 1  0.49b ± 0. 1 2  0.948 ± 0. 1 4  
0.37 < 0.00 1 0.5 8 
0 .02 < 0.00 1 0.03 
a,b,c,d,eMeans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Period 1 (n = 5), Periods 2 and 3 (n = 4), and Period 4 (n = 3). Treatment starter: Periods 1 and 3 (n = 4), Period 2 (n = 5), 
and Period 4 (n = 3). 
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Liver Metabolism 
Interpretation of hepatic flux is restricted due to low numbers of experimental 
units. However, the data that is presented in Tables 4. 14, 4. 1 5, and 4. 1 6  for blood and 
plasma metabolites and plasma hormones, respectively, does appear to be physiologically 
·normal. There was a net uptake of ACAC and butyrate by the hepatic tissues and a net 
release of BHBA at Period 2 that was similar in CON and TRT calves (Table 4. 14  and 
4. 1 5). The net hepatic ACAC and butyrate uptake and BHBA release seemed to be 
increasing with age in TRT calves as Period 3 fluxes was numerically greater than Period 
2.  This is supported by the observed increases in net portal supply of ketones and butyrate 
increasing at Period 3 (Table 4. 1 1  and 4. 1 2). 
Similarly there was a net hepatic uptake of lactate and propionate at Period 2 that 
can account for much of net release of glucose from the liver (Tables 4. 14  and 4. 1 5).This 
is more evident in Period 3 TRT data which had a numerically greater net hepatic release 
of lactate and propionate (Tables 4. 1 4  and 4. 1 5 ; 1 1 9 mmol/hr of propionate/2 + 65 
mmollhr lactate/2 = 92; 10 1% hepatic glucose release). Period 1 net hepatic release of 
glucose was not numerically different from that measured in Period 2 for TRT calves. 
Periods 2 and 3 had apparent precursors of propionate and lactate, but there was no 
propionate supplied in Period 1 .  Therefore, in the preruminant the portal supply of dietary 
glucose accounted for 50% (Table 4. 1 1 )  and the hepatic uptake of lactate can account for 
another 25% (Table 4. 14) of the hepatic glucose release in TRT calves. 
Table 4.14.  Means and standard errors for net liver flux of blood metabolites (mmol/h) in pre-weaning and post-weaning 
dai� calves receivin� calf starter with lasalocid �treatmentl or without � control) . 
Period and age (d) Effece 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenr (D) (A) 
Glucose 0.2 0.7 1 0 .55 
Control 34. 1 7  ± 20.67 5 1 .84 ± 20.67 
Treatment 68.76 ± 1 5 .27 64.66 ± 1 4.62 90.79 ± 1 4.62 
Acetoacetate 0. 1 1  < 0.00 1 0.74 
Control 3 .2 1 8 ± 1 .84 -5 .78bc ± 2.60 
Treatment -0.7 1 ab ± 1 .50 -8.34c ± 1 .84 - 1 5 .28d ± 1 .84 
(3-hydroxybutyrate 0.49 < 0.00 1 0.06 
Control 9. 1 0cd ± 7. 12  23 .95bc ± 1 0.07 
Treatment -0.3 1 d ± 5.82 44. 1 6b ± 7. 1 2  74.688 ± 7. 1 2  
Lactate 0.83 0.84 0.22 
Control -2.22 ± 19.88 -32.3 1 ± 26.92 
Treatment -32.58 ± 1 5 .99 - 1 1 .23 ± 1 9.03 -65 . 1 3  ± 1 9 .03 
Pyruvate 0.00 1 0.003 0.003 
Control 1 .04b ± 4.06 25 .998 ± 4.97 
Treatment -0.08b ± 2.95 -0. 1 4  b ± 3 .5 1  6.88b ± 3 .5 1  
a,b,c,d,cMeans within row and between dietary treatment not sharing like superscripts are different (P < 0.05) . 
1Probability of a greater F statistic. 
2Control starter: Period 1 (n = 2) except glucose (n = 1 ) and Period 2 (n = 1 ). Treatment starter: Period 1 (n = 3) except glucose (n = 2) 
and Periods 2 and 3 (n = 2). 
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Table 4.15.  Means and standard errors for net liver flux of plasma metabolites (mmol/h) in pre-weaning and post-weaning 
dai� calves receivin� calf starter with lasalocid �treatmentl or without (control). 
Period and age (d) 
Variable and 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet dietary assignmenr (D) 
NEFA 0. 1 3  
Control 1 4.388 ± 6.92 - 10.52b ± 8 .93 
Treatment - 1 2.28b ± 5 .47 -5 .6 1 b ± 6.3 1 -32 .27c ± 6.3 1 
Acetate 0.006 
Control -28.7 1 b ± 1 3 . 1 2  1 .98b ± 1 7.77 
Treatment 2.82b ± 10.26 48.978 ± 1 2.56 - 1 4.75b ± 1 2 .56 
Propionate < 0.00 1 
Control -4.671 ± 2.89 - 1 2 1 .9 1c ± 4.09 
Treatment 0.548 ± 2.36 -42.58b ± 2.89 - 1 1 9.23c ± 2.89 
Butyrate 0.002 
Control - 1 .248 ± 0.83 - 1 1 .72c ± 1 . 1 2  
Treatment -0.348 ± 0.65 -6.76b ± 0.79 -2 1 .7-rt ± 0.79 
a.b,c,ct,�eans within row and dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Period 1 (n = 2) and Period 2 (n ::: 1 ). Treatment starter: Period 1 (n = 3) and Periods 2 and 3 (n = 2). 
Effect1 
Age D x A  (A) 
0.20 0.03 
0.008 0.5 8 
< 
< 0.00 1 0.00 1 
< 0.00 1 0.02 
...... 
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Table 4.16. Means and standard errors for net liver flux of plasma hormones (nmol/h) in pre-weaning and post-weaning dairy 
calves receiving calf starter with lasalocid (treatment) or without (control). 
Period and age (d) 
Variable and dietary 
assignmenr 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) 
Insulin 
Control - 1 .44b ± 1 . 1 1 - 1 .77b ± 1 .56 
Treatment 2.788 ± 0.90 0. 1 2ab ± 1 . 1 1 -3 .64b ± 1 . 1 1 
Glucagon 
Control 0.20 ± 0.29 -0.0 1 ± 0.39 
Treatment -0.39 ± 0.23 0. 1 3  ± 0.28 0. 1 2  ± 0.28 
a,b,c,d,�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. 
Effect1 
Diet Age 
(D) (A) 
0.0 1 0.22 
0.47 0.6 1 
2Control starter: Period 1 (n = 2) and Period 2 (n = 1 ). Treatment starter: Period 1 (n = 3) and Periods 2 and 3 (n = 2). 
D x A  
0.34 
0.24 
-
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Total Splanchnic Flux 
As an expression of the combined effects of liver and PDV metabolism, only the 
net total splanchnic flux of lactate was not significant across sampling periods 1 ,  2, 3 
(Table 4. 17). Net splanchnic release of BHBA, acetate, propionate, butyrate and glucagon 
all increased in response to weaning (P < 0.05; Tables 4. 1 8  and 4. 1 9). Net splanchnic 
uptake of acetoacetate increased in response to weaning, whereas lactate appeared to 
decline. During Period 2 CON calves had a greater net splanchnic release of VF A than 
TRT calves (P < 0.05), but by Period 3 there were no observed differences attributable to 
the supplementation of lasalocid. 
DISCUSSION 
The results of lasalocid supplementation on BW and performance characteristics 
(Figure 4. 1 and Table 4.2) did not demonstrate any differences and these findings agree 
with those described in Chapter 3 .  While no statistical comparisons can be made between 
the two experiments, overall and pre-weaning ADG were numerically the same, but post­
weaning ADG appeared slightly lower in this experiment. This may have been due to 
calves in this experiment undergoing surgery. Also, this experiment had numerically 
lower DMI and feed efficiency than the previous experiment and may have been a result 
of calves in this experiment being housed in an controlled environment versus calves in 
the previous experiment housed outdoors during winter months. 
\ 
Table 4.17. Means and standard errors for net total splanchnic flux of blood metabolites (mmollh) in pre-weaning and post-
weanin� dai!I calves receivini calf starter with lasalocid (treatment� �r without (control�. 
· Period and age (d) Effect1 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A assignmenf (D) (A) 
Glucose 0. 1 7  0.00 1 0 . 1 2  
Control 75 .45b ± 19.64 42.86bc ± 19.64 45 .07bc ± 27.77 
Treatment 1 33 .868 ± 19.64 23 .78c ± 16 .03 76.26b ± 1 9.64 
Acetoacetate 0.54 0.04 0.73 
Control -0.54 ± 0.74 -2.56 ± 0.74 - 1 .58 ± 1 .05 
Treatment -0.93 ± 0.6 1 -2.3 1 ± 0.6 1 -2.57 ± 0.74 
J3-hydroxybutyrate 0. 1 5  < 0.00 1 < 0.00 1 
Control 8.65d ± 9.55 6 1 .32bc ± 9.55 83 .29b ± 1 3 .50 
Treatment - 1 .52d ± 7.79 38 .85c ± 7.79 1 5 1 . 1 98 ± 9.54 
Lactate 0.69 0.3 1 0.72 
Control -2 1 .78 ± 14.02 - 1 6.35 ± 14.02 6.88 ± 1 9.83 
Treatment -26.99 ± 1 1 .45 -8 .94 ± 1 1 .45 -9.58 ± 14.02 
Pyruvate 0.0 1 0.02 0.04 
Control -4.58b ± 2.99 0.4 1 ab ± 2.99 - 1 5 . 1 2c ± 4.24 
Treatment 4.288 ± 2.52 - 1 .60ab ± 2.45 -2.23ab ± 2.99 
a,b,c,d,cMeans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Periods 1 and 2 (n = 2) and Period 3 (n = 1 ). Treatment starter: Periods 1 and 2 (n = 3) except Period 1 glucose (n = 2) and 
Period 3 (n = 2). 
-
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Table 4.18. Means and standard errors for net total splanchnic flux of plasma metabolites (mmol/h) in pre-weaning and post-
weanin� dai� calves receivin� calf starter with lasalocid �treatment� or without ( controQ. 
Period and age (d) Effect1 
Variable and I (3 5) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  dietary assignment2 I. (D) (A) 
NEFA 0.69 0.005 0.8 1 
Control -7.248b ± 5 .86 -5 .45ab ± 5 .86 -23 .52bc ± 8.28 
Treatment - 1 1 .48ab ± 5 .07 -3 . 1 58 ± 4.78 -27.37c ± 5 .86 
Acetate 0.9 1 <0.00 1 0.08 
Control 7.34d ± 14.04 1 09. 16b ± 1 4.04 1 23 .448b ± 1 9.86 
Treatment 1 0.03d ± 1 1 .46 72. 1 1  c ± 1 1 .46 1 53 .608 ± 14.04 
Propionate 0.02 < 0.00 1 0.002 
Control -0.52c ± 2.75 22.978 ± 2.75 1 7.65ab ± 3 .89 
Treatment 2.3 1 de ± 2.24 7.54cd ± 2.24 1 3 .08bc ± 2.75 
Butyrate 0.24 < 0.00 1 0.09 
Control 0.54c ± 0.95 7.928 ± 0.95 7.26ab ± 1 .35  
Treatment 1 . 1 6c ± 0.78 4.78b ± 0.78 6.938b ± 0.95 
a,b,c,d.�eans within row and dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. 
2Control starter: Periods I and 2 (n = 2) and Period 3 (n = 1 ). Treatment starter: Periods I and 2 (n = 3) and Period 3 (n = 2). 
� 
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Table 4.19. Means and standard errors for net total splanchnic flux of plasma hormones (nmollh) in pre-weaning and post­
weaning dairy calves receiving calf starter with lasalocid (treatment) or without ( contro!}. 
Period and age (d) Effect1 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 (1 1 2) Diet Age D x A  assignmenr (D) (A) 
Insulin 
Control 1 .  70bc ± 1 .09 0. 1 3c ± 1 .09 1 .03abc ± 1 .69 
Treatment 3 .34ab ± 0.89 0.26c ± 0.89 4.788 ± 1 .09 
Glucagon 
Control 0. 1 1 c ± 0.24 0.60bc ± 0.24 1 .648 ± 0.33 
Treatment O.OSc ± 0.20 0.39c ± 0. 1 9  1 .02ab ± 0.24 
a,b,c,d,�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05)., 
1 Probability of a greater F statistic. ' 
0.05 0 .03 
0. 1 4  < 0.00 1 
2Control starter: Periods 1 and 2 (n = 2) and Period 3 (n = 1 ). Treatment starter: Periods 1 and 2 (n = 3) and Period 3 (n = 2). 
0.34 
0.54 
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Blood Flow 
The lowest portal blood flow rates were observed in Period 1 (pre-weaning) at 
1 45.5 and 1 1 7.3 L/h for CON and TRT when calves were only receiving milk replacer. 
These values agreed with the previously published preruminant portal blood flow rates of 
1 59.8 (mean of 24 hourly measurements; Ortigues et al., 1 995), 145.8 (Carr and 
Jacobson, 1 968), and 14 1 .2 Llhr (Durand et al., 1 988). Ortigues et al. ( 1995) also 
reported hourly blood flow rates across a 24-hr period for hepatic vein and hepatic artery 
of 1 82.4, and 22.6 L/hr, respectively. These data agree with our preruminant hepatic vein 
flow rates of 177.3 and 229.3 L/hr for CON and TRT, respectively. Hepatic artery flow is 
calculated by subtracting the measured portal flow from the measured hepatic flow and 
therefore requires a complete set of functioning catheters. The hepatic artery flow rate in 
this study (Table 4.3) was higher than the previously reported data and had a large 
standard error due to the low number of calves that had all three catheters functioning 
simultaneously. 
As calves increased in size, the portal blood flow increased significantly with 
each period resulting in a greater flow rate than the preceding measure (Table 4.3). 
Interestingly, when this data was corrected for body weight (Table 4.4), only Period 1 
remained significantly different from the other sample periods. This is most likely a 
response to the rapid growth of g�t tissues in response to the peri-weaning diet change. 
Huntington et al. ( 1 990) presented portal blood flow data from several different 
techniques and species corrected for BW. The average mature bovine portal blood flow 
measured using PAH dilution was 44 mL/min/kg. ·The values reported in this study for 
Perio� 4, when converted and averaged between CON and TRT was 84.9 mL/minlkg, 
109 
nearly twice that reported by Huntington et al. ( 1 990). If the previously reported adult 
portal flow rate was converted from BW to metabolic body weight the average flow was 
1 85 .2 rnUminlkg0·75 and the value for the current study was 258.2 rnUmin/kg0·75• Thus, 
when corrected for BW or metabolic BW measured portal flow was still greater in this 
study than other reports from adults. The bovine portal flow rates determined by P AH 
presented by Huntington et al. ( 1 990) were measured in much larger cattle, as the 
smallest weight reported at 21 1 kg, but the largest BW measured in the current study was 
during Period 4 (wk 1 6) and 81  kg. It is likely that this observed difference in reported 
portal flow rates is an effect of calves in the current study slowly adjusting their flow 
rates on a BW or metabolic BW basis as muscle growth catches up with the rapid 
increase in splanchnic tissue growth. 
The absence of an ionophore. related effect on blood flow was anticipated. 
Previous research using high-concentrate diets supplemented with monensin and 
salinomycin reported only a tendency for increased portal flow with ionophore 
supplementation (n = 3), but a significant decrease when monensin supplement was 
removed from a diet of chopped alfalfa hay (n = 2; Harmon et al., 1988). When high­
concentrate diets were supplemented with monensin no effects on portal blood flow were 
reported (n = 4; Harmon and Avery, 1 987). Ionophore supplementation in the current 
study did not affect blood flow rates. 
Arterial Concentrations 
Arterial concentrations are an important component in the calculation of net flux 
of a nutrient. When discussed alone they have the same limitations as the results from 
1 1 0 
jugular blood sampling presented and discussed for the experiment in Chapter 3 and 
would be repetitious. As such, they will currently be discussed as a component of net . 
nutrient fluxes below. However, it is worth briefly noting agreement between the two· 
experiments. Supporting the previous experiment in this study, glucose concentrations 
reached a nadir that coincided with weaning. Concentrations of NEF A were significantly 
reduced following weaning and were representative of adult concentrations reported for 
cattle and sheep (Bergman, 1 971 ). Acetate, propionate and butyrate all increased 
substantially post-weaning and were significantly lower in TRT than CON for all three 
VF A at Period 2. These concentrations exhibited similar patterns as age increased, but 
concentrations were substantially greater in this experiment than in the previous 
experiment or other published values (Quigley et al., 1 991b). (3-hydroxybutyrate 
concentrations were similar in trends between the two experiments. The current 
experiment had larger measured concentrations and is probably due to the decreased time 
until samples were analyzed and subsequently less spontaneous decarboxylation to 
acetone. Concentrations of individual calves measured in this experiment exceeded 2.0 
mmol/L on several occasions and in one individual, concentrations exceeded 3 .0 mmol/L 
(although, it did not exhibit any adverse symptoms of ketosis). This was interesting, since 
these blood concentrations exceed the published limits for peripheral tissue utilization of 
ketones (Bergman, 1971 ; Leng, 1 965) and the levels at which an adult would be 
exhibiting clinical symptoms of ketosis (Bergman, 1 984). However, these calves did not 
demonstrate the concomitant hypOglycemia observed in adults with hyperketonemia. 
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Portal-Drained Viscera and Liver Metabolism 
Glucose and glucose precursors - Periods 1 and 2. Net glucose flux shifted from 
a net portal release of glucose during Period 1 (Table 4. 1 1 ) to no significant portal­
venous difference (Table 4.8) and thus, no significant uptake or release during Period 2, 
3, and 4. This is indicative of development of the gut, as absorption of glucose from the 
mature gut on a fiber diet is negligible in ruminants (Bergman et al., 1 970) and the PDV 
will actually have a net utilization of glucose. The adult ruminant liver is responsible for 
85% of the total glucose production (Bergman et al., 1 970). The liver removes little or no 
glucose since there is minimal quantities arriving via portal or hepatic arterial blood. This 
is apparent by the low glucokinase activities of in the ruminant liver (Leat, 1 970; Ballard 
and Oliver, 1 969) and a half maximal velocity (half saturated) that is equal to about 10  
mM (Lehninger, 1 993). 
In the preruminant however, the gut appears to be the main glucose producing 
organ and the liver has high activities of glycolytic enzymes (Table 2 . 1  ). Lactate is the 
primary glucose precursor used by the preruminant liver, which has a better ability to 
convert lactate to glucose than adults (Donkin and Armentano, 1 995). In this regard, 
Period 1 portal supply of glucose (3 1 .9 mmollhr) can explain about 1 00% of hepatic 
glucose release in CON (34.2 mmol/L). Unlike CON, the hepatic glucose release in TRT 
calves (68.8 mmollhr) was 2-fold the net portal release (34.8 mmollhr). There also was a 
large net hepatic extraction of lactate in TRT (-32.6 mmollhr) that could account for 
another 1 5% of hepatic glucose release in TR T calves. The difference in net flux of 
insulin across the liver observed during Period 1 (Table 4. 1 6) between CON and TRT (-
1 .44 and 2.78 nmollhr) ,could also be contributing to the observed difference._ in net 
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hepatic release of glucose. Due to the significant post-prandial changes report in glucose 
and lactate concentrations in preruminants (Ortigues et al. ,  1 996; Quigley and Bernard, 
1 992) the small number of calves used in these determinations is likely a causal factor. 
The major glucose precursors are propionate, lactate/pyruvate, alanine, · and 
glycerol. The most important substrate for hepatic glucose production in fed ruminants is 
propionate which can account for over 50% glucose .synthesis (reviewed by Brockman, 
.1 993). Hepatic propionyl-CoA synthase has a high Vmax (maximum velocity) and a low 
Km (half maximum velocity; Ash and Baird, 1 973) and little propionate ever reaches 
hepatic venous blood (Bergman and Wolff, 1 971 ). This study numerically demonstrated 
(Table 4. 1 5) a net hepatic removal of propionate (TRT = -42.6 mmollhr) post-weaning 
that could account for 33% of the hepatic glucose release (TRT = 64.7 mmollhr). 
Post-weaning lactate is the secondary precursor, responsible for 1 5  - 20% of 
hepatic glucose production (Van der Walt et al., 1 983), and this experiment demonstrates 
�30% contribution of lactate to glucose (Table- 4. 14). Donkin and Armentano ( 1 995) 
demonstrated that the addition of propionate to ruminant hepatocytes caused a reduction 
in lactate incorporation into glucose. This observation is probably the result of preference 
of propionate over lactate as substrate for glucose production and the decreased activities 
of lactate dehydrogenase and pyruvate carboxylase in the adult liver (Table 2. 1 ). Net 
hepatic release of glucose at Period 2 in this study was 5 1 .8 and 64.7 mmol/L for CON 
and TRT. These values are · I ower than other reports of net hepatic glucose release in 
mature cattle (Huntington, 1 990). Net portal release of propionate and lactate can account 
for over 1 00% of CON and almost 50% of TRT hepatic glucose release. Amino acids 
1 1 3 
would likely make up any remaining contributions to glucose not accounted for in the 
metabolites measured in this study. 
Net portal nutrient flux in Period 3. The reported effects of ionophores include 
the modification of rumen bacterial populations that result in the secondary effect of 
altered molar ratios of VF A available, typified by an increase in propionate at the 
expense of acetate and butyrate (Russell and Strobel, 1 989; Bergen and Bates, 1984). Due 
to varying rates of rumen epithelial metabolism of individual VF A during absorption, 
rumen production is not necessarily reflected in PDV release. The effects of ruminal 
ionophore on rumen concentrations of VF A may not be reflected in the net portal flux of 
these nutrients. A limitation of the technique used in this study is that intracellular 
activity and intracellular dilution of a metabolite from intracellular metabolism cannot be 
determined (Brockman, 1 993; Heitmann, 1 989). This could be overcome by the use of 
isotope dilutions to permit the determination of unidirectional fluxes and the fate of a 
metabolite by measuring the appearance of the label in it's metabolic products 
(Brockman, 1 993 ; Heitmann, 1 989). This technique, while very informative, is very 
complex and time consuming and was beyond the physical capacity of personnel 
involved with this experiment. 
In the presence of increasing rumina} butyrate concentrations, there appears to be 
an increase in ACAC, but not BHBA production and portal appearance (Krehbiel. et al., 
1 992; Baldwin and Jesse, 1 996). Krehbiel and coworkers ( 1992) accounted for 26% of 
ruminally infused butyrate that appeared in portal blood. This suggested that 74% was 
metabolized to ACAC and BHBA, but they could only account for 14% of ruminally 
-
infused butyrate appearing as ACAC and BHBA. More recently, the portal appearance of 
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butyrate plus the unidirectional PDV flux of BHBA accounted for 62% of intraruminally 
infused butyrate (Kristensen et al., 2000b ). The portal recovery of intraruminally infused 
propionate was between 62% and 85% (Kristensen et al., 2000a, 2000b ). Possible 
explanations for the missing carbon in the above studies is oxidation of butyrate to carbon 
dioxide by rumen epithelial cells, or sequestering of infused rumina} VF A and by rumen 
microbes (Kristensen et al., 2000a). Because the current study did not measure rumina} 
VF A concentrations, conclusions regarding the metabolic origin of portal released 
metabolites are more speculative. 
Large and rapid increases tn post-weaning ketones have been previously 
demonstrated (Quigley et al., 1 991a; Quigley et al., 1992; Baldwin and Jesse, 1 992), but 
was either the result of single-site samples or in vitro cell incubations. This study 
observed large rapid increases in ketone concentrations in all veins and arteries sampled 
and to the knowledge of the author, this is the first attempt to measure net ketone fluxes 
peri-weaning. Portal flux of ACAC and BHBA for fed, non-pregnant, non-lactating sheep 
average 2.94 and 1 1 .5 mmollhr, respectively (Heitmann et al., 1 987), which was 
substantially lower than net portal appearance of ACAC and BHBA in 12  wk old calves 
reported in the current experiment (CON - 1 5 .6 & 87.04; TRT - 1 1 .0 & 48.6 mmol/L). 
However, for growing beef steers, net portal release of BHBA was 55 mmollhr 
(Huntington and Eisemann, 1988). In Period 3 net portal releases of ACAC, BHBA, and 
butyrate were greater in CON than TRT (Table 4. 1 1  ). This supports previous work that 
reported similar reductions in PDV release of BHBA in lasalocid supplemented wethers 
(Housewright et al., 1 994) and suggests modification of substrates being absorbed from 
the lumen of the rumen and metabolized by the epithelium. 
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As much as 90% of butyrate absorbed by the rumen epithelium is metabolized to 
ketones (Bergman, 1990) and is an effect of butyryl-CoA synthetase having the highest 
activity of the activating enzymes for VF A in the rumen epithelium (Ash and Baird, 
1 973). The activity of the hepatic isozyme of butyryl-CoA is substantial and the 
remaining butyrate that escapes metabolism by rumen epithelium enters via the portal 
blood and is normally extracted by the liver. This study demonstrated net portal release of 
butyrate at 24.2 mmol/h in TRT (CON = 36.6 mmol/L) and net hepatic extraction of -
2 1 .8 mmollhr for TRT calves. 
In the presence of butyrate, there are large reductions in rumen epithelial 
propionyl-CoA synthetase activity observed in vitro due to butyrate inhibition of 
propionyl-CoA synthetase (Harmon et al. ,  1 991 ; Ash and Baird, 1 973). The significantly 
greater net portal appearance of butyrate in CON calves may partially explain some of the 
other differences seen during this sampling period. Greater net PDV release of butyrate 
implies that more butyrate was absorbed and thus available for ketogenesis and would 
explain the significantly greater PDV release of ACAC and BHBA during this period. If 
the ionophore was affecting net nutrient release into the portal vein, a decrease in rumina} 
butyrate concentrations and absorption could lower the inhibition of rumen epithelial 
propionyl-CoA synthase in the rumen epithelium. Reduction of this inhibition may permit 
more absorbed propionate to be metabolized to lactate by the rumen epithelium and may 
explain why calves receiving the ionophore had a higher net portal release of lactate, but 
a lower net portal release of propionate Period 3 compared to CON. Conversely, a 
significant increase in net PDV release of propionate when supplementing monensin and 
salinomycin was demonstrated by Harmon et al. ( 1 988), but no effect on propionate 
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release in response to monensin supplementation was seen by Harmon and A very ( 1987). 
This study was differed in ionophore supplemented and diet type than the current 
experiment and may not be an adequate comparison. 
Total Splanchnic Metabolism 
The PDV (gastrointestinal tract -excluding the lower colon and rectum, pancreas, 
spleen, and associated omental and mesenteric fat) and liver tissues constitute total 
splanchnic tissues (TSP). Metabolites released by the TSP are representative of what is 
available to peripheral tissues after gut tissues have extracted their energetic cost of 
service from the nutrient supply (Reynolds, 2002). In the case of net TSP release of VF A 
in this experiment, the apparent increases across sampling periods in net portal release 
was not matched by net hepatic extraction (Table 4. 1 8), resulting in an increase in net 
TSP release of VF A. This is in contrast to reports for dairy cows (Reynolds et al., 2003), 
but were similar to reports of net total splanchnic release of VF A in growing beef steers 
(Huntington and Eisemann, 1988). Calves in the current study were also growing and the 
differences in net TSP release of VF A are likely the result of physiological status 
(growing vs. lactating) and how the liver may be partitioning nutrients to meet the 
different demands of lactation and growth. 
CONCLUSIONS 
The net portal appearance of ketones increased quickly with respect to diet 
changes at weaning and metabolite concentrations changed with age and weaning as 
1 1 7  
previously reported. Maximum net portal release of ketones was measured in calves 1 2  
weeks old, but maximums for VF A continued on to the 1 6  week sample period. A 
significant effect of lasalocid was observed on net portal release of nutrients in growing 
calves, with reduced releases of VF A, acetoacetate, and �-hydroxybutyrate release in 
ionophore supplemented calves. Our hypothesis was that any reduction in alimentary 
ketogenesis and circulating ketones below levels of maximum utilization by peripheral 
tissues would improve growth and feed efficiency. However, there was no obvious 
growth or feed efficiency improvement. Thus, calves supplemented with ... ionophore at 
feed-grade levels typically used to treat coccidiosis may have additional effects on 
nutrient proportions appearing in the rumen. The lack of any performance response 
related to the reduction of circulating ketones may be due to developing calves having a 
greater ability to peripherally metabolize ketones than the rates reported for adults. 
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DESCRIPTION OF CATHETERS 
1.  Hepatic and portal vein catheters ( -1 .2 mL capacity) : 
• Length of 100 em Tygon microbore tubing (0.050 x 0.090"; i.d. x o.d. ; Norton 
Performance Plastics, Akron, 0 H) 
• Silastic cuffs ( 1  em) at 4, 7, and 10  em from tip end (Dow Corning Silastic 
Silicone tubing, 0.062 x 0. 125"; i.d. x o.d.; Helix Medical, Inc., Carpenteria, CA) 
• Cuffs are tapered at the end facing tip end of catheter to facilitate insertion 
• Silastic tip (1 .5 em) tip wedged on to end of Tygon (with or without bevel) 
2. Mesenteric vein catheter (--0.9 mL capacity): 
• Length of 1 1 0 em Tygon micro bore tubing (0.040 x 0.070"; i .d. x o.d.; Norton 
Performance Plastics, Akron, OH) 
• Silastic cuffs ( 1 em) at 10 and 1 1 .5 em from tip end (Dow Corning Silastic 
Silicone tubing, 0.062 x 0. 125"; i.d. x o.d.; Helix Medical, Inc., Carpenteria, CA) 
• Cuffs are tapered at the end facing tip end of catheter to facilitate insertion 
• No silastic tip 
3. Mesenteric artery catheter ( -1 .3 mL capacity): 
• Length of 1 1 0 em Tygon microbore tubing (0.050 x 0.090"; i.d. x o.d.; Norton 
Performance Plastics, Akron, OH) 
1 35 
• Silastic cuffs ( 1  em) at 4 and 5 .5  em from tip end (Dow Corning Silastic Silicone 
tubing, 0.062 x 0. 1 25"; i .d. x o.d. ; Helix Medical, Inc., Carpenteria, CA) 
• Cuffs are tapered at the end facing tip end of catheter to facilitate insertion 
• No silastic tip 
NOTES: 
1. All catheters were soaked in 7% TDMAC Heparin (Polysciences, Inc., Warrington, 
PA) for 5 min. The TDMAC was also aspirated the length of the catheter during this 
5-min interval. 
2. Typically all catheters have a 1 .5 em silastic tip, but due to the small vessel size the 
tips for mesenteric catheters had to be removed to allow implantation. 
3. The typical amount catheter inserted into the mesenteric artery in previous surgeries 
is 20 em and in adults. However, insertion of this length of catheter into calves used 
in the present experiment had one of two results: a quality catheter with good patency 
or occlusion of the common mesenteric artery would cause a portion of small 
intestine to necrose and the calf would die (necropsy n = 3). 
• To minimize calf mortality a compromise was made and only 4-cm of catheter 
was inserted into the artery. A branch connecting to separate arteries (1--1) was 
always the preferred site of insertion and seemed to minimize potential for 
occlusion of blood supply. 
1 36 
4. If catheters are to be autoclaved with surgical instruments, use silastic grade medical 
tubing. If Tygon-type tubing is used, catheters must be sterilized with ethylene oxide 
(without hot air drying) or a comparable cold-sterilization agent. 
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EQUATIONS USED TO CALCULATE BLOOD FLOW AND NET FLUX 
1 .  Whole blood flow rates through splanchnic tissues is  calculated using the indicator­
dilution method: 
F = whole blood flow through the tissue in Umin 
IPAH = the infusion rate of PAH in optical density (OD) units/min 
CvPAH = the P AH OD units/L in the venous drain 
CaPAH = the PAH OD units/L in the arterial input 
o Portal and hepatic blood flows will be measured directly and hepatic 
arterial flow will be calculated as the difference. 
o Plasma flow will be obtained by subtracting that portion of the flow 
represented by the packed cell volume. 
2. Net fluxes of each metabolite across the individual tissues are calculated using the 
following equations: 
Portal-drained viscera flux = PF * (Cp - Ca) 
Hepatic flux = PF * (Ch - Cp) + AF * (Ch - C.) 
Total splanchnic flux = HF * (Ch - Ca) 
o PF, HF, and AF = the whole blood or plasma flow rates (Umin) in portal 
and hepatic veins and hepatic artery 
1 39 
o Cp, Ch, and Ca = the concentrations in portal and hepatic veins and hepatic 
artery of each metabolite in whole blood or plasma in some units of 
concentration/L 
o A positive net flux indicates net release and a negative net flux indicates 
net uptake of a metabolite by the specific tissue. 
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APPENDIX 3 
ACCESSORY TABLES FOR PART IV 
Table A3.1 .  Means and standard errors for plasma flow (Lih) and arterial packed .. cell volume in pre .. weaning and post .. 
weanin� dai� calves receivin� calf starter with lasalocid �treatmentl or without � controll. 
Period and age (d) 
Plasma flow and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) assignment 
Portal vein, llh2 
Control 1 1 1 .2d ± 14. 1 1 66.8c ± 1 5 .7  270.0ab ± 1 5 .7 294.28 ± 1 8 .2 
Treatment 84.6d ± 1 5 .7 1 66.7c ± 14. 1  24 1 .7b ± 1 5 .7 290.28 ± 1 8 .2 
Hepatic vein, Llh3 
Control 1 75 .0cd ± 25.7 1 98 .9cd ± 25 .7 234.7� ± 36.3 
Treatment 1 30.4d ± 25.7 272 .3b ± 25.7 357.38 ± 25 .7 
Hepatic artery, L/h4 
Control 60.7ab ± 37.9 45 .2b ± 37.9 
Treatment 52.7b ± 26.8 1 4s .s• ± 26.8 76.5 ± 26.8 
Packed-cell volume, %s 
Control 26.2c ± 0.4 26.7de ± 0.4 29.2b ± 0.4 30.88 ± 0.5 
Treatment 27.6cd ± 0.5 28.7� ± 0.4 29.7ab ± 0.5 30.98 ± 0.6 
a,b,c,d,�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. 
Effect1 
Diet Age 
(D) (A) 
0. 19  < 0.0 1 
0.03 < 0.0 1 
0. 1 7  0.24 
< 0.0 1 < 0.0 1 
D x A  
0.72 
0.0 1 
0. 1 1  
0.08 
2Control starter: Period 1 (n = 5), Periods 2 and 3 (n = 4), and Period 4 (n = 3). Treatment starter: Period 1 and 3 (n = 4), Period 2 (n = 5), 
and Period 4 (n = 3). 
3Control starter: Period 1 and 2 (n = 2) and Period 3 (n = 1 ). Treatment starter: Periods 1 through 3 (n = 2). 
4Control starter: Period 1 and 2 (n = 1). Treatment starter: Period 1 and 2 (n = 2). 
scontrol starter: Periods 1 and 2 (n = 6), Period 3 (n = 7), and Period 4 (n = 4). Treatment starter: Periods 1 and 3 (n = 5), Period 2 (n = 6), 
and Period 4 (n = 3). 
-
� 
-
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Table A3.2. Means and standard errors for hepatic concentration of metabolites (mmoVL) in pre-weaning and post-weaning dairy calves 
receiv!9 calf starter with lasalocid �treatmentl or without � controll. 
Period and age (d) Etrece 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenf (D) (A) 
Glucose 0.32 < 0.00 1 0.03 
Control 4.448 ± 0.07 3 .09d ± 0.09 3 .44c ± 0. 1 3  3 .70bc ± 0. 1 3  
Treatment 4.508 ± 0.07 2.84e ± 0.07 3 .64c ± 0.07 3 .98bc ± 0. 1 3  
Acetoacetate 0.39 < 0.00 1 0.07 
Control 0.0 1 5dc ± 0.002 0.047. ± 0.003 0.022cde ± 0.004 0.024cd ± 0.004 
Treatment 0.0 1 4e ± 0.002 0.036b ± 0.002 0.028c ± 0.002 0.022cde ± 0.004 
�-hydroxybutyrate 0.40 < 0.00 1 0.65 
Control 0.09 1 c ± 0. 1 3 7  1 .86 1 8 ± 0. 1 68 1 .6 1 08 ± 0.238 0.875b ± 0.23 8 
Treatment 0.08 1 c ± 0. 1 1 9 1 .5 128 ± 0. 1 3 7  1 .5868 ± 0. 1 3 7  0.82 1b ± 0.23 8 
Lactate < 0.00 1 < 0.00 1 < 0.00 1 
Control 0.494b ± 0.053 0.9488 ± 0.065 0.8658 ± 0.09 1 0.500b ± 0.09 1 
Treatment 0.452b ± 0.046 0.457b ± 0.053 0.520b ± 0.053 0.544b ± 0.09 1 
Pyruvate < 0.00 1 < 0.00 1 0 .02 
Control 0. 1 7 1  cd ± 0.0 19  0.3048 ± 0.024 0.309ab ± 0 .033 0.2 1 6bc ± 0.033 
Treatment 0. 1 3 1  d ± 0.0 1 7  0. 162cd ± 0.0 1 9  0. 1 5400 ± 0.0 1 9  0. 1 7600 ± 0.033  
a,b,c,d,�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05) . 
1Probability of a greater F statistic. 
2Control starter: Period 1 (n = 3), Period 2 (n = 2), and Periods 3 and 4 (n = 1 ). Treatment starter: Period 1 (n = �) except glucose (n = 3), 
Periods 2 and 3 (n = 3), and Period 4 (n = 1 ). 
Table A3.3. Means and standard errors for hepatic plasma concentration of metabolites (mmol/L) in pre-weaning and post-
weanin� dai!! calves receivin� calf starter with lasalocid �treatmentl or without (control�. 
Variable and dietary 
assignmenr 1 (35) 
NEFA 
Control 
. 
0.9088 ± 0.063 
Treatment 0.8768 ± 0.054 
Acetate 
Control 0.250d ± 0.03 1 
Treatment 0.232d ± 0.026 
Propionate 
Control 0.007e ± 0.0 1 1 
Treatment 0.0 1 0e ± 0.0 1 0  
Butyrate 
Control o.oosd ± 0.007 
Treatment 0.009d ± 0.006 
Period and age (d) 
2 (56) 
0.093b ± 0.077 
0.237b ± 0.063 
2.2043 ± 0. 1 1 3 
1 .67 1 be ± 0.079 
0.3 1 33 ± 0.078 
0. 1 60b ± 0.046 
0. 1 2 1  a ± 0.008 
0.072b ± 0.007 
3 (84) 
0.268b 
0.235b 
2.04 1 ab 
1 .694bc 
0.246ab 
0. 1 03c 
0.084b 
0.043c 
± 0. 1 09 
± 0.062 
± 0. 1 53 
± 0.08 1 
± 0.098 
± 0.037 
± 0.0 12  
± 0.007 
4 ( 1 12) 
0. 1 14b ± 0. 1 09 
0.084b ± 0. 1 09 
1 .6 1 7bc ± 0. 1 3 6  
1 .3 8 1  c ± 0. 1 26 
0.085c ± 0.057 
0.034d ± 0.037 
0.0 1 9cd ± 0.0 1 2  
0.007d ± 0.0 1 2  
a,b,c,d,�eans within row and dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. 
Effece 
Diet Age D x A  (D) (A) 
0.84 < 0.00 1 0.53 
0.003 < 0.00 1 0.46 
< 0.00 1 < 0.00 1 < 0.00 1 
< 0.00 1 < 0.00 1 0.00 1 
2Control starter: Period 1 (n = 3), Period 2 (n = 2), and Periods 3 and 4 (n = 1 ). Treatment starter: Period 1 (n = 4), Periods 2 and 3 (n = 3), 
and Period 4 (n = 1 ). 
-
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Table A3.4. Means and standard errors for hepatic plasma concentration of hormones (pmol/L) in pre-weaning and post­
weaning dairy calves receiving calf starter with lasalocid (treatment) or without (control). 
Variable and dietary 
assignmenr 1 (35) 
Insulin 
Control 36.25b ± 7.97 
Treatment 43.2� ± 6.89 
Glucagon 
Control 1 9.43c ± 2.8 1 
Period and age (d) Effect1 
2 (56) 3 (84) 4 ( 1 12) Diet Age (D) (A) 
0.29 < 0.00 1 
27. 1 8bc ± 9.76 79.208 ± 1 5 . 1 1 29.69bc ± 1 3 .80 
s.ooc ± 7.97 65 . 1 48 ± 7.97 25 .92bc ± 1 3 .80 
0.74 < 0.00 1 
36.748 ± 3 .44 36.27ab ± 4.86 20.77c ± 4.86 
Treatment 1 9.84c ± 2.43 33 .94ab ± 2.8 1 26.99bc ± 2.8 1 35 .99ab ± 4.86 
....... 
� � 
D x A 
0.34 
0.05 
a.b.c,d.�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Period 1 (n = 3), Period 2 (n = 2), and Periods 3 and 4 (n = 1 ). Treatment starter: Period 1 (n = 4), Periods 2 and 3 (n = 3), 
and Period 4 (n = 1 ). / 
Table A3.5. Means and standard errors for portal concentration of metabolites (mmol/L) in pre-weaning and post-weaning 
dai� calves receivini calf starter with lasalocid �treatmentl or without (control). 
Period and age (d) Effect1 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenr (D) (A) 
Glucose 0.74 < 0.00 1 0.93 
Control 4.35. ± o.o9 2.66c ± 0. 1 0  3 .30b ± 0.09 3 .30b ± 0. 1 0  
Treatment 4.448 ± 0. 1 0  2.6 1 c  ± 0. 1 0  3 .33b ± 0. 1 0  3 .32b ± 0. 1 3  
Acetoacetate 0.003 < 0.00 1 0.3 7 
Control 0.0 1 6d ± 0.003 0.0798 ± 0.004 0.077ab ± 0.003 0.075abc ± 0.004 
Treatment 0.0 14d ± 0.003 0.065c ± 0.004 0.068bc ± 0.004 0.068abc ± 0.005 
f3-hydroxybutyrate 0.706 < 0.00 1 0.22 
Control 0.079b ± 0.088 1 .5388 ± 0.097 1 .4248 ± 0.088 1 .5548 ± 0.097 
Treatment 0.080b ± 0.088 1 .4488 ± 0.097 1 .62 1 a ± 0.097 1 .3428 ± 0. 125 
Lactate 0.62 < 0.00 1 0.003 
Control 0.623c ± 0.077 1 .0 1 6b ± 0.084 0.897b ± 0.077 1 .002b ± 0.084 
Treatment 0.6 1 8c ± 0.084 0.886b ± 0.084 1 .3068 ± 0.084 0.850bc ± 0. 1 09 
Pyruvate 0.03 0.0 1 1 0.07 
Control 0 . 1 898b ± 0.0 12  0. 1 998 ± 0.0 1 3  0. 1 63bc ± 0.0 1 2  0. 1 93ab ± 0.0 1 3  
Treatment 0. 1 84ab ± 0.0 12  0. 1 35c ± 0.0 1 3  0. 1 44c ± 0.0 1 3  0. 1 97ab ± 0.0 1 7  
a.b,c,a:cMeans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Periods 1 and 3 (n = 6) and Periods 2 and 4 (n = 5). Treatment starter: Period 1 (n = 6) except glucose and lactate (n = 5); 
Periods 2 and 3 (n = 5), and Period 4 (n = 3). 
-
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Table A3.6. Means and standard errors for portal plasma concentration of metabolites (mmol/L) in pre-weaning and post-
weanin� dairy calves receivin� calf starter with lasalocid �treatment� or without � controQ. 
Period and age (d) 
Variable and dietary 
assignmenf 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) 
NEFA 
Control 0.8678 ± 0.043 0.208b ± 0.043 0. 1 69b ± 0.039 0. 1 70b ± 0.043 
Treatment 0.9408 ± 0.039 0.202b ± 0.043 0.2 1 8b ± 0.043 0.2 1 3b ± 0.055 
Acetate 
Control 0.287c ± 0.094 2.226b ± 0. 1 03 2 .038b ± 0.094 2.6 1 68 ± 0. 1 03 
Treatment 0.283c ± 0.094 2.08 1 b ± 0. 1 03 1 .948b ± 0. 1 03 2 .203b ± 0. 1 33 
Propionate 
Control 0.036d ± 0.032 0.7598 ± 0.035 0.7808 ± 0.032 0.626bc ± 0.035 
Treatment 0.030d ± 0.032 0.6 14bc ± 0.035 0.592c ± 0.035  0.708ab ± 0.045 
Butyrate 
Control 0.0 1 9d ± 0.0 12  0. 1978 ± 0.0 1 3  0. 1 54bc ± 0.0 1 2  0. 1 5 1 bc ± 0.0 1 3  
Treatment 0.02 1 d ± 0.0 12  0. 1 6 1 ab ± 0.0 1 3  0. 1 33bc ± 0.0 1 3  0. 1 1 3 c ± 0 .01 7  
Effect1 
Diet Age D x A  (D) (A) 
0.20 < 0.00 1 0.82 
0.03 < 0.00 1 0.29 
0.0 1 < 0.00 1 < 0.00 1 
0 .02 < 0.00 1 0.4 1 
a,b,c,d,eMeans within row and dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probabil ity of a greater F statistic. 
2Control starter: Periods 1 and 3 (n = 6) except NEFA for Period � (n = 5) and Periods 2 and 4 (n = 5). Treatment starter: Period 1 (n = 6), 
Periods 2 and 3 (n = 5), and Period 4 (n = 3). 
• 
Table A3.7. Means and standard errors for portal plasma concentration of hormones (pmol/L) in pre-weaning and post­
weaning dairy calves receiving calf starter with lasalocid (treatment) or without (control). 
Period and age (d) Effect1 
Variable and dietary 
assignmenr I (35) 2 (56) 3 (84) 4 ( 1 12) 
Insulin 
Control 30.5 l b ± 7.55 20.9 1 be ± 8.27 66.8�3 ± 7.55 72 .093 ± 8 .56 
Treatment 40.02b ± 7.66 7.69c ± 8.27 73 .6 13 ± 8 .27 35 .50b ± 1 0 .68 
Glucagon 
Control 1 8 .28d ± I .80 26.75b ± 1 .97 � 23 .42bc ± 1 .80 26.43b ± 1 .97 
Treatment 2 1 .53bcd ± 1 .97 32.683 ± 1 .97 23 .34bcd ± 1 .97 I 8 .82cd ± 2.55 
a,b,c,d.eMeans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
Diet Age 
(D) (A) 
0. 1 6  < 0.00 1 
0.79 < 0.00 1 
D x A  
0.04 
0.0 1 
2Control starter: Periods I and 3 (n = 6) and Periods 2 and 4 (n = 5). Treatment starter: Period I (n = 6) except glucagon (n = 5); Periods 2 
and 3 (n = 5), and Period 4 (n = 3) . 
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Table A3.8. Means and standard errors for hepatic venous-arterial concentration differences of metabolites (mmol/L) in pre-weaning and 
Eost-weanini da� calves receivini calf starter with lasalocid �treatmentl or without � controll. 
Period and age (d) Effect1 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 12) Diet Age D x A  assignmenr (D) (A) 
Glucose 0.96 0.003 0.98 
Control 0.2768 ± 0.035 0. 1 57bc ± 0.043 0. 1 3 8abc: ± 0.06 1 
Treatment 0.275ab ± 0.043 0. 1 52c ± 0.035  0. 1 50c ± 0.043 
Acetoacetate 0.5 1 0.005 0.88 
Control -0.003ab ± 0.002 -0.0 10c ± 0.002 -O.OOSabc ± 0.003 
Treatment -0.0028 ± 0.002 -0.008bc ± 0.002 -o.oos•bc ± 0.002 
J3-hydroxybutyrate 0.37 < 0.00 1 0.0 1 
Control 0.028d ± 0.024 0.236b ± 0.028 0.246ab ± 0.040 - -
Treatment 0.006d ± 0.024 0 . 123c ± 0.023 0.3 1 8a ± 0.028 
Lactate 0.4 1 0. 1 9 0. 1 9  
Control -0.082 ± 0.022 -0.068 ± 0.027 0.0 1 5  ± 0.03 8 
Treatment -0.0 1 6  ± 0.024 -0.042 ± 0.022 -0.023 ± 0.027 
Pyruvate 0.02 0.04 0. 1 0  
Control -0.024ab ± 0.007 -0.0003a ± 0.009 -0.047b ± 0.0 1 3  
Treatment -o.oo8a ± 0.008 -0.004a ± 0.008 -0.006a ± 0.009 
a,b,c,d.�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. 
2Control starter: Period 1 (n = 3), Period 2 (n = 2), and Period 3 (OF 1 ). Treatment starter: Periods 1 and 2 (n = 3) except Period 1 glucose 
(n = 2), and Period 3 (n = 2). 
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Table A3.9. Means and standard errors for hepatic venous-arterial plasma concentration differences of metabolites (mmol/L) 
in ere-weanin� and £2St-weanin� dai� calves receivin� calf starter with lasalocid (treatment) or without (control). 
· Period and age (d) - Effect1 
Variable and dietary I (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignment2 (D) (A) 
NEFA 0.36 0.03 0.99 
Control -0.0438b ± 0.0 1 8  -0.026ab ± 0.022 -0.09 1 b ± 0.03 1 
Treatment -0.027ab ± 0.0 1 8  -0.0 1 31 ± 0.0 1 8 -0.072b ± 0.022 
Acetate 0.0 1 < 0.00 1 0.0 1 
Control 0.045c ± 0.047 o.sss• ± 0.058 0.5 198 ± 0.082 
Treatment 0.040c ± 0.047 0.257b ± 0.047 0.4521 ± 0.058 
Propionate < 0.00 1 < 0.00 1 < 0.00 1 
Control -0.00 1 d  ± 0.009 0. 1 098 ± 0.0 1 1 0.072b ± 0.0 1 5  
Treatment 0.007d ± 0.009 0.023cd ± 0.009 0.038bc ± 0.0 1 1 
Butyrate 0.0 12  < 0.00 1 0.0 1 1 
Control 0.00 1d ± 0.003 0.0351 ± 0.004 0.03 1 8b ± 0.005 
Treatment o.oosd ± 0.003 0.0 1 8c ± 0.003 0.02 1 be ± 0.004 
a,b,c,d,eMeans within row and dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Period 1 (n = 3), Period 2 (n = 2), and Period 3 (n = 1 ). Treatment starter: Periods I and 2 (n = 3), and Period 3 (n = 2) . 
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Table A3.10. Means and standard errors for hepatic venous-arterial plasma concentration differences of hormones (pmol/L) in 
pre-weani�nand post-weaning dairy calves receiving calf starter with lasalocid (treatment) or without (control). 
Period and age (d) Effect1 
""""'" 
Vl 
0 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenf (D) (A) 
Insulin 0. 1 4  0.03 0.48 
Control 4.59b ± 2.3 8 -1 .89b ± 3 .04 4.30ab ± 4.5 1 
Treatment 4.70ab ± 2.38 1 .28b ± 2.3 8 1 2.08• ± 2.9 1 
Glucagon < 0.00 1 < 0.00 1 0.002 
Control 0.45cd ± 0.67 3 .29b ± 0.82 7.048 ± 1 . 1 7  
Treatment o.soc ± 0.67 - 1 .43d ± 0.67 2.73b ± 0.82 
a.b.c.d.�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1 Probability of a greater F statistic. 
2Control starter: Period 1 (n = 3), Period 2 (n = 2), and Period 3 (n = 1 ). Treatment starter: Periods 1 and 2 (n = 3), and Period 3 (n = 2). 
Table A3.1 1 .  Means and standard errors for hepatic-portal venous concentration differences of metabolites (mmol/L) in pre-
weanini and ;eost-weanini dai� calves receivini calf starter with lasalocid �treatment) or without � control). 
Period and age (d) 
Variable and dietary 
assignmenr 1 (3 5) 2 (56) 3 (84) 
Glucose 
Control 0.07bc ± 0.043 0. 1 74ab ± 0.06 1 
Treatment -0.033c ± 0.037 0. 1 968 ± 0.043 0. 1 868 ± 0.043 
Acetoacetate 
Control -0.0031 ± 0.003 -0.02 1 b ± 0.004 
Treatment -0.00 11 ± 0.002 -0.04 1 c ± 0.003 -0.036c ± 0.003 
13-hydroxybutyrate 
Control 0.03 1bc ± 0.0 1 5  0.078ab ± 0.022 
Treatment 0.006c ± 0.01 1 0. 1 203 ± 0.0 1 5  0. 1261 ± 0.0 1 5  
Lactate 
Control -0. 1 38 ± 0.03 8 -0. 1 2 1  ± 0.054 
Treatment -0. 128 ± 0.027 -0.088 ± 0.038 -0. 1 68 ± 0.038 
Pyruvate 
Control -0.003b ± 0.009 0.0943 ± 0.0 12  
Treatment -0.032c ± 0.006 -0.00 1 b ± 0.009 0.0 1 8b ± 0.009 
4 ( 1 1 2) 
a,b,c,d,�eans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
Effect1 
Diet Age 
(D) (A) 
0.39 0.00 1 
0.003 < 0.00 1 
0.6 1 < 0.00 1 
0.60 0.49 
< 0.00 1 . < 0.00 1 
D x A 
0. 1 9  
< 0.00 1 
0.04 
0.77 
< 0.00 1 
2Control starter: Period 1 (n = 2) and Period 2 (n = 1 ). Treatment starter: Period 1 (n = 4) except Period 1 glucose (n = 3), and Period 2 and 
3 (n = 2). 
-
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Table A3.12. Means and standard errors for hepatic-portal venous plasma concentration differences of metabolites (mmol/L) 
in ere-weanin� and eost-weanin� dai!! calves receivin� calf starter with lasalocid (treatmentl or without � control). 
Period and age (d) Effect1 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenr (D) {A) 
NEFA 0.78 0 . 1 8  0.35 
Control 0.0 1 9  ± 0.028 -0.050 ± 0.040 
Treatment -0.0 1 8  ± 0.020 -0.030 ± 0.028 -0.09 1 ± 0.028 
Acetate 0.33 0.8 1 0.74 
Control -0.02 1 ± 0.022 -0.023 ± 0.032 
Treatment -0.053 ± 0.0 1 6  -0.039 ± 0.024 -0. 1 3 0  ± 0.024 
Propionate < 0.00 1 < 0.00 1 < 0.00 1 
Control -0.026a ± 0.0 1 0  -0.59 1 d  ± 0.0 1 5  
Treatment -0.0 1 61 ± 0.007 -0.380b ± 0.0 1 0  -0 .483c ± 0.0 1 0  
Butyrate < 0.00 1 < 0.00 1 < 0.00 1 
Control -0.0 1 2• ± 0.003 -0.058b ± 0.003 
Treatment -0.0 1 3a ± 0.002 -0.078c ± 0.002 -0.080c ± 0.002 
a,b,c,d,�eans within row and dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
2Control starter: Period 1 (n = 2) and
. 
Period 2 (n = 1 ). Treatment starter: Period 1 (n = 4) and Period 2 and 3 (n = 2). 
Table A3.13. Means and standard errors for hepatic-portal venous plasma concentration differences of hormones (pmol/L) in 
pre-weaning and post-weaning dairy calves receiving calf starter with lasalocid (��atment) or without (control). 
Period and age (d) Effece 
Variable and dietary 1 (35) 2 (56) 3 (84) 4 ( 1 1 2) Diet Age D x A  assignmenf (D) (A) 
Insulin 
Control -8 .23ab ± 2.4 1 -8 .53ab ± 3 .4 1  
Treatment -3 .24a ± 1 .74 -0.5 1 a ± 2.4 1 - 1 4.32b ± 2.4 1 
Glucagon 
Control - 1 .93 ± 0.90 -0.25 ± 1 .28 
Treatment -2. 1 0  ± 0.64 -0.38  ± 0.90 -0.58 ± 0.90 
a.b.c,d,cMeans within row and between dietary treatment not sharing like superscripts are different (P < 0.05). 
1Probability of a greater F statistic. 
0.0 1 
0.88 
2Control starter: Period 1 (n = 2) and Period 2 (n = 1 ). Treatment starter: Period 1 (n = 4) and Period 2 and 3 (n = 2). 
0 .64 
0.08 
0.56 
0.98 
� 
VI w 
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ACETOACETATE ANALYSIS 
This procedure is a modification of the method of Mellanby and Williamson (1 974). The 
analysis is a spectrophotometric determination based upon the compound nicotinamide 
adenine dinucleotide (NAD) and it's unique ability to absorb a specific quantity of light 
of a specific wavelength. Acetoacetate is indirectly determined from the concentration of 
NAD+ through the following chemical reaction: 
P-hydroxybutyrate 
dehydrogenase 
HOOC-CH2-CO-CH3 + NADH, W IIIIa HOOC-CH2-CHOH-CH3 + NAD+ 
(acetoacetate) (J3-hydroxybutyrate) 
Acetoacetate is reduced to J3-hydroxybutyrate in a 1 : 1 stoichiometry with the oxidation 
of the cofactor nicotinamide adenine dinucleotide (NADH) to NAD+ in the presence of 
the enzyme J3-hydroxybutyrate dehydrogenase (E.C. 1 . 1 . 1 .30). Because of the 1 : 1 
conversion, the change in absorption between the reduced and oxidized forms of 
nicotinamide adenine dinucleotide permits the calculation of acetoacetate. 
REAGENTS 
A. 1 .0 M Perchloric Acid (HCl04) 
B. 1 .0 M Potassiwn Hydroxide (KOH) 
C. 0. 1 M Phosphate Buffer (pH = 6.8) 
1. Monobasic Potassiwn Phosphate (KH2P04): 1 .36 g � 1 00 mL dH20 
2. Dibasic Potassium Phosphate (K2HP04): 1 .74 g � 1 00 mL dH20 
3. Mix equal volwnes of each solution, check pH, and adjust if necessary with one 
or the other. 
1 56 
D. 2.0 mM NADH (Sigma Chemical Co., cat. # N-8 129; disodium salt; 98% purity; FW 
= 709.4): 0.010  g NADH � 6.0 mL dH20. NOTE: Make up on day of use and store 
in amber bottle at 2 - 6°C until needed. 
E. J3-Hydroxybutyrate dehydrogenase (E.C. 1 . 1 . 1 .30; Roche Diagnostics Corporation, 
Indianapolis, IN, cat. # 127-84 1 ;  Grade II; 5 mg/mL ). 
F. 1 .5 mM Acetoacetate Standard (ACAC; Sigma Chemical Co., cat. # A-8509; Lithium 
salt; 90-95% purity): 0.01 620 g ACAC � 1 00 mL dH20. 
1. Dilute stock standard to the following concentrations for working standards: 0. 1 5, 
0.09, 0.075, 0.045, and 0.0225 mM. 
2. Use two zero concentration standards as blanks. 
3. Standards (and blanks) must be taken through entire procedure as small amounts 
of perchlorate will affect enzyme activity. 
4. Pipette into 50 mL polypropylene centrifuge tubes: 1 .0 mL of standard and 1 .0 
mL of 1 .0 M HCI04. 
5. Neutralize with KOH to pH between 6.0 and 8.0 (Remember to record volume of 
buffer added when adjusting pH! !). 
6. Centrifuge at 1 ,500 x g for 15 min. 
7. Standard dilutions: 
a. 0 . 1 5  mM � 2.0 mL of 1 .5 mM ACAC plus 1 8.0 mL dH20 
b. 0.09 mM � 12.0 mL of (a) plus 8.0 mL of dH20 
c. 0.075 mM � 4.0 mL of(a) plus 4.0 mL of dH20 
d. 0.045 mM � 1 0.0 mL of (b) plus 1 0.0 mL of dH20 
e. 0.0225 mM � 1 0.0 mL of (d) plus 10.0 mL of dH20 
SAMPLE COLLECTION AND PREPARATION 
A. All procedures leading up to the reading of the samples must be carried out at 2 - 6°C 
and samples must be analyzed the day of collection. 
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B. Mix equal volumes of whole blood and 1 M HC104 immediately after sampling (e.g. 
- add 2 mL of whole blood to 15 mL centrifuge tube containing 2 mL of 1 M HC104), 
vortex. 
C. Centrifuge at 1 ,500 x g for approximately 1 5  min. 
D. Pipette desired volume of supernatant into 50 mL polypropylene centrifuge tube (e.g. 
- 2 mL is adequate volume to single samples of both ketone assays and also 
maintains the 1 : 1 ratio of sample to 1 M HC104) 
E. Neutralize excess HC104 with KOH so that final pH is between 6.0 and 8.0 
(Remember to record volume of buffer added when adjusting pH! !). 
F. Centrifuge off the potassium perchlorate precipitate formed at 1 ,500 x g for 1 5  min 
and pour off supernatant (or can pipette from supernatant if extreme care is taken not 
to aspirate precipitate, as this will disqualify the sample). 
ANALYSIS 
A. Pipette the following into 12 x 75 mm borosilicate culture tubes: 
1 .  0 .5  mL phosphate buffer 
2. Sample - 1 .0 mL for fed animals (0.5 mL sample + 0.5 mL dH20 for fasted 
animals) 
3. Standard - 1 .0 mL 
4. 0.05 mL NADH 
5. Vortex 
B. Read Et at 340 run. 
C. Add 0.005 mL of J3-hydroxybutyrate dehydrogenase, vortex 
D. Incubate at room temperature for ca. 22 min. 
E. Read E2 at 340 run. 
NOTES: NADH will slowly oxidize at room temperature, but at a relatively constant rate 
in all samples (see diagram). The zero · concentration ACAC standards can be used to 
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control/compensate for this. Pipette NADH into all of the tubes at a set time interval (e.g. 
- 1 5 - 60 sec; typically about as fast as one can read samples in the spectrophotometer). 
Then read E 1 in all tubes at the same timed interval. Add the enzyme at the same 
intervals and incubate. Read the E2 at the same timed intervals. 
En�e E2 E I I ...,.--+----..... �--"":::.::"" "
=
••• .J.J.ooooooooooooo oo o o oooooo oo o o o o oo oooooo oo o o o oo o ooooo o ooo o • • O • • O O o :oo" ' ' ' '""'" " """ 
t - - - - - - - - - _ _  - - - - : 6E due to NADH decomposition 
AE due to ACAC + 
NADH decomposition 
TIME 
Alternatively, (less realistically) you can do the samples one at a time and take several E 1  
and several E2 readings to determine the rate of decay of NADH. In practice this takes 
longer and the creation of two "parallel" lines is very subjective (often the decay of 
NADH is low, but it must be taken into account). 
CALCULATIONS 
A. Calculate Et - E2 for all blanks, standards, and samples. 
B. Calculate 1\Estd - �Ebtank and 1\Esample - �blank 
C. Plot a standard curve of the known concentration vs. �std - LlEbtank 
D. Extrapolate the concentrations of the samples using LlEsample - LlEbtank from the curve. 
E. Multiply by the appropriate dilution factors. 
APPENDIX 5 
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1 59 
1 60 
Jl-HYDROXYBUTYRA TE ANALYSIS 
This procedure is a modification of the method of Williamson and Mellanby ( 1 974). The 
analysis is a spectrophotometric determination based upon the compound nicotinamide 
adenine dinucleotide (NADH) and it's unique ability to absorb a specific quantity of light 
of a specific wavelength. Jl-hydroxybutyrate is indirectly determined from the 
concentration ofNADH through the following chemical reaction: 
P-bydro:xybutyrate 
dehydrogenase 
HOOC-CH2-CHOH-CH3 + NAD+ -----ill-• HOOC-CHrCO-CH3 + NADH, W 
(J3-hydroxybutyrate) (acetoacetate) 
J3-hydroxybutyrate is oxidized to acetoacetate in a 1 : 1 stoichiometry with the reduction 
of the cofactor nicotinamide adenine dinucleotide (NAD+) to NADH in the presence of 
the enzyme J3-hydroxybutyrate dehydrogenase (E.C. 1 . 1 . 1 .30). Because of the 1 : 1 
conversion, the change in absorption between the oxidized and reduced forms of 
nicotinamide adenine dinucleotide permits the calculation of J3-hydroxybutyrate. 
REAGENTS 
A. 1 .0 M Perchloric Acid (HCl04) 
B. 1 .9 M Potassium Hydroxide (KOH) 
C. 0. 1 M Tris -HCl buffer (pH = 8.5) 
1. 2.42 g of Tris � ca. 50 mL with dH20 (Sigma Chemical Co., cat.#, T- 1378) 
2. pH � 8.5 with 1 M HCl 
3. Using dH20 q.s. to 200 mL 
D. Hydfa:Zine-Tris Buffer: Make up on day of use. 
1. 0.05 g EDTA 
2. 12.5 mL of IM HCl 
3. 2.5 mL ofhydrazine hydrate (Sigma Chemical Co., cat.# H-0883) 
4. Q.s. to 50 mL with Tris-HCl buffer 
5. Check pH, should be around 8.5 .  
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E. 1 5 .0 mM NAD+ (Sigma Chemical Co., cat. # N-6522; free acid; 98% purity; FW = 
663.4): 0.03 g NAD+ � 3 .0 mL dH20. NOTE: Make up on day of use and store in 
amber bottle at 2 - 6°C until needed. 
F. �-Hydroxybutyrate dehydrogenase (E.C. 1 . 1 . 1 .30; Roche Diagnostics Corporation, 
Indianapolis, IN, cat. # 127-84 1 ;  Grade II; 5 mg/mL ). 
G. 2.0 mM �-Hydroxybutyrate Standard (BHBA; Sigma Chemical Co., cat. # H-6501 ;  
Sodium salt; 98% pure): 0.0656 g BHBA � 250 mL dH20. 
1 .  Dilute stock standard to the following concentrations for working standards: 2.0, 
1 .6, 1 .2, 0.8, and 0.4 mM. 
2. Use two zero concentration standards as blanks. 
3. Standards (and blanks) must be taken through entire procedure as small amounts 
of perchlorate will affect enzyme activity. 
4. Pipette into 50 mL polypropylene centrifuge tubes: 1 .0 mL of standard and 1 .0 
mL of 1 .0 M HCl04. 
5. Neutralize with KOH to pH between 6.0 and 8.0 (Remember to record volume of 
buffer added when adjusting pH! !). 
6. Centrifuge at I ,500 x g for 1 5  min. 
7. Standard dilutions: 
a. 2.0 mM � 20.0 mL of2.0 mM BHBA plus 0.0 mL dH20 
b. 1 .6 mM � 1 6.0 mL of 2.0 mM BHBA plus 4.0 mL of dH20 
c. 1 .2 mM � 12.0 mL of2.0 mM BHBA plus 8.0 mL of dH20 
d. 0 .8 mM � 8 .0 mL of2.0 mM BHBA plus 12.0 mL of dH20 
e. 0.4 mM � 4.0 mL of 2.� mM BHBA plus 1 6.0 mL of dH20 
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SAMPLE COLLECTION AND PREPARATION 
A. All procedures leading up to the reading of the samples must be carried out at 2 - 6°C 
and samples may be analyzed the day of collection or stored at -20°C for ca. one 
week. 
B. Mix equal volumes of whole blood and 1 M HCl04 immediately after sampling (e.g. 
- add 2 mL of whole blood to 1 5  mL centrifuge tube containing 2 mL of 1 M HCl04), 
vortex. 
C. Centrifuge at 1 ,500 x g for approximately 1 5  min. 
D. Pipette desired volume of supernatant into 50 mL polypropylene centrifuge tube (e.g. 
- 2 mL is adequate volume to single samples of both ketone assays and also 
maintains the 1 : 1 ratio of sample to 1 M HCl04) 
E. Neutralize excess HCl04 with KOH so that final pH is between 6.0 and 8.0 
(Remember to record volume of buffer added when adjusting pH! !). 
F. Centrifuge off the potassium perchlorate precipitate formed at 1 ,500 x g for 1 5  min 
and pour off supernatant (or can pipette from supernatant if extreme care is taken not 
to aspirate precipitate, as this will disqualify the sample). 
ANALYSIS 
A. Pipette the following into 1 2  x 75 mm borosilicate culture tubes: 
1 .  0.5 mL hydrazine-tris buffer 
2. Sample or standard - 0.25 mL for fed animals (0. 1 mL sample for fasted animals) 
3. Water - 0.75 mL for fed animals or standards (0.9 mL for fasted animals) 
4. 0.05 mL NAD+ 
5. Vortex 
B. Read Et at 340 nm. 
C. Add 0.005 mL of �-hydroxybutyrate dehydrogenase, vortex 
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D. Incubate at room temperature for ca. 45 min. 
E. Read E2 at 340 nm . 
NOTES: NADH and hydrazine slowly form a complex that absorbs at 340 nm. The 
hydrazine "captures" the NADH and prevents it from being converted back to the 
oxidized form. Therefore, a slow and constant increase in absorbance with occur, but at a 
relatively constant rate in all samples (see diagram). The zero concentration BHBA 
standards can be used to control/compensate for this. Pipette NAD+ into all of the tubes at 
a set time interval (e.g. - 1 5  - 60 sec; typically about as fast as one can read samples in 
the spectrophotometer). Then read Et in all tubes at the same timed interval. Add the 
enzyme at the same intervals and incubate. Read the E2 at the same timed intervals. This 
is pretty much like the ACAC assay, but in reverse. 
i 
L\E due to BHBA + 
NADHI hydrazine complex 
CALCULATIONS 
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I 
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Et  TIME 
A. As for ACAC, except AE is calculated from E2 - Et .  
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GLUCOSE ANALYSIS 
Determination of whole blood glucose was done using the Sigma Diagnostics glucose kit 
(#5 1 0; Sigma Diagnostics, St. Louis, MO). The procedure uses an enzymatic colorimetric 
that is based upon the following coupled enzymatic reactions: 
Glucose Oxidase , Glucose + 2H20 + 02 ... Gluconic acid + 2H202 
H202 + o-Dianisidine 
(colorless) 
Peroxidase --------iiJII.• Oxidized o-Dianisidine 
(brown) 
REAGENTS 
A. PGO Enzymes (500 units of glucose oxidase, 1 00 Purpurogalin units of Peroxidase 
and buffer salts; Sigma cat. # 5 1  0-6). 
1 .  One capsule is  diluted with dH20 to 1 00 mL and stored in  amber bottle at 2 -
6°C. 
B. 0-Dianisidine Dihydrochloride (Sigma cat. # 5 10-50). 
1.  Pre-weighed vial is diluted with dH20 to 20 mL and stored at 2 - 6°C. 
2. A 1 .6 mL aliquot of this solution is added to the 1 00 mL of the PGO enzyme 
solution. 
3. The combined Enzyme-Color Reagent Solution is stable up to 1 month 
refrigerated (2 - 6°C) unless turbidity or color forms. 
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C. Glucose Standard Solution (1  00 mg/dL; Sigma cat. # 635- 1 00). Consists of a solution 
of (3-D-glucose, 100 mg/dL (5.56 mmol/L) in 0. 1 %  benzoic acid and stored at 2 -
6°C. 
D. 0.3 N Barium Hydroxide solution (Sigma cat. # 14-3) 
E. 0.3 N Zinc Sulfate solution (Sigma cat. # 14-4) 
SAMPLE COLLECTION AND PREPARATION 
Blood samples should be collected in a container with a suitable anticoagulant. 
1. Immediately after sample is collected, pipette 0.2 �L of blood into test tube 
containing 1 .8 mL dH20 and mix. 
2. Add 1 .0 mL barium hydroxide, vortex 
3. Add 1 .0 mL zinc sulfate, vortex and cap. 
4. Tubes are then centrifuged at 3 x g for 1 5  min at 4 °C. 
NOTES: It is recommended that the samples remain refrigerated until analysis steps and 
that analysis proceed as soon as possible. Blank and standard are prepared in a similar 
manner except 0.2 mL dH20 and 0.2 mL of glucose standard are used, respectively, in 
place of blood. 
ANALYSIS 
Prepare blank, standard, and sample tubes in duplicate as follows: 
1. Add 0.2 mL of supernatant from the respective centrifuged blank, standard, and 
sample tubes. 
2. Add 2.0 mL of Enzyme-Color Reagent Solution to each tube, vortex 
3. Incubate all tubes in a waterbath at 3 7°C for 3 0 min or at room temperature for 4 5 
min. NOTE: Avoid direct exposure to sunlight or direct bright light. 
4. Following incubation, remove all tubes from waterbath. 
5. Read at 450 run. 
6. Readings should be completed within 30 min. 
CALCULATIONS 
Blood Glucose (mgldL) = (absorbance of unknown/absorbance of standard)* I OO 
For conversion to mmol/L = glucose (mgldL)/1 8  
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LACTATE ANALYSIS 
This procedure is adapted from that of the Sigma Lactate Kit (Sigma Chemical Co., St. 
Louist MO, cat. # 826-UV). The standard calibrations and procedures have been modified 
for use on a micro titer plate reader. The principle of this procedure is based on the 
conversion of lactate to pyruvate by lactate dehydrogenase (E .C.# 1 . 1 . 1 .27) in the 
presence ofNAD+: 
· HOOC-CHOH-CHJ + NAD+ 
(lactate) 
lactate 
dehydrogenase 
-------IJII• HOOC-CO-CH3 + NADHt W 
(pyruvate) 
When excess NAD is present, all lactate is converted to pyruvate. Measurement of 
NADH before· and after addition of the enzyme allows the amount of lactate originally 
present to be determined. This is due to the absorbance ofNAD (280 nm) differs from the 
absorbance of it's reduced analog NADH (340 run). 
REAGENTS 
The following were all purchased through Sigma Chemical (St. Louist MO): 
A. Lactate dehydrogenase ( # 826-6) 
B. NAD (Sigma Chemical Co., cat. # N-6522; free acid; 98% purity; FW = 663.4); store 
in dessicator in freezer 
1 .  Use 10  mg ofNAD per 10  samples 
2. To make the working buffert add 2.0 mL glycine buffer (see below) and 4.0 mL 
of water per 10  mg ofNAD used. 
3. Working buffer is stable at room temperature for 4 hr, or for 24 hr at 2 - 6°C. 
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C. Lactic acid; 4.44 mmol/L; (#826-10) 
1 .  To make stock standard solutions add the following: 
a. 4.44 mmol/L � 1 .000 mL lactate standard plus 0.0 mL water 
b. 2.22 mmol/L � 0.500 mL lactate standard plus 0.500 mL water 
c. 1 . 1 1  mmol/L � 0.250 mL lactate standard plus 0.250 mL water 
d. 0.555 mmol/L � 0. 1 25 mL lactate standard plus 0.875 mL water 
e. 0.000 mmol/L � 0.00 mL lactate standard plus 1 .00 mL water 
2. To make working standards add 0.2 mL of each stock standard to 0.4 mL of the 
8% perchloric acid. Vortex and store at 2-6°C. Discard after 3 d. 
D. Glycine Buffer (#826-3) 
1. Contains glycine (0.6 mol/L), and hydrazine (0.5 mol/L). pH = 9.2. Store at 2 - 6 
°C and discard if turbidity is present. 
2. Glycine buffer may also be made by adding 23 g of glycine to 20 mL of hydrazine 
hydrate (54% hydrazine; Sigma #H9507) and q.s. to 500 mL with distilled water. · 
The pH of the solution should be approximately 9. 
E. Perchloric acid (8% w/v). Not supplied with kit. Prepare by adding 1 40 mL of 70% 
(w/w) Perchloric acid to a 2 L volumetric flask. Add distilled water to volume. 
SPECIMEN COLLECTION and STORAGE 
A. After blood sample is obtained, pipet as soon as possible, 2.0 mL of blood into a 
centrifuge tube containing 4-mL of cold 8% perchloric acid, vortex. 
B. Centrifuge mixtur� for 1 5  - 20 min at 1 500 x g at 4 °C. 
C. Remove supernatant and store at -20°C until analyzed. Analysis should be conducted 
as soon as possible, usually within two weeks. 
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ANALYSIS 
A. Pipet 200 flL of NAD-glycine working buffer into each well of a 96-well microtiter 
plate. Add 20 flL of blank, standard, or sample, mix gently (set up so reader mixes 
before reading). 
B. Read absorbance (Et) at 340 nm (Bio-Kinetics reader, model EL340, Bio-Tek 
Instruments, Winooski, VT). 
C. Add 1 0 J.1L of lactate dehydrogenase to each well, mix. Inc�bate plates for 1 5  min at 
37°C (or 30 min at 25°C). 
D. Read absorbance (E2) at 340 nm . 
E. Take difference between E2 - Et . Regress absorbance difference of standards against 
concentrations for calculation of samples. 
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PYRUVATE ANALYSIS 
This procedure is adapted from that of the Sigma Pyruvate Kit (Sigma Chemical Co., St. 
Louis, MO, cat. # 726-UV). The standard calibrations and procedures have been modified 
for use on a microtiter plate reader. The principle of this procedure is based on the 
conversion of pyruvate to lactate by lactate dehydrogenase (E.C.# 1 . 1 . 1 .27) in the 
presence '"ofNADH: 
HOOC-CO-CH3 + NAD+ 
(pyruvate) 
lactate 
dehydrogenase 
-----�·� HOOC-CHOH-CH3 + NAD+ 
(lactate) 
When excess NADH is present, all pyruvate is converted to lactate. Measurement of 
NADH before and after addition of the enzyme allow_� the amount of pyruvate originally 
present to be determined. This results because the absorbance of NADH (340 nm)differs 
from the absorbance of it's oxidized analog NAD (280 nm). 
REAGENTS 
The following were all purchased through Sigma Chemical (St. Louis, MO): 
A. Trizma Base Solution (#726-4) 
B. NADH (Sigma Chemical Co., cat. # N-8 129; disodium salt; 98o/o purity; FW = 709.4) 
1 .  Use 1 mg ofNADH per 10 tubes 
2. To make the working buffer, add 2.2 mL Trizma Base per 1 .0 mg ofNAD used. 
3. Working buffer is stable at room temperature for 4 hr, or for 24 hr at 2 - 6°C. 
C. Pyruvic Acid Standard Solution (# 726-1 0); 4 mg/dL (0.45 mmol/L). 
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1 .  To make stock standard solutions add the following: 
a. 0.068 mmol/L --+ 0.2 mL pyruvate standard plus 3 . 8  mL water 
b. 0. 1 36 mmol/L --+ 0.4 mL pyruvate standard plus 3.6 mL water 
c. 0.204 mmol/L --+ 0.6 mL pyruvate standard plus 3.4 mL water 
d. 0.272 mmol/L --+ 0.8 mL pyruvate standard plus 3.2 mL water 
e. 0.340 mmol/L --+ 1 .0 mL pyruvate standard plus 3.0 mL water 
' 2. To make working standards, add 2.0 mL of stock standard (or water for blank) to 
4.0 mL of 8% perchloric acid. 
D. Lactate dehydrogenase (#826-6) 
F. Perchloric acid (8% w/v). Not supplied with kit. Prepare by adding 140 mL of 70% 
(w/w) Perchloric acid to a 2 L volumetric flask. Add distilled water to volume. 
SPECIMEN COLLECTION and STORAGE 
A. After blood sample is obtained, pipet as soon as possible, 2.0 mL of blood into a 
centrifuge tube containing 4-mL of cold 8% perchloric acid, vortex. 
B. Centrifuge mixture for 1 5  - 20 min at 1 500 x g at 4 °C. 
C. Remove supernatant and store at 2-6°C until analyzed. Analysis should be conducted 
as soon as possible, usually within four weeks. 
ANALYSIS 
A. Pipet 1 mL of blank, standard, and samples into 12 x 75 culture tubes. 
B. Add 250 J.1L of Trizma base to tubes, vortex. 
C. Add 250 J.1L of Trizma-NADH solution to tubes, vortex. 
D. Take Et reading at 340 nm. 
E. Quickly add 10 f.1L of lactate dehydrogenase, vortex. 
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F. After minimum 5 min incubation at room temperature read E2 at 340 run . 
G. Take difference between E2 - Et .  Regress absorbance difference of standards against 
concentrations for calculation of samples. 
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NON-ESTERIFIED FATTY ACID ANALYSIS 
Plasma non-esterified fatty acids (NEFA) concentrations can be quantifi�d using a 
WAKO NEFA C kit (Wako Chemicals USA, Inc., Richmond, VA). This kit utilizes an 
enzymatic colorimetric method that is based upon the following reactions: 
R-COOH + ATP + CoA 
Acyi-CoA synthase 1111-
Acyl-CoA + AMP + PPi 
Acyl-CoA + 02 
Acyi-CoA oxidase ...., .... 2,3-trans-enoyl-CoA + H202 
Peroxidase 
Purple Quinone Product + 4H20 
MEHA = 3-methyl-N-ethyl-N-(p-hydroxyethyl)-aniline 
4-AAP = 4-aminoantipyrine 
REAGENTS 
A. Color Reagent A: provided lyophilized in glass vials that consists of: acyl-CoA 
synthase, ascorbate oxidase, coenzyme A, adenosine triphosphate, 4-aminoantipyrine 
B. Solvent A: bottle containing 65 mL aqueous solution that consists of: 0.05 M 
phosphate buffer (pH = 6.9), 3 .0 mM magnesium chloride, surfactant, and .stabilizers 
C. Color Reagent B: provided lyophilized in glass vials that consists of: acyl-CoA 
oxidase and peroxidase 
D. Solvent B: bottle containing 130 mL aqueous solution that consists of: MEHA and 
surfactant 
E. NEF A Standard Solution: bottle containing 1 0  mL aqueous solution that consists of: 
1 .0 mmol/L Oleic acid, surfactant, and stabilizers 
PREPARATION 
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A. Preparation of samples: 
1 .  If plasma/serum samples were frozen, adequate thawing to room temperature and 
mixing of thawed sample are essential for precision. 
2. If using plasma, be aware of the potential for fibrin clots to interfere with sample 
pi petting. 
B. Preparation of standards: 
1. Dilute provided standard (1 000 J.lEq/L) with dH20 to provide 125, 250, 500 
J.tEq/L standards (serial dilution). 
2. Validation tests show distilled water as an acceptable dilutent. 
C. Preparation of Reagent A: 
1. Mix Color Reagent A by adding 1 0 mL of the Solvent A io each vial. 
2. Gently invert the vial until contents are completely dissolved. 
3. Combine with 1 3 .3 mL of dH20. 
4. Mix again and record preparation date. 
D. Preparation of Reagent B: 
1. Mix Color Reagent B by adding 20 mL of Solvent B to each vial. 
2. Gently invert until contents are completely dissolved. 
3. Combine with 33 .3 mL of dH20. 
4. . Mix again and record preparation da�e. 
NOTE: After reconstitution, store Color Reagents A and B in amber bottles at 2 - 6°C 
for up to 5 days. One set of A and B vials is sufficient to analyze 66 tubes. 
ANALYSIS 
A. Assay blank, standards, and samples in duplicates. 
B. Add 50 J.lL of serum, plasma, standard, or blank to each tube 
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C. Add 350 J.lL of Color Reagent A mixture, vortex 
NOTE: Can refrigerate for up to 60 min at 2 - 6°C if necessary. 
D. Incubate tubes in waterbath at 37°C for exactly 20 min. 
E. Following incubation, add 800 J.lL of the Color Reagent B mixture to each tube, 
vortex. 
F. Incubate a second time at 37°C for exactly 20 min. 
G. Remove tubes from waterbath, allow to equilibrate at room temperature for 5 min. 
H. Read at 550 nm using a blank prepared with reagents and should be completed within 
60 min. 
NOTES: 
1 .  Do not mix reagents and supplies from test kits bearing different lot numbers. 
2. This assay is sensitive to heparin and plasma samples using heparin as an 
anticoagulant are unsuitable. 
3. Samples that are hemolyzed or overly icteric may yield inaccurate results. 
4. Ascorbic acid interferes with the assay so ascorbate oxidase is automatically included 
in the Reagent A mixture. 
5. Although not used in this experiment, a useful modification of the NEF A C kit for use 
with a 96-well plate was published by Johnson and Peters ( 1993. J. Anim. Sci . 
7 1  :753-756). 
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PARA-AMINOHIPPURIC ACID ANALYSIS 
Blood concentrations of para-aminohippuric acid (P AH) are measured colorimetrically. 
Standards used in the assay are dilutions of the P AH used in the corresponding sampling 
sesston. 
REAGENTS FOR FILTRATE 
A. 20% Trichloroacetic acid (TCA; ChCCOOH) 
B. Distilled H20 
METHOD FOR FILTRATE 
A. Pipette 1 .0 mL of whole blood or standard into a 1 5  mL polypropylene centrifuge 
tube containing 5 mL of dH20, vortex. 
B. Pipette 5.0 mL of the blood or standard and dH20 mixture into a second 1 5  mL 
polypropylene centrifuge tube containing 5.0 mL of TCA, vortex. 
C. Let stand 60 min or overnight (can be left at this stage if refrigerated). 
D. Filter samples through Whatman #4 filter paper into 1 6  x 1 50 mm flint glass culture 
tubes. 
E. Add boiling chip to each culture tube and place a marble on top of each tube. 
F. Boil over low heat in a water bath for 30 min after fme bubbles appear in each tube. 
G. Remove from water bath and allow to cool to room temperature before removing 
marbles. 
H. Standards from 1 .5% P AH infusion solution are made and processed following the 
same steps as outlined for samples (considered 1 0: 1 0  dilutions). 
1 .  Make up a 1 :500 dilution for sheep (or animals under 250 kg) from 1 .5% infusion 
.solution. 
2. Make up a 1 : 1 00 dilution for dogs from 0.25% infusion solution. 
3. Used a 1 : 1 000 dilution from 1 .5% infusion solution for calves � 1 00 kg). 
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4. Blank consists of 5 mL of dH20 and 5 mL of TCA. 
NOTE: Be sure to run these dilutions through the same procedures as the blood samples, 
but do not have to boil 
REAGENTS FOR ANALYSIS 
A. 1 .2 N Hydrochloric Acid (HCl; Fisher Scientific Co., cat.# A-1 44-S): a 1 : 1 0  dilution 
of 12.4 N HCl considered close enough. 
B. Sodium Nitrite (NaN02; Sigma Chemical Co., cat. # S-2252): 1 00 mg of NaN� 
brought up to 1 00 mL with dH20. 
C. Ammonium Sulfamate (NH40S02NH2; Sigma Chemical Co., cat. # A-8670): 500 mg 
of ammonium sulfamate brought up to 1 00 mL with dH20. 
D. Coupling Reagent (N-1 -Naphthylethylenediamine dihydrochloride; Sigma Chemical 
Co., cat. # N-5889) 1 00 mg of coupling reagent brought up to 1 00 mL with dH20. 
NOTE: All reagents should be refrigerated in amber bottles and can be stored indefinitely 
or until turbidity or color develops. 
ANALYSIS 
A. Pipette 1 .0 mL of blank, standard, or filtrate into 12 x 75 mm borosilicate culture 
tubes in duplicate. 
B. Add 0.2 mL of 1 .2 N HCl to all tubes, vortex. · 
C. The following steps should be done with no more than 5 min between additions and 
tubes should be vortexed after each addition to all tubes: 
1. 0. 1 mL sodium nitrite, vortex 
2. 0. 1 mL ammonium sulfamate, vortex 
3. 0. 1 mL coupling reagent, vortex 
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D. Wait 1 0  min (minimum) for color development. 
E. Read absorbance on spectrophotometer at 540 nm. 
F. Calculations are made as a percentage of the standard. 
PAH STOCK INFUSION SOLUTION (10°/o) 
A. Para-aminohippuric acid (Eastman Kodak Corp., cat. # 5704): NOTE: This product is 
no longer available; a substitute can be obtained from Sigma Chemical Co., 
cat.#A1422. 
B. Sodium Hydroxide (Fisher Scientific Co., cat. # S-3 1 8) 
C. 0.9% Physiological Saline Solution (PSS; Fisher Scientific Co., cat. # AB7 138-09-
1 9) 
D. Dissolve each reagent separately in PSS: 
1 .  44.9 g of PAH 
2. 1 0.5 g ofNaOH 
E. Add the NaOH solution to the P AH solution and stir (may have to heat gently to fully 
dissolve). 
F. Filter through Whatman #4 filter paper. 
G. Titrate filtrate to pH to 7.4 with 1 N HCl or 4 M NaOH. 
H. Bring final volume to 500 mL. 
I. Store 1 50 mL aliquots in sterile containers at -20°C. 
J. For 1 .5% PAH infusion solution take a 1 50 mL aliquot and bring volume up to 1000 
mL with PSS and filter through 0.22 micron filter into a sterile container (Nalgene 
MF75 Series filter units; Fisher Scientific Co., cat. # 09-740-2A). 
K. Store refrigerated (2-6°C) until used (be sure to allow infusate to warm to room 
temperature before infusion into animal). 
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VOLATILE FATTY ACID ANALYSIS 
The principle of this method is chromatographic separation of volatile fatty acids based 
on the procedure of Reynolds et al. ( 1 986; J. Anim. Sci. Suppl. 63( 1 ):424) and 
modifications by Quigley and Heitmann ( 1991 ; J. Anim. Sci. 69: 1 1 78-1 1 87) and 
Reynolds et al. (2002; J. Dairy Sci. 85 : 1 804- 1 8 14). Sample preparation is performed 
using ion exchange chromatography to concentrate and separate VF A from other plasma 
compounds and sample analysis for VF A is performed using gas chromatography. 
REAGENTS 
NOTE: Always use the highest purity water when making up reagents. 
A. H20ffriton-X mixture - 20 J.LL Triton X- 1 00 (Sigma cat. # T9284) per 250 mL H20. 
NOTE: triton X-1 00 is very viscous and difficult to accurately pipette. 
B. 1 M NaOH - 40.0 g ofNaOH per liter of water. 
C. 1 0  mM NaOH - Dilute 5 mL of 1 M NaOH to 500 mL. NOTE: Make each day of 
use! 
D. 1 M HCl - Dilute 83 mL of concentrated HCl to 1 liter. 
E. 0. 1 75 M (5%) Zinc Sulfate - 1 OOg ZnS04· 7H20 (reagent grade; uneffervesced); 
, dissolve in water to make 2 liters (can also use 0.3 N ZnS04; Sigma cat. # 14-4, 500 
mL). 
F. 0. 1 5  M Barium Hydroxide - 95 g Ba(OH)r 8H20; dissolve in recently boiled and 
cooled deionized H20 to make· 2 liters. Fairly stable kept in stoppered container and 
out of contact with air (can also use 0.3 N Ba(OH)2; Sigma cat. # 14-3, 500 mL). 
Actual concentrations of the zinc and barium solutions are not so important, but they 
must exactly neutralize each other. To check this: 
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1. Pipette exactly 1 0 mL of ZnS04 solution to an Erlenmeyer flask containing 
approximately 40 mL of H20. Add 2 drops of phenolphthalein indicator (0.5 g/dL 
in 95o/o EtOH). 
2. Slowly titrate with Ba(OH)2 solution, while under constant mixing (use a stirring 
bar in flask). 
3. Titrate until 1 drop of Ba(OH)2 solution turns the titrated solution a faint pink that 
lasts approximately 1 minute. 
4. The titration of 1 0.0 mL of ZnS04 should require 1 0.0 (± 0.05 mL) of Ba(OH)2 
solution. 
5. If solutions do not exactly neutralize, dilute or strengthen the ZnS04 solution to 
achieve neutrality. Do not attempt to alter the Ba(OH)2 solution. 
6. Repeat titration . . .  if necessary. 
7. Keep zinc and barium solutions tightly stoppered. Ba(OH)2 solution will have a 
white precipitate of BaC03 upon prolonged exposure to air. 
G. 0.01 M Oxalic acid 
H. Stock blood standard - The stock solution used is composed of: 
Acid MW 
Acetate 60.0 
Propionate 74.0 
Butyrate 88. 1 
Isobutyrate 88. 1 
Valerate 1 02 . 1  
Isovalerate 1 02. 1 
Approximate 
giL 
3.0 
0.9 . 
0.8 
0.4 
0.4 
0.4 
Approx. final cone. 
after dilution (mM) 
2.0 
0.5 
0.4 
0.2 
0. 1 5  
0. 1 5  
I. Working blood standard - Add 4 mL of stock blood standard and 4 mL of stock 
internal standard to 1 00 mL volumetric and q.s. to volume with 0.01 M oxalic acid. 
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J. Stock internal standard (6.56 mM) - Weigh 0.0762 g of 2-ethylbutyric acid (MW = 
1 1 6. 1 6) and q.s. to 1 00 mL with water. 
K. Working internal standard (WISTD; 1 .3 1  mM) - Add 50 mL of stock internal 
standard to a 250 mL volumetric flask. Quantum sufficit to volume with water. 
SAMPLE COLLECTION AND STORAGE 
A. Serum - Blood drawn into a tube which does not contain an anticoagulant and 
allowed to clot. Serum is separated from clot and may be stored refrigerated for 
several days (2 - 6°C) or frozen. 
B. Plasma - Add whole blood directly to a tube containing an anticoagulant. Most 
coinmon anticoagulants may be used. May be stored frozen ( -20°C). 
ION EXCHANGE MATERIALS 
A. Materials: 
1 .  AG 50W-X8: 1 00-200 mesh cation resin; top column (Bio-Rad cat. # 142- 144 1 ). 
2. AG 4-X4: free base form; 100-200 mesh anion resin; bottom column (Bio-Rad 
cat. # 140-4 341 ). . 
3. Polypropylene Econo-Column (Bio-Rad cat. # 73 1 -1 550) 
B. Packing: 
1. Pack columns by preparing a slurry of resin in water. Allow resin to settle and 
remove fmes with a transfer pipette or by pouring off. Stir up and allow to settle 
two more times. Remove fines each time. 
2. Agitate slurry by swirling with a transfer pipette and transfer into columns: 
a. Cation column: 1 .8 mL resin. 
b. Anion column: 0.6 mL resin (may add slightly more, as resin will shrink). · 
C. Column Regeneration: 
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1 .  Cation (top column): 
a. Fill reservoir (1  0 mL) with 1M NaOH. Stir up resin (with first filling) 
b. Rinse twice with water 
c. Fill reservoir with 1 M  HCl twice 
d. Rinse twice with water, or until the eflluent is neutral. 
2. Anion (bottom column): 
a. Fill reservoir with 1 M  NaOH twice. Stir up resin with first filling. 
b. Rinse with water twice. 
D. NOTES: 
1 .  Always keep columns covered with water (when leaving overnight etc.). If 
allowed to sit overnight or longer, ALWAYS leave water over the resin bed and 
plug the outlet (Do not let the resins dry). 
2. Prior to use, stir up resins with a transfer pipette. This will minimize the 
establishment of channels through the resins. 
3. Resins have a very long lifespan. If cared for properly, > 1 00 samples can pass 
through resin without affecting performance. When resin has degraded beyond 
use the flow rate rapidly decreases to zero. 
SAMPLE PREPARATION 
A. Add the following to 50 mL centrifuge tubes: 
1 .  6 mL waterffriton-X. 
2. 2 mL whole blood or plasma. 
3. Vortex and let stand for 5 minutes. 
4. Add 4 mL of barium hydroxide; vortex; and let stand for 5 minutes. 
5. Add 4 mL of zinc sulfate; vortex; and let stand for 5 minutes. 
6. Centrifuge for 1 5  minutes at 1 5,000 x g 
B. To a second tube (50 mL - polypropylene), add the following: 
1 .  0.4 mL of WISTD. 
2. Decant supernatant from above centrifugation step. 
3. Vortex. 
ASSAY PROCEDURE 
A. Regenerate columns as above; store resins in water until ready for use. 
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B. Unplug the outlet of each column and resin should immediately be stirred with a 
Pasteur pipette. As mentioned above, this will prevent air bubbles and promote an 
even flow through the column. After water has completely drained through, place 
cation tubes on top of anion columns. 
C. Pour supernatant/WISTD mixture into top of cation column. Allow sample to drip 
through both columns simultaneously and completely. 
NOTES: 
1.  All liquid will not go onto the column at once. 
2. Pour liquid slowly and deliberately. Try to disturb the top of the resin bed as little as 
possible. May be advantageous to add initial amounts in a drop-wise manner and then · 
pour in remaining sample. 
D. Rinse empty tubes twice with 2 mL of water and pour into columns. Let each rinse 
drip through completely before adding the next. Do not collect effluent. 
E. Rinse top (cation) column once with 2 mL of water (being careful to rinse down the 
sides of column and avoid stirring up resin bed). Allow to drip through. Do not 
collect effluent. 
F. Remove the top column. Plug each coltunn and fill with water. 
G. Rinse bottom (anion) column once with 2 mL of water (being careful to rinse down 
the sides of column and avoid stirring up resin bed). Allow to drip through. Do not 
collect effluent. 
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H. Place storage vials beneath each anion column. Add 1 0  mL of 1 0  mM NaOH to each 
column and allow to drip through completely. 
NOTE: The pH of the collected liquid should be above 1 1  to minimize the loss of VF A. 
Check a minimum of 1 sample per rack (if required adjust with 10 mM NaOH). 
I. Place vials in convection oven until dry (overnight); temperature should not exceed 
50°C. 
NOTES: 
1. Do not allow samples to remain in oven for extended periods of time. 
2. Samples may also be lyophilized - collect in plastic storage vials, freeze vials, and 
then freeze dry overnight. 
J. Reconstitute with 1 mL 0.0 1 M oxalic acid and mix. 
K. Add 0. 1 mL'ofregenerated cation resin to solution. 
L. Allow sample to stand for one hour 
M. Filter solution using a 0.45 J.Lm syringe filter and transferred to a gas chromatograph 
vial and cap. 
Alternative method: Transfer sample to microcentrifuge tube and centrifuge for 5 
minutes. Pipette supernatant from tube (being careful not to disturb the resin "pellet") 
into a gas chromatograph vial and cap. 
GAS CHROMATOGRAPHY 
A. Use an J&W Scientific HP-FFAP gas chromatography column 1 0 m x 0.53 mm x 1 .0 
J.Lm capillary column (Agilent Technologies Inc.; Palo Alto, CA). 
B. Carrier gas - helium at 1 00 mL/minute (head pressure at 5 psi); flame ionization 
detector - using a Hewlett Packard model 5890 gas chromatograph, with an automatic 
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sampler model 7673A and a HP 6890 Series integrator (Hewlett Packard, 
Wilmington, DE). 
C. Injection volume = 1 f.lL (splitless injection) 
D. Oven temperature = 80°C; injector temperature = 1 80°C; detector temperature = 
250°C 
E. Run time is 30 minutes. 
F. Sample acid concentrations corrected for recovery of internal standard. 
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